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Abstract
Humans and fungi have a complex relationship, especially in regards to the many
fungal secondary metabolites that can be produced. When secondary metabolites
are toxic to animals and humans they are defined as mycotoxins. Fungi can grow on
crops pre-harvest and post-harvest, and have the potential to produce mycotoxins
which occur regularly in animal feed and food for human consumption. In high doses,
mycotoxins cause variety of problems that result in economic losses and extreme
health issues. However, multiple mycotoxins will co-occur in nature and commonly
occur in low doses. Thus chronic low daily doses of multiple mycotoxins overtime
may result in wear and tear on the body, as well as disease development later in
life (for both animals and humans). The goal of this thesis is to provide a broad
review of current literature on mycotoxins ranging in topics from their biochemical
synthesis and control to their toxicity in various organisms. To accomplish this, in
this thesis we look at mycotoxin contamination from a wide perspective and from
different disciplines in order to understand how our agricultural practices, trade and




Introduction and Brief History
Innumerable mysteries lie within the vast depths of the fungal kingdom. These lower
eukaryotes have a ubiquitous presence and represent some of the greatest diversity
known to man. The scale and range of phenotypic diversity of fungi (yeasts, molds,
and mushrooms) further drives the curiosity to understand the genotypes behind
them. A jack of all trades, they vary in size, shape, and habitat and fulfill various
roles where they act as communication network links between plants, nutrient cy-
clers, decomposers of various chemical compounds, and producers of a wide variety
of metabolites. Attempts to predict the number of species within this kingdom have
been difficult to secure with numbers ranging from several hundred thousand up
to 9.9 million [Hawksworth, 2001]. A conservative estimate of 1.5 million species
was hypothesized by the British mycologist Dr. David L. Hawksworth in the early
1990s [Hawksworth, 1991]. However, recent research and scientific evidence from
sequencing technologies and large scale environmental sampling suggest a number
of around 5.1 million [Blackwell, 2011, O’Brien et al., 2005]. The number of fungi
that have been identified is of a much smaller magnitude (≈ 70, 000), of that num-
ber just about 3,000 fungal genomes are being or have been sequenced, and over
900 genome sequences are available for research [Aylward et al., 2017]. It stands
to reason that these number estimates should continue to grow as should our un-
derstanding of fungal species diversity through the advancement and application of
improved sequencing methods coupled with genomic research.
Whether we realize it or not, the natural world is connected through fungal inter-
actions with virtually all living and dead things. Consider for example, mycorrhizal
symbiosis, which is a quintessential relationship between soil fungi and over 90%
of plant species [Allen et al., 2003, Voegele and Mendgen, 2007]. They can exist in
different kinds of medium (soil, water, and living organisms) and thrive in many dif-
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ferent environments including those that are hostile and extreme [Blackwell, 2011].
The phylum Ascomycota encompasses a wide range of fungal extremists; such as
species from genus Aspergillum and Penicillium, which have been found thriving
in subzero whether conditions on the Antarctic mountain ranges and in highly ra-
dioactive environments on board the International Space Station [Dadachova and
Casadevall, 2008]. One theory by Dr. Arturo Casadevall, a distinguished profes-
sor of molecular microbiology, immunology, and infectious disease, suggests that
there may even be a connection between selection ability of pathogenic fungi and
mammalian evolution. In a very broad sense, his theory suggests that the devel-
opmental evolution of mammals from the end of the cretaceous period to now was
possible because a fungal filter selected for mammals against reptiles [Casadevall,
2005,Casadevall, 2012]. While this may be a hard stretch, mushrooms, molds, and
yeasts have undoubtedly helped shape human existence, especially alongside agricul-
tural development. From the worship of pagan gods of harvest to the development
of antibiotics, the known or unknown impact of fungal effects permeates different
aspects of civilization and society [Dugan, 2008].
The onset of agriculture was a game changer for humans but also a wide spread
opportunity for fungus, specifically plant-pathogenic fungi such as those belonging
to the genus Claviceps, Fusarium, Aspergillum, and Penicillium. These fungi grow
on and infect cereal crops, nuts, and pulses in the field or on grains, seeds, and
fruits in storage vessels after harvest, these opportunists can cause serious problems
to food production and health around the world. One of the most studied and ex-
traordinary examples of interaction between plant-pathogenic fungi, a staple crop,
and human/animal disease is that of Claviceps purpurea, ergot alkaloids, and rye.
Rye (Secale cereale) holds an undoubtedly sordid past throughout the ages as told
through archeobotanical records and findings. Indigenous to Anatolia, rye had hum-
ble origins as a weed that migrated across Europe with other cereal (barley, oats,
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and wheat) crops used for cultivation during Neolithic times [Hillman, 1978,Behre,
1992]. Its ability to persist in acidic soils with poor drainage and unfavorable frosty
climate garnered the plant a competitive edge in some regions, however, evidence
for its initial cultivation as a crop did not arise until after the introduction of new
harvesting methods and technology in the early pre-Roman Iron Age; tools like
sickles and the Gallo-Roman machine that harvested the stem near the ground and
had less selectivity against weeds like rye [Behre, 1992]. Over the course of several
centuries, rye production gradually expanded throughout Europe and Russia and
became a highly cultivated, permanent crop thus establishing itself as a dietary and
economic staple for the growing populations of the medieval period [Behre, 1992].
So what is the problem? Part of the problem is in ryes susceptibility to the fungus
Claviceps purpurea. Unlike other self-pollinating (cleistogamy) crops such as wheat
or barely, rye is a cross-pollinating (xenogamy) crop and thus their florets must
be opened, which also allows for easy infection by ascopores of Claviceps purpurea.
Cleistogamy is an effective avoidance mechanism which reduces the potential risk
of ergot infection [Miedaner and Geiger, 2015]. The ergot (sclerotia) which form on
florets after infection, can fall off during winter and remain dormant until conditions
are optimal (hard frost) and germination begins again [Behre, 1992]. Additionally,
Claviceps purpurea is biotrophic (needs to keep rye host alive), and can hi-jack the
plants auxin/cytokinin homeostasis by directly secreting its own auxin/cytokinin
like molecules that help it facilitate infection and go unnoticed by the plants im-
mune response [Oeser et al., 2017]. Claviceps spp. can infect a wide range of hosts
within the Poaceae grass family, specifically the entire subfamily of Pooideae (which
includes all major cereals) and many true grass species within the subfamily Arundi-
noideae [Pažoutová et al., 2000]. The climactic distribution of Claviceps purpurea
favors temperate regions but can also be found from the Arctic to subtropical re-
gions. They are not specialized for hosts but by climatic conditions [Pažoutová
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et al., 2000,Miedaner and Geiger, 2015].
Historians and researchers have found various religious, medical, and cultural
records (texts, chronicles, and painting) from western Europe that depict a rather
unbelievable scene of dry gangrenous dismemberment, mass hysteria, formication
(the sensation of insects crawling under your skin) and the dance macabre [Nemes,
2002, Nemes and Goerig, 2002]. The disease responsible, ignis sacar (holy fire, St.
Anthonys Fire, or Kriebelkrankheit) is more commonly known as ergotism and is a
result of consuming the ergot sclerotia on rye grain that has been infected by Clav-
iceps spp. Outbreaks and epidemics occurred periodically throughout the middle
ages and especially in times preceding poor harvests and famines, but it was not
until the high middle ages and on that widespread devastation due to ergot poi-
soning was recorded [Nemes, 2002, Alm and Elvev̊ag, 2013]. Regions west of the
Rhine (i.e. France and Spain) had more cases of gangrenous ergotism, while eastern
regions (Germany) had convulsive ergotism [Nemes, 2002,Alm and Elvev̊ag, 2013].
People of all socioeconomic classes could be effected, especially the poor and pil-
grims (peregrinos) on religious journeys to Santiago de Compostela [Nemes, 2002].
It was the affliction of the latter which spurred the development of the Antonite-
Hospitals run by monks in the clerical order belonging to the lay fraternity of St.
Anthony during the 11th and 12th centuries. These Antonite-Hospitals were solely
dedicated to curing ergotism, and therefore they only admitted those with certain
diagnosis of the disease so that they could miraculously cure it by administering
foods free or ergot, herbal wines with potentially vasodialating and analgesic ca-
pacity, and Antonites-balsalm (a trans-dermal therapeutic system) [Nemes, 2002].
Over the next few centuries, the Antonites became one of the most impressive and
extensive international medical welfare systems made up of hundreds of monasteries,
hospitals, churches, and hostels/hotels located critical points (i.e. mountain passes
and bridges) along the different paths leading to Santiago [Nemes, 2002, Alm and
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Figure 1.1: Puente Románico de Puente la Reina. Medieval Bridge in Puenta la
Reina, Navarra, Spain along the Camino de Santiago with a modern day pilgrim.
Photo credit Isobel Pribil.
Elvev̊ag, 2013]. Following the 16th century, the St. Anthony order began to grad-
ually disintegrate out of existence in the late 1700s, some researchers suggest that
they were integrated into the knights hospitallers while others suggest that it was in
part due to the debauched behavior of the monks [Nemes, 2002, Alm and Elvev̊ag,
2013].
Ergotism became increasingly prevalent after the 16th and 17th centuries which
coincided with significant global cooling and the onset of the Little Ice Age; and
knowledge/information about the cause of holy fire became well known which was
slightly remedied by preventative agricultural practices (switch to potatoes, field
burning after harvest, cleaning grain) [Nemes, 2002, Miedaner and Geiger, 2015].
However, ergot poisoning still persisted, Alm & Elvev̊ag 2012 reviewed transcripts
from Norwegian witchcraft trials in the late 1600s for possible incidences by com-
paring known symptoms with comments referring to witches cursing other peoples
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bread, witches cursing peoples limbs to fall off, the feeling of ants crawling under
skin, demonic convulsions, paralysis, and of course burning and freezing sensations.
It has also been suggested to be the cause of witch epidemics in England and Salem,
Massachusetts, however, not enough conclusive evidence or cursed bread has been
uncovered yet [Alm and Elvev̊ag, 2013]. Several more outbreaks occurred across
Western and Eastern Europe in the 1700s painting a rather perilous picture of mor-
bid devastation and social revolutions [Alm and Elvev̊ag, 2013, Nemes, 2002]. In
the early 1900s the ergotamine culprit was isolated and since over 50 alkaloids have
been studied, these are broken up into three groups: i) clavines, ii) lysergic acid
amides, and iii) peptides. Different kinds of alkaloids are produced by the endo-
phythic Epichloë spp. and the parasitic Aspergillus and Penicillium spp. ( [Klotz,
2015]). Ergot alkaloids are structurally similar to serotonin, norepinephrine, and
dopamine (common tetracycline ergoline ring) so they have agonistic/antagonistic
behavior or neurotransmitter receptors depending on the dose or the fungi that pro-
duces them, as well as the ability to bind to beta-adrenergic receptors; they can
affect the central nervous system, the endocrine system and reproductive function,
the immune systems, and have been shown to cause fat necrosis in the intestines
of livestock [Klotz, 2015]. Its use in medicine has been been seen for hundreds
of years beginning with midwives for inducing childbirth and stopping postpartum
hemorrhage around 350 AD, and is currently used today to treat neurological and
endocrine disorders [Burn, 2000,Micale et al., 2006,Miedaner and Geiger, 2015,Alm
and Elvev̊ag, 2013]. Despite strict regulations in place for food and feed; livestock
are regularly effected. In the US alone, ergot alkaloid poisoning costs the livestock
industry $860 million a year [Coufal-Majewski et al., 2016].
Not to be overshadowed, Aspergillus spp. infect nuts, maize, other grains in the
field as well as various commodities in storage, they are capable of producing afla-
toxins (AF) A.7, sterigmatocystin (STE), cyclopiazonid Acid (CPA), ochratoxins
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(OTA) A.6, and clavine alkaloids [CAST, 2003]. In 1998, aflatoxin contamination
in the southern USA was estimated to have resulted in $85 million to $100 mil-
lion in losses in Arkansas, Louisiana, Mississippi, and Texas [Abbas et al., 2012].
Penicillium spp. primarily grow in storage and can produce OTA, citrinin (CIT)
A.3, patulin (PAT) A.5, CPA, and various other toxins that are found in special
cheeses [Hymery et al., 2014]. Fusarium spp. of fungi produce fumonisins (FB1,
FB2, and FB3) A.2, type a and b trichothecenes (i.e. DON and T-2) A.4, zear-
alenone (ZEA) A.8, and various emerging mycotoxins such as enniatins (ENN) and
beauvericin (BEA) A.9. Some of these have their own diabolical histories and have
been responsible for multiple outbreaks of disease and death throughout the 21st
century in animals and humans [CAST, 2003]. Clearly, mycotoxins have always
been around and our exposure to them is not necessarily new, however, there are
so many things that we do that can exacerbate the problem without realizing it.
For example, our selective breeding for various features in livestock and poultry
(i.e. dairy cows that yield more milk or poultry with increased growth rate) to
accommodate growing demands of consumers have resulted in serious metabolic
and immune disorders, which in turn could make them more sensitive to mycotoxin
exposure [Scheele, 2011, Rauw et al., 1998]. Also all the other chemicals and phar-
maceutical compounds that we are exposed to could have interacting effect, Thus,
those low background doses that seem insignificant, over time may actually be bigger
problems in combination with other agriculture, diet, lifestyle, and genetic related
factors.
For humans and animals, it would be beneficial to reduce the intake of and
exposure to mycotoxins via dietary contamination. Though it is not possible to
completely eliminate mycotoxin occurrence, there are methods for management,
mitigation, and prevention that may provide an effective barrier against the negative
effects on agricultural production and health. Consistent research and biomonitoring
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Table 1.1: Major Mycotoxigenic Fusarium spp. in products and mycotoxins pro-
duced (adapted and modified from [CAST, 2003]).
is necessary to discern the effect of chronic low level mycotoxin exposure so that the
public can be informed and educated as to help make consumer choices that drive
market and regulatory changes. For the purpose of this paper, emphasis will be
placed primarily on AFB1, OTA, FB1, ZEA, and DON.
1.1 Fungal genomics and host-plant interactions
To date, there are more than 400 mycotoxins that have been identified [Berthiller
et al., 2007, Škrbić et al., 2012, Li et al., 2018, De Mets et al., 2018]. Primary
metabolism and metabolites are essential for normal growth, development, repro-
duction of their producing organisms, and are the precursor molecules for sec-
ondary metabolism; therefore, secondary metabolites undergo production during
limited/specific phases of the fungal life cycle [Keller et al., 2005,Bennett and Bent-
ley, 1989]. Interestingly enough, Keller & Hohn 1997 have reported that genes
required to for a fungus to express a fungal secondary metabolites are usually clus-
tered together on a single chromosome [Keller and Hohn, 1997].
Because many different organisms (even those that are phylogeneticaly unre-
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lated) share similar secondary metabolic capabilities, it is thought that these clusters
can arise through Horizontal Gene Transfer (HGT), in which the DNA is transmitted
from one genome to another. A study conducted by Wisecaver et al. 2014, investi-
gated 208 different fungal genomes and 247, 202 enzyme encoded genes responsible
for a variety of metabolic reactions to asses the involvement of gene innovation
strategies such as gene duplication (GD) and HGT in the evolution of clustered
and non-clustered metabolic pathways. Their results showed that, both HGT and
GD give rise to clustered metabolic diversity, however GD was the more common
process [Wisecaver et al., 2014]. This makes sense, especially in regards to bioactive
compounds that imbue some kind of selective advantage. The physical linkage of
gene and clustering of genes is an efficient system because i) it reduces the amount of
regulatory steps in the biosynthetic machinery, ii) Chromatin based mechanisms, hi-
stone acetylases, deacytelases, methlytransferases control fungal SM biosynthesis by
placing repressing chromatin domains on SM clusters during primary metabolism so
that no SM production occurs with primary metabolism, then replacines will repro-
gram the chromatin landscape to for transcriptional activation [Gacek and Strauss,
2012]. Secondary metabolism produces a diverse array of complex chemical com-
pounds through specialized biosynthetic pathways regulated by transcription factors
(TFs) that are activated in response to some biotic or abiotic stimuli; these can be
global regulators or pathway specific [Trienens and Rohlfs, 2012]. Global TFs that
Table 1.2: Metabolic Gene Clusters for Mycotoxin in Select Plant-Pathogenic Fungi.
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correspond to environmental signals are i) PacC that responds to pH, ii) CCAAT-
binding complex CBC that responds to iron, iii) AreA that responds to nitrogen,
iv) the Velvet complex which responds to light, and v) CreA that responds to car-
bon [Woloshuk and Shim, 2012]). Cluster specific TFs are sequence specific binding
proteins like zinc fingers and luecine zippers [Woloshuk and Shim, 2012]. One of
the most important things to realize about mycotoxin gene clusters is that they are
co-regulated, thus a shared regulation method means that multiple types of myco-
toxins can be expressed together, especially if they share share the same pre-cursor
molecule (i.e. Acetyl-CoA and the joint expression of OTA and CIT) [Geisen et al.,
2017]. For the most part, mycotoxins are thought to help fungal strains adapt to
their environment and thus by acting as i) virulence factors (i.e. DON), ii) antibiotic,
iii) antioxidant, and iv) mineral storage [Geisen et al., 2017]. In addition to external
factors, internal host factors may also play a large role in mycotoxin accumulation.
Metabolites produced by the host or other organisms within the host could poten-
tially alter the mycotoxin biosynthesis pathway. Kumar et al., 2017 describe two
possible host mechanisms that could modulate fungal mycotoxin cluster activation
and accumulation: i) pathogen-modified nutritional factors present in the host that
become precursors for activation of the mechanism of mycotoxin production and ii)
natural chemical factors present in the host that directly modulate the transcrip-
tion factors that induce mycotoxin production” [Kumar et al., 2017]. Plants are able
to both metabolize (with Phase I and II reactions) and compartmentalize (Phase
III) mycotoxins. Phase I reactions may convert mycotoxins into phytotoxic com-
pounds, while phase II conjugation reactions reduce its toxicity, then phase III will
sequester the the glucose or GSH conjugated mycotoxins into vacuoles or bind them
irreversible to the cell wall [Berthiller et al., 2013]. These are effectively known as
’masked’ mycotoxins, and they they may no longer be toxic to the plant, but upon
ingestion in animals and humans can be transformed back into the parent compound
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and once again be toxic [Berthiller et al., 2013].
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Chapter 2
Control, Prevention, and Detection
Mycotoxins circulate through the environment and contaminate various resources.
Secondary metabolites are allelopathic, meaning they have a direct or indirect, harm-
ful or even beneficial effect on another organisms from the biochemicals they pro-
duce [Keller et al., 2005]. It is unrealistic if not impossible to eliminate mycotoxins,
therefore, more research about a mycotoxin role in different ecological and agricul-
tural settings, occurrence under different conditions, and its interactions with other
organisms is necessary. The effect of mycotoxins on some of these ecosystems re-
mains largely unknown, however, it is important to understand how, why, and in
what forms are they getting there in order to mitigate undesirable outcomes to the
best of our ability. With this knowledge we can help prevent, control, and decon-
taminate mycotoxins in our environment. Figure 2.1 represents of flow diagram of
how mycotoxin move through the environment, from this we can see potential ar-
eas where mycotoxins can be monitored, identified, and perhaps prevented to some
extent.
2.1 Pre-harvest Control and Prevention
2.1.1 Soil Tillage and Crop Rotation
There are many kinds of soil tillage management practices: conservation tilling (no-
till, reduced-tilling) and conventional tilling [Conservation Technology Information
Center, 2008,Towery and Werblow, 2010]. Tillage systems effectively alter the chem-
ical, biological, and physical property of a soil. The degree of physical mixing of a soil
can alter the distribution of nutrients, microbial communities, and complexity of a
substrate [Towery and Werblow, 2010]. In conservation tilling systems, 30% or more
of crop residue is left on the surface after planting, this allows for high accumulation
of organic matter and can influence the type of microbial organisms that dominate
soil. It also helps reduce nutrient loss, prevent erosion, and help with water reten-
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Figure 2.1: The green boxes are mycotoxin producing fungi, the blue boxes repre-
sents influencing environmental factors, pink boxes are other interacting organisms,
yellow boxes are steps or areas, boxes with purple outline indicate areas or organisms
that can potentially alter the mycotoxin compound (i.e. conjugation, degradation,
or detoxification). The blue sing arrows show factors can influence fungi, the red
double arrows show competition between organisms, and the black single end or dou-
ble end arrows represent the flow of mycotoxigenic fungi and mycotoxins (modified
from [Abid, 2012]).
tion in the soil [Towery and Werblow, 2010]. In conventional tilling (deep tilling,
sub-soiling) systems, less than 30% of the plant residue is left on the surface and is
instead plowed/buried into the soil [Conservation Technology Information Center,
2008,Towery and Werblow, 2010]. Some research studies suggest that burying con-
taminated detrital matter in order to reduce the spread of plant pathogenic fungi to
the next crop may decrease the spread and subsequent mycotoxin contamination,
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however, there has yet to be any significant differences between the incidence of
certain mycotoxins and the use of conventional versus no till management [Marocco
et al., 2008,Ariño et al., 2009].
The high accumulation of organic matter and debris associated with no-till can
influence the microbial community ecology by favoring fungal decomposers [Wid-
strom et al., 2003,Angle, 1987a,Angle, 1987b]. A study conducted by Sipilâ et al.,
2012, looked at cross-site microbial communities under different tillage regimes (till
and no-till) and the effect on Fusarium fungistasis in soil and the extent at which soil
conditions can inhibit fungal germination and growth. They looked at bacterial and
actinobacterial markers (16rRNA) in terminal restriction fragment length polymor-
phism (T-RFLP), phospholipid fatty acid (PLFA) analyses, and conducted fungis-
tasis biotests on the model organism Fusarium culmorum to elucidate predictions
based on long-term tillage practices and link microbial markers (16S rRNA T-RFLP,
Actinobacteria-specific T-RFLP, and PLFA) with soil fungistasis. It was found that,
microbial biomass, fungal biomass, and C/N ratio all correlated with the strength
of fungistasis. In general, it is no specific management strategy or bacterial strain
but the higher activity in the soil that had had greater impacts on plant pathogen
suppressiveness due to the high microbial biomass, increased interaction and com-
petition, and greater amount of resources to support these interactions [Sipilä et al.,
2012,Weller et al., 2002].
The FAO/CAC recommend no-till management practice for reducing mycotoxin
contamination in crops [Widstrom et al., 2003, Codex Alimentarius Commission,
2003]. Though it may seem counter intuitive, because plant residues can act as
a reservoir for mycotoxigenic fungi, it may have positive effect on reducing my-
cotoxin concentration by i) limiting water and nutrient loss from soil which helps
alleviate plant stress and subsequent fungal infection and mycotoxin production, ii)
encouraging higher microbial (bacteria and fungi) soil activity at the surface layer
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that strengthen soil fungistasis [Widstrom et al., 2003, Sipilä et al., 2012, Angle,
1987a,Angle, 1987b].
Crop rotation is an advantageous agricultural practice because it has the poten-
tial to limit pathogen inoculation, reduce soil erosion, diversify the nutrient use so
there is time for them to be replenished. GAP recommend that highly susceptible
crops should not be planted consecutively nor should they be rotated with another
susceptible crop [Codex Alimentarius Commission, 2003]. Peanuts, maize, sorghum,
and small grains (wheat, oats, rye) are amongst the more susceptible crop types. A
better rotation crop would be one that is significantly less susceptible like soybeans
or forage crops [Codex Alimentarius Commission, 2003].
Abbas et al., 2012 studied the implications of mycotoxin (aflatoxin and fumon-
isin) production by soil Aspergillus flavus in different corn-soybean rotation systems
in the Mississippi Delta region [Abbas et al., 2012]. Over four years (2005-2008),
they planted and studied 8 different corn and soybean rotations that were under
conventional tillage (common practice for sandy soils of southeastern coastal plains)
and the resulting A. flavus soil populations and contamination [Widstrom et al.,
2003]. Soybean is a poor substrate for aflatoxin production, possibly due to low
C/N ratio or the greater amount of nitrogen than carbon [Shotwell et al., 1978,Ab-
bas et al., 2012]. The results of their study and other similar studies indicated that
i) soybeans had greater colonization by non-aflatoxigenic isolates compared to corn
which had a greater specificity for aflatoxigenic strains, ii) rotating soybean and
corn helped to reduce A. flavus propagules in soil thus reducing potential for corn
inoculum and aflatoxin production, iii) rotating with soybeans also helps reduce the
production and contamination of fumonisins in corn [Abbas et al., 2012,Abbas and
Bosch, 1990].
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2.1.2 Cultivar Selection and Breeding
Selecting the right cultivars will help to reduce mycotoxin accumulation through
various mechanisms that allow the plants to either resist infection and growth from a
plant pathogenic fungi or suppress fungal production of a mycotoxin after infection
[Brown et al., 1999, Warburton and Williams, 2014]. There are several ongoing
breeding programs for many crops such as the UDSA-ARS Genetic Enhancement of
Maize (GEM) project which partners and cooperates with many public and private
industries and researchers from around the world [USDA-ARS et al., 2018].
Maize and wheat are some of the most intensely studied and developed geneti-
cally modified crops and as a result have commercially available cultivars [Warburton
and Williams, 2014]. Conventional approaches revolve around selection for breed-
ing based on observed variation and controlled mating, while modern/advanced
techniques implement various gene modification and recombination technologies
[Podevin et al., 2012, Onaga and Wydra, 2016]. Screening for desirable traits of
resistance can be done through inducing infection epidemics on different cultivars,
where the superior phenotypic trait can be assessed visually (assisted by digital imag-
ing analysis) or with the help of molecular markers and genetic sequencing [Steiner
et al., 2017]. There is no singular trait that controls host resistance to fungal infec-
tion and mycotoxin accumulation [Steiner et al., 2017, Milgroom et al., 2014]. The
traits are complex, quantitative, and have a high degree of Gene x Environment
interaction [Milgroom et al., 2014].
2.1.3 Planting/Harvesting, Irrigation, Fertilization, and Plant Density
The dates at which seeds are planted and harvested vary by region, crop type,
favorable weather conditions to plant/harvest, and a variety of other human factors
(see Table 2.1). It is generally recommended to adhere to timely planting and
harvesting as to avoid unfavorable disease development at susceptible times (i.e
anthesis) or prolonged disease exposure by late harvesting, which has been found to
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Table 2.1: Planting and harvesting dates for different crops in the US. (data from
[USDA-NASS, 2010]).
severely increase mycotoxin contamination levels and other negative impact on the
crop.
Parsons & Munkvold, 2012 conducted a two year field study on Fusarium ear
rot (FER) maize caused by Fusarium verticillioides in 6 different locations in the
US (Garden City, KS; Johnsotn IA; Tifton, GA; Union City, TN; Waimea, HI;
and Woodland, CA) and the subsequent contamination of fumonisins [Parsons and
Munkvold, 2012]. In order to determine what factors play a role in disease severity
and mycotoxin contamination, they evaluated cultural practices such as planting
date and hybrid type as well as location and environmental factors such as rainfall,
temperature, insect populations, and symptom specific contamination. The results
of their studies illustrated that when planted early (relative to the date instruc-
tions indicated for the hybrid plant types for each region) there was a lower disease
severity, less FB1 levels, and less insect damage. Additionally, locations with dry
conditions and increased insect population levels (thrips) were at greater risk for
fumonisin contamination.
In comparison to corn grown in the Midwest, corn from the southeastern U.S. has
been reported to have higher contamination levels of of aflatoxins from Aspergillus
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flavus infection [Tubajika et al., 2000]. The higher temperatures and greater humid-
ity in some southern states, such as Louisiana, could consequently have increased AF
levels. A study by Tubajika et al., 2000, experimented with three different planting
dates (March, April, and May) and four different harvest moisture (15, 20, 25, and
30%) for a corn hybrid (Pioneer Brand 3167) [Tubajika et al., 2000]. Ultimately,
their results indicated that an early March planting date followed by harvesting at
a moisture percentage below 20% would be a good plan of action for reducing AF
contamination.
Competition for resources permeates every aspect of life, and especially for
plants. Each plant is competing for space, nutrients, water, and light. When these
resources become limited, stress conditions in the plants can occur and have neg-
ative impacts. Ways in which these stressors can be amended are through proper
seeding ratios for plant density, weed control, irrigation, and fertilization [Ariño
et al., 2009, Parsons and Munkvold, 2012]. Crop production must find a balance
for plant density that allows them to obtain high yields without compromising the
quality or inducing stress conditions that can lead to fungal infection and mycotoxin
production. Plant density is affected by weeds that are present in the field, there-
fore effective removal and control strategies should be considered. Environmental
conditions of the area (i.e. drought) will also determine the acceptable plant den-
sity. Even hybrids that are high-density tolerant can experience yield reductions and
mycotoxin accumulation under severely stressed conditions [Tokatlidis et al., 2010].
How this in turn affects fungal growth and mycotoxin production is dependent on
many things ranging from host-species type to temperature. However, the general
idea is that greater stress conditions lead to plant disease susceptibility, especially
those that favor fungal growth and mycotoxin production.
With regards to irrigation in plants, it is important to adhere to proper timing
and the methods used for irrigation. There is much debate as to whether there is any
18
significant effect of irrigation on fungal growth and mycotoxin production, but some
research has shown that irrigation can help improve abiotic stress conditions [Codex
Alimentarius Commission, 2003]. When drought and heat stress occurs irrigating
can help relieve plant stress, however, different host-species and fungi will have
different responses to the amount and timing of the water application. The use of
drought tolerant plants such as pearl millet instead of corn in extremely dry land
environments is also advised for reducing water stress in plants [Wilson et al., 2006].
For some fungi, dry weather conditions can cause sporulation in crop debris, and
when followed by rain the conidia can be spread by splashing. Sprinkle irrigation
can have the same effect and can also cause splash dispersal [Aldred and Magan,
2004a,Ariño et al., 2009]. Studies have shown that height of host plant is an indicator
for their susceptibility to fungal infection and disease severity; short plants are
more likely to be inoculated by splash dispersal during flowering or grain filling
stages [Ariño et al., 2009]. Therefore, the the type of irrigation used during anthesis
should be one that minimizes potential conidia dispersal. For maize, water stress
mitigation has been shown to reduce fumonisin contamination and infection from F.
verticilloides and aflatoxins from A. flavus, however, some suggest that the reduction
of temperature in the crop canopy from irrigation, may have a considerable affect
in limiting the production of aflatoxin [Torelli et al., 2012, Widstrom et al., 2003,
Fortnum, 1987].
Nitrogen fertilization also has mixed results with regards to its ability to sup-
press, hinder, or encourage fungal infection and mycotoxin production [Codex Al-
imentarius Commission, 2003]. Nitrogen fertilization can affect crop canopy by
increasing canopy density that then can lower temperature and indirectly preserve
humidity by reducing light penetration and wind speed [Hofer et al., 2016]. Hofer
et al., 2016 conducted a study on nitrogen fertilization and its effect on FHB in
spring barley. Both field and green house experiment plots were subjected to soil-
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inoculation treatments with F. culmorum and F. avenvceum as a way to simulate
increased pathogen pressure; fungal genomic DNA was isolated and then quanti-
fied with quantitative realtime polymerase chain reaction (qPCR) while mycotoxins
(DON and ENN) were quantified using liquid chromatography tandem mass spec-
trometry LC-MS/MS analysis [Hofer et al., 2016]. In unfertilized control plots, they
found higher amounts of DNA and mycotoxins in the barley compared to those that
were fertilized. Other studies have found increased FHB and mycotoxin production
in wheat from increased nitrogen input [Lemmens et al., 2004]. The difference is
nitrogen effects could be the result of many factors involving the type of nitrogen
used, environmental conditions, host species, and much more.
2.1.4 Chemical and Biological Control (Weeds, Insects, and Fungi)
Weed control is necessary for many reasons, they can act as an inoculum source for
fungi and can spread diseases to crops [Widstrom et al., 2003,Mourelos et al., 2014].
They also compete with the crop plants for resources which can create stressful
conditions. How farmers choose to deal with weeds has a variety of impacts and a
farmer must consider the best method for their region, crop type, financial means,
etc. There are several different weed management strategies for weed control with
different crop types, each have pros and cons; i) mechanical removal of weeds is labor
intensive and disturbs soil possibly leading to erosion and loss of water; ii) flooding
fields can be effective for suppressing weeds in rice paddy fields but may also impact
root branching which in turn might affect symbiosis with arbuscular mycorrhizal
fungi (AMF); iii) chemical treatment with herbicides such as glyphosate are the
most wide-spread and most used weed control strategies but can impair plant defense
mechanism while increasing the virulence of pathogen populations [Widstrom et al.,
2003,Johal and Huber, 2009].
Insect management is critical during pre-harvest, post-harvest, and storage/
transportation. Fungal infection can be exacerbated by physical damage from feed-
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ing invasion and act as a vector for infection. The severity of Fusarium ear rot (FER)
in maize and Fusarium head blight (FHB) in wheat, has been linked to the severity
of insects/pests such as corn borers, cutworms, ear worms, and thrips [Dmello et al.,
1999,CAST, 2003]. The benefit of insecticides is the indirect reduction of mycotox-
ins by reducing the insect population and thus eliminating any potential damage
they could inflict on the crop. As a bonus, however, some insecticides (i.e. naled,
an organophosphate) have been shown to directly reduce mycotoxin production by
reducing fungal growth as well [Dmello et al., 1999].
In order to curtail fungal infection in crops pre-harvest, fungicides can also be
helpful. However, they can also cause many other issues. Therefore, the use of
fungicide as a management tool requires careful consideration and should only be
considered as part of an integrated management plan and never as a sole control so-
lution. Following manufacturer recommendations and literature about appropriate
application and timing will help with obtaining the best results and reducing disease
severity and mycotoxin incidence. Application of fungicides is recommended at an-
thesis (flowering) when a plant is most susceptible to infection [Codex Alimentarius
Commission, 2003].
Factors that can reduce a fungicides efficacy or increase undesirable results are
i) selection for resistance to fungicide, ii) stimulation of mycotoxin production, iii)
differential reactions of crops/hybrids [CAST, 2003, Schmidt-Heydt et al., 2012].
The Fungicide Resistance Action Committee (FRAC) is dedicated to coordinating
with/between different companies that market fungicides in the hopes to implement
appropriate strategies and solutions for minimizing the risk of fungicide resistance
and disseminating vital information on the chemistry, resistance, mechanisms, and
management of fungicides [FRAC, 2007]. Selection for fungicide resistance geno-
types depends on many factors and can be managed by adjusting the amount and
frequency of application or through the use of fungicide mixtures (alternating with
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different types) [Milgroom et al., 2014].
Fungicides that are recommended for use with pre-harvest plant pathogens are
azole chemicals. They have been studied extensively under both in vitro and field
conditions for Fusarium spp. and Aspergillus spp. [Magan et al., 2011,FRAC, 2007].
Azole fungicides (FRAC CODE 3) are demethylation inhibitors (DMI), their mech-
anism of action is to inhibit sterol biosynthesis in membranes and are considered a
medium risk for fungicide resistance [FRAC, 2007]. Mateo et al., 2017 assessed the
ability of azole fungicides (prochloraz, tebuconazole, and prochloraz+tebiconazole)
to control A. flavus growth and AF production in maize and on YES (yeast-extract-
sucrose) solid medium under different temperature (25 and 37◦C) and aw (0.95 and
0.99) conditions [Mateo et al., 2017]. Prochloraz was the most efficient at reduc-
ing A. flavus growth and had the lowest AF production, and all fungicides were
more successful at higher water activity (0.99). It was also shown that at a certain
temperature (25◦C), aw (0.99), and the fungicide mixture prochloraz + tebucona-
zole (0.01±0.005 mg/L) at low doses enhanced AF production [Mateo et al., 2017].
Reconfirming that sub-inhibitory levels fungicides may actually promote mycotoxin
production because of any stress put on the species by the fungicide [Dmello et al.,
1999, Edwards and Godley, 2010, Mateo et al., 2017]. The results of their study
exhibited information on the interaction between azole fungicide treatment and en-
vironmental factors. This is especially important to understand given the changing
climate conditions because increasing temperatures can cause additional environ-
mental stress that can result in mycotoxin production as well as drive an ecological
shift towards more xenotolerant species [Magan et al., 2011,Mateo et al., 2017].
Fungicides such as quinone outside inhibitors (QoI) are not recommended for
treatment on Fusarium spp. as they tend to increase DON production in wheat [Ell-
ner, 2005]. QoI or strobilurins (FRAC CODE 11) have multi-site actions, inhibit
mitochondrial respiration and disrupt the electron transport chain and ATP pro-
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duction in fungi [FRAC, 2007]. They are high risks for fungicide resistance [FRAC,
2007]. Additionally, they have a greening-effect on plants where they delay senes-
cence until later on in the season [Dmello et al., 1999, Fromme et al., 2017, Ellner,
2005]. Ellner et al., 2005 found that applications of QoI fungicides on field tests
before blossom resulted in increased DON contamination compared to untreated
controls [Ellner, 2005].
Makers of certain fungicides have been shown to advertise their product as a pro-
phylactic treatment, even in the face of low pathogen pressure for disease, because it
might help increase water retention and nitrogen use efficiency and in turn produce
a higher yield; however, Fromme et al., 2017 tested this on sorghum in the absence
of pathogen pressure and found that there was no effect on overall plant health or
yield [Fromme et al., 2017]. In an effort to reduce the use of chemical pesticides
several biological control methods have been developed, which includes resistant
cultivars of plants. Ideally, these microorganisms, bioactive metabolites (i.e. pheno-
lic compounds and antioxidants), or essential oils can help to control infection and
reduce mycotoxins by several means including competition for nutrients, detoxifi-
cation of mycotoxins, and much more [Tsitsigiannis et al., 2012]. Microorganisms
that have antagonistic ability towards toxigenic fungal species have been evaluated
based on their ability to reduce mycotoxin contamination [Köhl et al., 2011]. Afla-
toxin and ochratoxin production by Aspergillus spp. can be controlled by bacteria
(lactic acid bacteria and Bacillus spp.), nontoxigenic Aspergillus strains or strains
that can degrade mycotoxins, and yeasts [Tsitsigiannis et al., 2012, Varga et al.,
2010]. Mycotoxins (trichothecenes, fumonisins, etc.) produced by Fusarium spp.
can be controlled by bacteria (Bacillus, Paenibacillus, Pseudomonas, and Strepto-
myces spp.), non-toxigenic Fusarium spp., and yeast [Tsitsigiannis et al., 2012].
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Table 2.2: Storage fungi and temperature and aw parameters that promote their
growth and mycotoxin production (adapted from [Paster et al., 1995, Aldred and
Magan, 2004b,Mannaa and Kim, 2016,Zong et al., 2015,Fleurat-Lessard, 2017]).
Fungi Mycotoxin Temp. for growth /mycotoxin prod. aw growth/myotoxin prod.
Fusarium graminearum ZEA -/25-30 /0.98
Fusarium spp. FB1 30/15-30 0.88/0.93
Fusarium spp. DON 20-25/29-30 0.90/0.93
Aspergillus flavus AFB1 35/28 0.78 - 0.85/0.84-0.99
Aspergillus parasiticus AFB1 35/33 0.84-0.95/0.99
Aspergillus ochraceus OTA -/30-37 0.77/0.85
Penicillium verrucosum OTA -/25 0.80 - 0.95/0.83-0.95
Penicillium expansum PAT -/23-25 0.82 -0.84/0.99
2.2 Post-harvest and storage control/prevention
Good Hygiene Practices (GHP) begin with proper harvest protocol and follow
through with good storage and good manufacturing practices (GSP and GMP re-
spectively) [Codex Alimentarius Commission, 2003,CAST, 2003]. During the post-
harvest and storage stage the predominant mycotoxigenic fungi shift to Aspergillus
spp. and Penicillium spp.; this ecological succession can be attributed to dramatic
difference in storage environment conditions [Lacey et al., 1980,Aldred and Magan,
2004b, Mannaa and Kim, 2016]. Lacey et al., 1980 classified the successional traits
into four eco-physiological groups i) hygrophillic (i.e. Fusarium spp. and Claviceps
spp.), ii) cryotolerant (i.e. Penicillium spp.), iii) thermotolerant (i.e. Aspergillus
flavus and A. nidulans ), and iv) xerotolerant (i.e. Aspergillus spp.) [Lacey et al.,
1980]. Some of the factors that determine the shift in species depend on tolerance to
low oxygen, low aw, and low temperatures (see Table 2.2) [Mannaa and Kim, 2016].
In addition to the production of mycotoxins, fungal activity in stored grains
can cause discoloration, dry matter losses (carbohydrates used as energy source),
heating, lipid and protein degradation, emission of volatile metabolites and odors,
decrease quality and germination viability [Aldred and Magan, 2004b]. Some of
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these can act as indicators and can be easily detected in storage fungi.
2.2.1 Harvesting and Storage
Leading up to harvest time, simple steps can be taken to reduce excessive crop
contamination by i) equipment care and maintenance, ii) pre-harvest field monitor-
ing, and iii) proper drying/cleaning procedures [CAST, 2003]. All field equipment
that has any contact with seeds, plants, or soil should be regularly cleaned to re-
duce spreading fungal contaminants and maintained to ensure proper function to
avoid delayed harvests or damage to crop. Delayed harvest times, damaged ker-
nels, and contact with soil are associated with increased risk of fungal growth or
mycotoxin production. Pre-harvest field monitoring, sampling, and testing to lo-
cate pocket/areas that are infected (several methods will be discussed in the next
section) can help reduce the spread of fungal infection and mycotoxin production
because they can be harvested separately. Additionally, monitoring for water con-
tent, humidity, and temperature in the environment or within the crop canopy can
have huge effects on mycotoxin production [Fleurat-Lessard, 2017]. After harvesting
at a low moisture content, grains should be cleaned, separated based on different
characteristics (i.e. market quality, moisture content, crop type, or protein content),
and all grain should be dried properly to ensure moisture content levels are below
that which is favored for fungal growth and mycotoxin production [Fleurat-Lessard,
2017].
In accordance with good hygiene practices, all containment devices need to be
cleaned before and after use and all storage or transportation facility for food
commodities should be well maintained to prevent for leaks, pests, and fungal
growth [CAST, 2003]. Good storage practices suggest that conditions are cool, dry,
and well ventilated, and the moisture content should not exceed 14.5% [Mannaa
and Kim, 2016]. A large part of best (good) practices is having proper documen-
tation, which can help officials, producers, and consumers keep track of potentially
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hazardous products and to allow for interventions, if hazardous products are found.
Proper documentation can also ensure that the crop meets any regulation compli-
ance necessary for different areas [Codex Alimentarius Commission, 2003].
2.2.2 Detection Methods and Sampling
In order to monitor fungal activity and mycotoxin production, appropriate sam-
pling methods and analytical testing methods must be used. For on-field mon-
itoring methods and sampling/testing at pre-harvest stages, digital imaging and
analysis can be used to identify diseases or screen for resistant phenotypes [Li et al.,
2014]. Different digital imaging, sensing, processing, and analysis techniques from
the past three decades has been reviewed by Berbedo 2013. In the past, imaging
analysis were limited by the need for apparent and visible symptoms or patterns to
distinguish healthy plants from infected plants (Berbedo 2013). Current optical sen-
sor techniques that have promising potential for use and application in the field are
thermography, chlorophyll fluorescence imaging, and hyperspectral techniques [Fang
and Ramasamy, 2015, Bauriegel and Herppich, 2014]. In addition, spore traps can
help track and control plant disease by fungal airborne inoculum and monitoring of
pathogen populations [West and Kimber, 2015, West et al., 2017]. These kinds of
sensors can be hand held portable devices or mounted on different platforms such as
unmanned aerial vehicles (UAV), tractors/trucks, stationary posts, or using satellite
technology [West et al., 2017].
Fungal pathogens can cause a huge range of plant responses in physical appear-
ance and biochemical processes; for example: leaf color, canopy morphology, canopy
density, and disturbances in photosynthesis, transpiration, and respiration [Fang
and Ramasamy, 2015, West et al., 2017]. These responses can be measured across
the electromagnetic spectrum. Imaging methods can help reduce infection in the
field by prompting fungicide or pesticide application. However, in the event that the
infection is detected too late, harvest control applications can be taken to harvest
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areas with high infection and damage separately from areas that are not [West et al.,
2017,Bauriegel and Herppich, 2014]. It is often helpful to use vegetation indices such
as normalized difference vegetation index [Li et al., 2014]. While these sensors are
helpful, they are limited by the statistical algorithms used for data analysis, field
of view of the sensor, sub-optimal environmental conditions, and more [West et al.,
2017]. Sensors for monitoring and early detection of storage fungi are the electronic
nose (EN) and CO2 micro sensors are simple and fast qualitative detection meth-
ods [Fromme and O’connor, 2012,Fleurat-Lessard, 2017]. For more information on
classical methods of detection as well as sequencing methods for used for novel fun-
gal identification with research driven understanding of fungal genomics see 2.3, 2.4,
and 2.5.
Many regulatory sampling and detection methods are conducted by government
agencies or by private industries, after harvest, before transfer/transportation, upon
receiving shipments, or at various identified critical control points [FAO, 2001]. Un-
der the United States Grain Standards Act (USGSA), the American Market Act
(AMA), and the Grain Quality International Act (GQIA), USDA/GIPSAs Fed-
eral Grain Inspection Service (FGIS) is authorized to test for AFs in corn, wheat,
sorghum, and soybeans and DON in barley, corn, oats, and wheat to ensure they are
below the maximum levels. There are several testing labs across the united states
that offer testing services and produce/sell validated test kits (i.e Romer Labs and
EnviroLogix). The kinds of well validated tests that are approved by GIPSA are:
enzyme linked immunosorbent assay (ELISA), monoclonal antibody affinity chro-
matography, lateral flow strip, fluorescence technology, and on specific request or
case-by-case basis high performance liquid chromatography (HPLC) [USDA and
FIGS, 2018].
In the US, it is prohibited to use unauthorized test kits or sampling methods.
These analytical methods require sample preparation with solvent extraction (spe-
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cific to mycotoxin chemical properties), filtration, cleanup, dilution, and reference
method (i.e. LCMS) with reference material (use of commercial standards) [CAST,
2003]. Sampling procedures have been extensively reviewed, and protocols are dis-
cussed in the GIPSA/USDA handbook and EU sampling handbook [USDA and
FIGS, 2018]. Adherence to proper sampling plans for specific toxins and matrices
(products) is necessary in order to obtain the most accurate reflection of myco-
toxin contamination, because the sampling step is the largest source of variation
and uncertainty [CAST, 2003]. Currently there are sampling plans for aflatoxins,
fumonisins, and deoxynivalenol but none for OTA, T-2, and other emerging mycotox-
ins [CAST, 2003]. Sampling protocols can be specific to: i) lot weight, ii) analytical
method, iii) product being sampled, and iv) mycotoxin being tested [CAST, 2003].
From the representative lot, incremental samples (number of incremental samples
reflect the distribution of the mycotoxin) are collected then homogenized/aggregated
and sub-samples are further prepared and divided for replicate testing [CAST, 2003].
This process, however, loses information on the actual spatial distribution in the
bulk/lot sample. A study by Rivas-Casado et al., 2009 on DON in bulk storage
samples proposed that sampling plans for mycotoxins with known spatial structure
should also consider the incremental sample point location to improve estimates [Ri-
vas Casado et al., 2009]. However, as the product moves through various stages of
the food chain (transporting, milling, processing, etc.), a mycotoxins heterogeneous
distribution will decrease thus reducing its variability [Rivas Casado et al., 2009].
Therefore the sample point location would not bee as telling later in the grains
processing journey as it is at the beginning.
2.2.3 Decontamination
Decontamination methods should meet certain standards and require considerations.
First, processing methods should reduce mycotoxin level; mycotoxins can be phys-
ically removed, transformed/detoxified by chemical or biological means, or can be
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adsorbed to solid surfaces. Specific structural groups give mycotoxins their toxicity
(i.e. lactone rings, epoxy group), and when modified they may become less toxic (see
Figure 2.2) [Karlovsky et al., 2016]. Not all treatments will yield a metabolite with
reduced toxicity, some masked metabolites might be released and therefore have
increased bioavailability and toxic potential [Karlovsky et al., 2016]. Second, the
cost is effective and the method readily usable; the method should be economically
feasible for consistent use and technologically appropriate for a wide demographic
range. Also its process should be effective enough to remove mostly contaminated
grains without high losses of uncontaminated grains. Third, the quality and safety
of product should not be compromised; regardless of method used, there should









Thermal cameras (8000-14000 nm) and near
infrared cameras (700-1200 nm) capture
images and colors that are then analyzed for
canopy of leaf temperatures or fungal infection.
Reduced transpiration from infections can
increase leaf temperature by closing stomata at
early stage of infection. Water content can also
be detected and can appear cooler.
- Can detect plant disease
and monitor through water
transpiration
- Monitor heterogeneity of
soil borne pathogens
- Costs have been decreased
in the past years
- Not specific for diseases, does not
i.d. infection type
- Dependent on statistical method
application
- Does not distinguish between
diseases with similar patterns










Measured on leaves as function of incident
light and change in fluorescence patterns used
to analyze pathogen infections, which can be
from alterations in photosynthetic electron
transport reactions. Use of charge-coupled
device (CCD) cameras with light application
(UV or LED).
- Sensitive detection before
visible symptoms appear
- Dependent on statistical method
application
- Requires subsequent diagnostic









Measures the change in reflectance that occur
from changes in biophysical and biochemical
characteristics after infection. Measures
contiguous spectral bands with use of NIR
instruments, hyper spectral cameras, and
thermal cameras.
- Used for plant phenotyping
and crop disease
identification
- Robust and fast analysis
- Cameras have data
collection in 3 dimensions
- Dependent on statistical method
application
- Requires subsequent diagnostic
method for isolate i.d.




Device captures air particulate samples (dust,
spores, pollen, plant, microscopic materials)
onto a sticky surface or with airflow
manipulation to collect samples in a tube.
When sample collections are at threshold levels
can indicate disease infection on plants.
- Monitor changes in
pathogen populations
- Can help target crucial
times when crop protection
agents need to be applied
- ID possible for large, visually
characteristic spores
- Does not identify to species level
without uncertainty; requires
subsequent diagnostic methods
- Weather interferes with inoculum
detection; needs forecasting
models
- Spatial variability in spore
concentration related to disease
risk is uncertain
Table 2.3: Detection methods, their use, and advantages/disadvantages for the pre-
harvest period [Fang and Ramasamy, 2015, West and Kimber, 2015, West et al.,
2017, Bauriegel and Herppich, 2014, Li et al., 2014, Fromme and O’connor, 2012,
Niessen, 2007, Xu et al., 2016, Cellini et al., 2017, Lezar and Barros, 2010, Olarte
et al., 2015,Emri et al., 2017,Riccombeni and Butler, 2012,Fleurat-Lessard, 2017].
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Table 2.4: Detection methods, their use, and advantages/disadvantages in the post-
harvest period [Fang and Ramasamy, 2015, West and Kimber, 2015, West et al.,
2017, Bauriegel and Herppich, 2014, Li et al., 2014, Fromme and O’connor, 2012,
Niessen, 2007, Xu et al., 2016, Cellini et al., 2017, Lezar and Barros, 2010, Olarte
et al., 2015,Emri et al., 2017,Riccombeni and Butler, 2012,Fleurat-Lessard, 2017].








Device samples air from head space above the
grain bulk sample. It has an array of sensors
(metal-oxide semiconductors) that can detect
molecules from several chemical classes or
with diverse functional groups (VOC, odor)
and interpret the data with pattern recognition
strategies (neural networks).
- Non - destructive
- Recognizes signatures of
targeted fungal metabolites
- Portable devices for in situ
measurement of grain bulk
- Semi-quantitative, detects
above or below legal limits
- Limited by high variability of
spoilage level
- Does not quantify





Production of CO2 is associated with moisture
content above threshold levels. Monitoring for
CO2 in grain bulk can help identify places
where fungi is growing , safe grain storage has
CO2 levels between 400-500 ppm, levels of
3000 ppm or more indicate fungal spoilage.
- Screening for spoilage that
is occurring allows for
intervention and control
- Fast results
- Does not determine type or
location of spoilage












Qualitative/semi-quantitative fast visual test
can detect presence of a target analyte
(mycotoxin) in the sample matrix. A sample is
placed on the sample pad and then travels to
the conjugate pad where the target molecule
will react with its antibody conjugated Tag.
Then the mix moves toward a third ‘capture’
molecule in the test zone to immobilize the
complex and its concentration there forms a
visible result.
- Fast and commercially
available and easy to use
- Approved/used by GIPSA
- Sample preparation and pre-
treatment required (toxin
extraction and clean up, solvent














Assay uses antibodies specific to a particular
antigen to immobilize and then identify/detect
the substance by producing a visible signal.
This can also be used for plant pathology and
biomarkers from mycotoxin interaction. There




- Approved/used by GIPSA
- Sample preparation and pre-
treatment required (toxin
extraction and clean up, solvent










Quantitative method based on fluorescence
resonance energy transfer (FRET).
- Approved/used by GIPSA
(ex. FluoroQuant®)




- Preparation of sample can be
destructive
- Needs alternative reference method















- Not good for low regulatory level
threshold







- Can be used
to quantify at
any point
See section #__ - Standard reference
methodology for some
mycotoxins (AF)







- Can be used
to quantify at
any point




- Simultaneous analysis on
mycotoxins
- Can be used for biomarker
analysis in organisms
- Costly equipment and special
training required
- Solvent extraction and preperation
could destroy sample
- Matrix related issues
ee 4.2.1
See 4.2.1
be no undesirable alterations to the nutritional quality or sensory properties of the
product, nor should there be residual chemicals that could be harmful to consumer
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separately or in conjunction with any mycotoxins present [Kabak et al., 2006,Varga
et al., 2010]. This can be accomplished through physical, chemical, and microbial
methods. In addition to treatments that we use specifically to manage both fungal
presences and mycotoxin levels. Additionally, food additives (binders, prebiotics,
probiotics, and enzymes) can be added to feed or food as a way to further reduce
toxicity of mycotoxins by reducing absorption or promoting excretion [CAST, 2003].
Table 2.5: Sequencing methods, their use, and advantages/disadvantages [Fang and
Ramasamy, 2015,West and Kimber, 2015,West et al., 2017,Bauriegel and Herppich,
2014,Li et al., 2014,Fromme and O’connor, 2012,Niessen, 2007,Xu et al., 2016,Cellini
et al., 2017,Lezar and Barros, 2010,Olarte et al., 2015,Emri et al., 2017,Riccombeni
and Butler, 2012,Fleurat-Lessard, 2017].



























Genomic markers allow for the detection of
targeted mycotoxigenic species by adding the
following components to a solution with the
target sequence: i) a pair of primers that
hybridize with the flanking sequences of the
target, ii) all four deoxyribonucleoside
triphosphates (dNTPs), and iii) a heat-stable
DNA polymerase. One cycle of PCR requires
strand separation, then hybridization of
primers, followed by DNA synthesis. This can
be carried out for n cycles with 2n-fold
amplification. Quantification of fungal biomass
production (can be correlated with mycotoxin
content). Depending on the gene within the
fungal genome being targeted, different PCR
methods will be used.
- High specificity and
sensitivity, can detect and
quantify
- Results within 24 hrs
- Can be used to genotype
resistant plant cultivars or
fungi
- Requires complicated set up and
training for use
- Requires DNA/RNA extraction
- Needs alternative methods for
reference (i.e. LC-MS/MS)

















Microarray slide made up of species- or genus-
specific oligonucleotide probes from rRNA
internal transcribed spacers (ITS) or elongation
factor1-a (EF-1a) to identify polymorphisms,
fluorescent labeling is added during PCR step.
Target sequence samples are amplified,
purified, and hybridized. Images of the probe
intensities can be read and then processed and
analyzed with software programs.
For more information please see Lezar &
Barros 2010, Olarte et al. 2015, and Emri et al.
2017.





- Multiple organism i.d. at
same time
- Growing fungal sequence
collections available in
online database
- Low cost relative to RNA-
seq
- Requires extensive training and set
up for use (need prior sequence
library for comparison (biased),
preparation of the DNA chip with ,
extensive preparation of target
DNA with PCR)
- Dependent on statistical method
application; require software to
store and process data and
eliminate background noise
- Cross-Hybridization artifacts
- Can not detect isoforms or
structural variation and does not
provide sequence data
















Next generation sequencing (NGS) technology;
has variety of methods. The input RNA is
isolated then reverse transcribed to cDNA,
amplified with PCR and then sequenced. Them
the sequences can then be processed, analyzed,
and compared using software programs.
For more information please see Riccombeni &
Butler 2012.
- Not dependent on prior
sequence information, can








- Requires extensive training and set
up for use
- Expensive
- Dependent on statistical method
application; biases not well
understood





Physical processes/methods can reduce mycotoxin contamination by removing por-
tions of contaminated grain or contaminated parts. The process of sorting grains
(removing contaminated from non-contaminated) can be accomplished through ba-
sic hand sorting, flotation and density segregation and more advanced high-speed
techniques, such as optical color sorting. Generally, sorting of grains and products
has been shown to reduce all mycotoxin levels in maize, cereals, nuts, apples, grapes,
and beans (cocoa and coffee) [Varga et al., 2010,Karlovsky et al., 2016,CAST, 2003].
Optical color sorting is especially important for removing ergot sclerotia rye (purple-
black color) from unaffected rye due to the high correlation between the presence of
ergot sclerotia and the contamination of ergot alkaloids [Tittlemier et al., 2015]. It is
important to note, however, that grain infected by some fungi may not always show
visible symptoms, thus optical sensing methods may not reject the afflicted kernels,
this can be overcome by using a series of sorting, washing/treating, and then re-
sorting. This can be seen in peanut processing where electronic color sorting (ECS)
is able to remove a high percentage (70%) of discolored peanuts (indicated by afla-
toxigenic fungi colonization), however, when followed up by blanching (removal of
seed coat from kernels) and subjected to ECS again a reduction of 91% for mean
aflatoxin content has been shown [Dorner, 2008,Cole et al., 1995].
Washing grains or sieve cleaning (with various filter sizes) grains can help re-
move dust, broken kernels, and particulate matter which may be harboring fungal
spores or mycotoxins. Washing with water has been shown to be somewhat effec-
tive for water-soluble mycotoxins such as DON, however, mycotoxins that are not
water-soluble such as ZEA could be washed with the addition of sodium carbonate
solutions [Karlovsky et al., 2016]. Therefore knowledge about a mycotoxins solubil-
ity and partition coefficient is necessary (See Figure 2.6). Dehulling (to remove the
husk/hull) and pearling (to remove the bran of a grain) of grains are necessary pre-
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requisites to milling/grinding. They can also effectively reduce mycotoxin content
because fungi are relegated to the surface of the grain and mycotoxins are known
to accumulate in the bran fraction [Karlovsky et al., 2016]. The removed husk and
bran can be used in animal feed ingredients (if within accept limits for mycotoxin
contamination) or in biofuels [CAST, 2003].
Thermal inactivation can occur during raw product processing, industrial com-
modity processing (i.e. biscuit, pasta, bread making), and at home in the kitchen
when items are prepared. Theoretically, by the time any product (be it flour, un-
cooked pasta, rice, or bread) has been purchased by the consumer, it has undergone
significant treatment and testing and levels are well below tolerable or suggested
daily intakes, but even if not, the way people cook things may have some effect
Figure 2.2: Toxic structural groups and possible modification reactions (adapted
from [Karlovsky et al., 2016]).
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on mycotoxin degradation. Thermal treatments, do have the potential to cause
unwanted nutritional and quality effects and require a great deal of energy to be
effective. There are many kinds of thermal treatments/cooking such as extrusion
cooking (forces product through a mold and heats to a high degree), roasting, frying,
baking, pasteurization, evaporation, etc. which all have varying degrees of effect de-
pending on the type product being treated (raw or in a formula for something else),
the duration of the method, the mycotoxin (ZEA and FB1 are more resistant to
heat treatments), and other processing factors (i.e. pH of formula, other added
ingredients) [Varga et al., 2010,CAST, 2003].
Irradiation can destroy mycotoxigenic fungi and mycotoxins with non-ionizing
(photon energy below 10eV; solar, UV, microwave) or ionizing (photon energy
greater than 10 eV, Co60, high energy electron beams) processes [Karlovsky et al.,
2016, Freita-Silva et al., 2015, Calado et al., 2014]. These can be done as an indus-
trial processing treatments and can occur naturally in the environment from solar
radiation, for example the phototransformation of ZEA in natural waters [Emı́dio
et al., 2017]. Radiation works by causing either direct damage to DNA or indirectly
through generation of oxidative radicals through radiolysis/photolysis [Le Caër,
2011, Farkas, 2006, Emı́dio et al., 2017]. When water molecules are ionized and
excited, they split into the positively charged radicals (H2O
+) and the negatively
charged free solvated electrons (e−), these products (e−, H•, HO•, HO•2, OH
−,
H3O
+, H2, and H2O2) are reactive with any substrate and can break down organic
molecules [Le Caër, 2011,Emı́dio et al., 2017,Calado et al., 2014].
A review article by Calado et al., 2014 discusses several aspects of using irradia-
tion for food processing and notes that many factors can influence its effectiveness
for controlling fungi within a food matrix such as, “ i) the fungal strain (inherent
ability to overcome the DNA damage) and load, ii) fungal form (spore are incredibly
resistant to radiation) and age, iii) moisture of spores/ food matrix, iv) temperature
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before and after treatment.” Adversely, for destroying mycotoxins they discuss, “i)
type and concentration of mycotoxin, ii) presence of other chemical compounds, iii)
formation of toxic degradation products,” [Calado et al., 2014].
Doses of irradiation in food should not exceed 10 kGy, which is sufficient for
controlling fungal growth, however, in order to reduce a significant amount of my-
cotoxins amounts >10 kGy are used [Freita-Silva et al., 2015, Calado et al., 2014].
Part of the problem with using irradiation is that some units are very costly and
consumers have a negative association with it, however, switching to alternatives
like electron beams over gamma rays can reduce energy costs has a better recep-
tion [Freita-Silva et al., 2015, Calado et al., 2014]. Further more, any use of theses
energy or radiation sources can be used to ionize gas and generate plasma under
different temperatures and pressures. These plasma species (O, HO•, O3, H2O2, and
peroxynitrate) have high oxidative potential, thus Cold Plasma (CP) technology has
the capacity to be an even greater alternative to radiation technology for fungal and
mycotoxin control but requires more research and attention at this time [Hojnik
et al., 2017,Pankaj et al., 2018].
Chemical
The use of chemical treatments such as acids, bases, and oxidizing/reducing agents
is widely used and applied in conjunction with other physical treatments (thermal,
irradiation, etc.), however, chemical residues may persist in the product and the
environment. Acidic treatments (or additives) with a pH (< 3) that is less than
the optimum for fungal growth (range 3 - 5) can be used as anti-fungal, antimicro-
bial, and preservation for food processing but very few have mycotoxin degradation
abilities [CAST, 2003, Ray and Liewen, 2004]. Basic treatments with alkaline con-
ditions pH (>10) such as ammoniation and nixtamilization (soaking/cooking in
alkaline solution and hydrolyzes ester bonds), have been effective for some myco-
toxins (AFB1 and FB1). Ammoniation is not recommended for detoxification of
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OTA contaminated food/feed but it is allowed for aflatoxin contaminated products
in several states such as Arizona, California, Texas, Alabama, and Georgia [Varga
et al., 2010]. Alkaline conditions are very unstable for mycotoxins and can be the
first step of degrading mycotoxins with lactone rings [Karlovsky et al., 2016,CAST,
2003]. The use of oxidizing agents such as ozone gas (O3) or reducing agents like
sodium bisulfite have also been shown to detoxify and degrade multiple mycotox-
ins [Karlovsky et al., 2016, CAST, 2003]. Most of these treatments are dependent
upon the pH conditions, duration of the treatment, temperature, atmospheric con-
ditions, and subsequent treatment/ processing conditions.
In addition to the use of herbs, spices and essential oils for their pleasing taste
or smell, their phenolic antioxidants impart some antimicrobial/anti-fungal activity
which helps with food preservation and acts akin to the natural defense response
for the plant itself can have [Ray and Liewen, 2004]. Studies have shown that in
excessive quantities, they can inhibit mold growth and mycotoxin production [Ray
Table 2.6: Physical and Chemical Decontamination: Mycotoxin levels reduced and
experimentally demonstrated (green), mycotoxin level reduced partially/or effective
at inhibiting fungi from producing mycotoxins (yellow), No effect on mycotoxins/Not
compatible (red), not enough information (white) (adapted from [Karlovsky et al.,
2016,CAST, 2003,Calado et al., 2014,Ray and Liewen, 2004]).
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and Liewen, 2004]. El Khoury et al., 2017 investigated the ability of phenolic acid
extracts and essential oils from several herbs and plant (bay leaves, cumin, fenugreek,
melissa, mint, sage, anise, chamomile, fennel, rosemary, and thyme) to control A.
carbonarius S402 growth and prevention of OTA production on synthetic grape
medium (SGM) at 28◦C for the duration of 4 days. None affected the growth,
however, results indicated that essential oils were more potent than phenolic extracts
on reducing the production of OTA [El Khoury et al., 2017].
Biological Transformation
Fermentation (could be considered chemical) using microorganisms have mecha-
nisms that can reduce the level of mycotoxins in contaminated products. The use of
yeast and lactic acid bacterial strains (LABs) has been used for thousands of years
for the brewing of beer and wine or the production of yogurts and cheese, as well as
ensilage for hay [CAST, 2003]. The fate of various mycotoxins during the brewing
process has been reviewed by Inoue et al., 2013, showing that most mycotoxin levels
are reduced from adsorption to yeast and then removal with the spent grain [Inoue
et al., 2013]. The LABs, Oenococcus oeni, which is found on grapes and is involved in
the malolactic fermentation for wine, is able to cellularly bind to OTA [Varga et al.,
2010, Del Prete et al., 2007]. Processing of milk with AFM1 has various degrees of
success, however, a study by Shigute & Washe 2018, investigated the effect of LAB
species (from genre Lactobacillus, Pediococcus, Enterococcus, Streptococcus, and
Lactococcus) on the reduction of AFM1 in the traditional Ethiopian production of
the fermented milk, Ergo. These LABs are commonly isolated from the traditional
smoked clay pot vessels used in this milk fermentation process. Their results demon-
strated that LABs strains were able to reduce up to 57.33% of AFM1 [Shigute and
Washe, 2018].
As mentioned earlier, there are several fungi and bacterium that can biode-
grade mycotoxins as well as several other hazardous chemical compounds [Chanda
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et al., 2016]. Before a mycotoxin biotransforming organism can be used commer-
cially it must be found, characterized, and assessed. A recent review by Zhu et
al., 2017, explained the necessary methodologies for development: i) identify en-
vironmental source/screen from identified groups, ii) identify the detoxification ac-
tivity/biotransformation product, iii) safety assessment for functional strain and
biotransformation product, iv) isolate, identify, clone/express enzymes responsible,
and v) validate process and feasibility. Microbial organisms from fish, rumen, and
chicken intestines as well as soil bacterium have been isolated and studied for their
ability to detoxify or degrade certain mycotoxins [Zhu et al., 2016,He et al., 2016].
He et al., 2016 used a soil enrichment scheme to screen for aerobic bacteria capa-
ble of detoxifying DON and NIV. They found a Desulfitobacterium species that
was capable of aerobic de-epoxidation of DON and NIV into dE-DON and dE-NIV,
both compounds were assayed/ tested for toxicity and were found to be less toxic
than their precursors [Pierron et al., 2016,Eriksen et al., 2004,He et al., 2016]. Fer-
enczi et al., 2014 screened Cupriavidus basilensis R16 through a genome project and
found that it was able to cleave OTAs peptide bond and transform it into OTα
and phenylalanine [Ferenczi et al., 2014]. They then conducted an in vivo analy-
sis based on morphological alterations in kidney and spleen weight and changes in
expression of OTA-affected genes in kidney tissue [Ferenczi et al., 2014]. For more
information about mycotoxin degrading microorganisms please see additional review
materials [Young et al., 2007,Zhu et al., 2017].
Feed additives: chemo-protection, binding agents/adsorbents, and En-
zymes
Microorganisms also offer a potential mechanism for mycotoxin binding instead of
degradation. The polysaccharides, proteins, and lipids that comprise cell walls have
many functional groups and hydrophobic adsorption sites which may bind a wide
variety of mycotoxins [Campagnollo et al., 2015]. This chemoprotection allows bi-
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ological effects of mycotoxins to be modified through dietary components (i.e. the
addition of folate to wheat), use of phytochemicals in the diet/ nutrient as medi-
ated histone modifiers, and probiotics/pre-biotics [Gao and Tollefsbol, 2015,CAST,
2003].
Campagnollo et al., 2015 reported that beer fermentation residue (BFR) with
Saccharomyces cerevisiae obtained from brewers spent grains (brewing byproduct)
has been suggested for use to bind to mycotoxins in poultry and cattle feed. There
was low binding ability to AFB1, OTA, or DON at pH 3.0 and 6.5, but had highest
binding capacity for ZEA and was able to reduce bioavailability of ZEA in con-
taminated feedstuffs by more than 70% [Campagnollo et al., 2015]. Calcium mont-
morillonite clay and activated carbon have been shown to have success in binding
to AFB1 and DON respectively and preventing them from being absorbed in the
intestinal tract in several model animals studies [Devreese et al., 2014,Wang et al.,
2008]. Enzymes that have been successfully isolated and identified from microorgan-
isms can be purified and added to feed like the fumonisin carboxyl esterase FumD
(FumDIFUMzyme) which degrades FB1 to HFB1 and has been shown in swine and
Turkey [Masching et al., 2016]. The addition of Bacillus subtilis to laying hen feed
is capable of counteracting adverse effects of mycotoxins on laying performance, im-
Table 2.7: Food/feed additives for potential animal species and their effect at pro-
tecting against mycotoxins.
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prove egg quality, and reduce accumulation of AF residues in egg because spores of
B. subtilis germinate in animals intestinal tract and secrete helpful enzymes that can
degrade AF and ZEA [Jia et al., 2016]. This approach of using the organisms means
you don’t have to produce the enzyme. Although some feed additives have shown
promising results in many birds and mammals, the feed additives designed/intended
for these animal models may not be efficient in fish species. This is demonstrated by
Hooft et al., 2017, where a commercial feed additive had no effect on alleviating the
effects of DON on the growth of nutrient utilization in rainbow trout (Oncorhynchus
mykiss) [Hooft and Bureau, 2017].Additionally, mycotoxin binders and detoxifiers
may interact with other nutritional components in food, thus limiting their efficiency
and potentially causing other complications.
2.3 Summary
Farmers can protect their crops and financial future as well as ensure safe food/feed
by following GAP, GSP, GHP, and GMP recombinations before, during, and after
harvest. During the pre-harvest stage: i) conservation tillage systems for increased
water and soil retention and diverse microbial activity, ii) crop rotation with non-
/less-susceptible hosts to reduce continued transmission, iii) cultivar section with
breeding programs for resistant host phenotypes, iv) avoiding mono-culture crops
by planting a variety, v) planting and harvesting on dates which adhere to recommen-
dations to avoid unfavorable weather conditions during critical plant development
times, vi) plan for optimal plant density which reduces plant stress from competition
for resources over high yields, vii) appropriate timing for irrigation and fertilization
(also the method and type), viii) chemical treatment for weeds, insects, and fungi
with the correct type and quantity as prescribed by manufacturer and avoid pro-
longed exposure, ix) have an integrated plan that utilizes different methods from
each part. During harvest and pre-harvest stages, good hygiene, storage, and man-
ufacturing practices should be followed to prevent storage fungi from contaminating
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products. Storage containers should be cleaned, maintained, and monitored. Dif-
ferent processing methods have a variety of results on mycotoxin control either by
inhibiting fungal growth or production of toxins or by altering the chemical structure
of the compound to reduce its toxicity.
There are many uncertainties with mycotoxin binders and detoxifiers at this time,
and the adverse affects of there interactions with over feed components and nutrients
is still under investigation. More evaluations on the efficiency of mycotoxin binders
in ruminant, pig, and poultry and especially aquatic species is necessary [Hooft and
Bureau, 2017].
More information is needed for use biological control agents (i.e resistant plant
cultivars and non-toxigenic strain), specifically on the introduction of non-toxigenic
strains to control toxin producing strains. Some research has suggested that un-
der laboratory conditions, mating of two different species of Aspergillus resulted in
hybrid progeny with a different mycotoxin profile [Olarte et al., 2015]. A deeper un-
derstanding of the genes and mechanism that produce mycotoxins can be achieved
through transcriptomic analysis like DNA microarray and RNA-seq. Thus more
transcriptionally active mycotoxin production pathways or detoxification pathways




Toxicity in Animals and Humans
Over the past several decades, there have been many in vivo and in vitro toxicity
studies, as well as metabolic and kinetic studies, on several model species. This
section will discuss the absorption, distribution, metabolism, and excretion processes
of a few different mycotoxins briefly, as well as some of their well known effects in
livestock animals, aquatic species, and humans. Additional focus will be placed
on mycotoxin implications on intestinal health, immune response, and reproductive
system dysfunction.
3.1 Absorption, Distribution, Metabolism, and Excretion
During absorption, a mycotoxin (or other contaminant) is transferred from the ad-
ministration site into the circulation of the organism [World Health Organization,
2009]. Most human and animal exposure to mycotoxins occurs via food ingestion,
however, animals and humans that come into close contact with grain dust may also
be at risk of inhalation and dermal contact [Niculita-Hirzel et al., 2016]. Factors that
will determine a mycotoxins absorption characteristics can be its ionization, molec-
ular weight, and solubility. Mycotoxins and their metabolites can be partitioned
into different body tissues depending on their chemical nature. Entry into specific
tissues can be limited to either lipid soluble chemicals due to barriers with tight
junctions between endothelial cells that prevent water soluble molecules from leav-
ing the lumen of blood vessels, or by the selectivity of transporter proteins [Anzai
et al., 2010,Pfohl-Leszkowicz and Manderville, 2007]. ABC transporters in the lumi-
nal membrane of intestines help to counteract absorption and increase excretion of
xenobiotics and drugs [Anzai et al., 2010]. Biotransformation process structurally al-
ters any administered mycotoxin so that it may be excreted and eliminated from the
organism. Phase I metabolism systems can be microsomal (i.e cytochrome P450s,
cyclooxygenases, epoxide hydrolase, etc.) or non-microsomal (i.e. alcohol/aldehyde
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dehydrogenases, monoamine oxidases, and esterases) and can cause oxidation, re-
duction, hydroxylation, hydrolysis, and epoxidation reactions. This process acts
to convert the the toxin into more polar metabolite by either adding a functional
group (-OH, -NH2, -COOH) or by un-masking them; mycotoxins may be inacti-
vated but some are activated (i.e. AFB1 and OTA). Many mycotoxins have been
shown to occur in food and feed in their metabolized fungal and plant derivatives,
these can then be activated by the consuming organisms system [Berthiller et al.,
2013,Maresca, 2013]. Phase II metabolism acts to further increase a mycotoxins sol-
ubility, through conjugation reactions and covalent binding of glucuronide, glucoside,
sulfate, glutathione, and amino acid, or with acetylation and methylation reactions.
If ingested, the mycotoxins undergo metabolism by enzymes and microflora in the
intestine first, however, the liver is the major site for metabolism [Sousa et al., 2008].
Biotransformation can also occur in the cells of the kidneys, lungs, plasma, testes,
placenta, adrenal glands, and even the brain. Mycotoxins can be excreted via re-
nal (urine) and biliary (fecal) secretions and through milk from lactational transfer.
Compounds can also be passively reabsorbed in the distal and renal tubules leading
to enterohepatic circulation. This section will be broadly discussed to give an idea
about how mycotoxins are absorbed, distributed, transformed, and excreted. Should
you wish to read about these processes with more specific criteria about clearance,
elimination, and excretion rates please refer to reviews and articles cited according
to the mycotoxin.
3.1.1 AFB1
Aflatoxins are rapidly absorbed from the small intestines by passive diffusion (duo-
denum is major site of absorption); AB1 and AFB2 are more rapidly absorbed than
AFG1 and AFG2 [Kensler et al., 2010,CAST, 2003,Wen et al., 2016]. After AFB1
is absorbed, it is non covalently bound to albumin and can be transported through-
out the body to other tissues. AFB1 can be hydroxylated by CYP enzymes into
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Table 3.1: ADME for various mycotoxins.
AFM1, AFQ1, AFP1 and then excreted into urine or milk [CAST, 2003]. Alter-
natively, various liver CYP450 can transform AFB1 into AFB1-8,9-epoxide which
can then proceed to i) react with DNA or RNA to form AFB1-adducts (i.e. AFB1-
N7-Guanine) that can either be repaired or will undergo G-T transversion that will
become a fixed mutation after two rounds of DNA synthesis leading to mutagenicity
and carcinogenicity (this has been shown in codon 249 of the p53 tumor suppressor
in human liver), ii) undergo hydrolysis by microsomal epoxide hydrolase enzymes to
AFB1-8,9-dihrydrodiol then bind to albumin to form AFB1-albumin products, or iv)
conjugated by phase II glutathione-s-transferase (GST) and excreted in urine [McG-
lynn et al., 1995,Wen et al., 2016]. Additionally, Guindon-Kezis et al., 2014 showed
Table 3.2: Adverse effects on cells. Mycotoxins can cause effect (green), unknown
(white). Adapted from [Wen et al., 2016].
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Table 3.3: IARC classified groups of carcinogens.
that treatment with AFB1 on female A/J mice of 50 mg/kg AFB1 (i.p.) resulted
in oxidative stress in the liver and lungs [Guindon-Kezis et al., 2014]. The in-
creased levels of DNA oxidation products (8-hydroxy-2-deoxyguanosine (8-OHdG)
and 5-hydroxy-2’-deoxycytidine (5-OHdC)), increased immunoreactive protein 8-
oxoguanine glycosylase (OGG1), and increased base excision repair. Thus the ox-
idative DNA damage might lead to carcinogenicity [Guindon-Kezis et al., 2014].
Aflatoxins have the ability to decrease protein synthesis, disrupt lipid metabolism,
and interfere with mitochondrial respiration [Wen et al., 2016]. AFB1 is a group 1
carcinogen and its hydroxylated metabolite AFM1 is a group 2B carcinogen [Kensler
et al., 2010,CAST, 2003,Wen et al., 2016]. Anorexia, malaise, vomiting, and jaun-
dice are a few of the early symptoms associated with aflatoxicosis and hepatotoxic-
ity [CAST, 2003, Ngindu et al., 1982, Azziz-Baumgartner et al., 2005]. There have
been many outbreaks of aflatoxicosis, the most recent was in 2004 [Onsongo, 2004].
In the wake of a food shortage, eastern and central provinces of Kenya experienced
a severe aflatoxicosis outbreak, in which 317 cases of acute hepatic failure and 125
deaths during a time period in which maize samples reached AFB1 levels of 4,400 -
8,000 ppb [Onsongo, 2004,Azziz-Baumgartner et al., 2005]. A case-study conducted
in the area by Azziz-Baugartner et al., 2005 collected home grown maize samples
for AFB1 concentration as well serum albumin from participants for AFB1-lysine
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adducts and positive hepatitis B surface antigen (HBsAg-positive). Serum albumin
with AFB1-lysine adducts at or above 0.25 ng/mg was and HBsAg-positive is con-
sidered a risk factor for aflatoxicosis and hepatocellular carcinoma [CAST, 2003,Wen
et al., 2016, Kensler et al., 2010]. Chronic exposure to lower levels of AFB1 cause
reduced weight gain, low feed conversion, immunosuppression, carcinogenesis (liver
cancer), and encephalopathy [Kensler et al., 2010,CAST, 2003,Wen et al., 2016].
OTA
The amount of OTA that is absorbed depends on the species and ranges from
1.6% in fish, 40% in chickens to 66% in pigs and 93% in humans [Ringot et al.,
2006, Kőszegi and Poór, 2016, Bernhoft et al., 2017]. The non-ionized (OTA0) and
monoanion (OTA−) forms of OTA are passively absorbed in the stomach and prox-
imal jejunum [Ringot et al., 2006]. No specific transport mechanisms have not been
implicated in the transport of OTA across intestinal epithelial cells, therefore, it
has been suggested to be a result of simple diffusion [Berger et al., 2003, Ringot
et al., 2006]. OTA absorption is more efficient at a pH closest to 6 (apical) than
a pH 7.4 (basolateral), showing that the apical to basolateral passage of OTA is
more common [Maresca et al., 2001,Berger et al., 2003]. It has been suggested that
intestinal absorption may be limited by the efflux of the toxin by transporter pro-
teins which counteracts absorption, adds a protective tissue barrier, and acts in the
elimination [Pfohl-Leszkowicz and Manderville, 2007]. The multi drug resistance-
associated protein ATP-Bincing Cassette C2 and breast cancer resistance-associated
protein (BCRP) have been implicated in this process [Berger et al., 2003]. The in-
testinal microflora in ruminants and rodents has been shown to hydrolyze OTA
into OTα (less toxic metabolite), which has been found in urine [Heussner and
Bingle, 2015]. OTA is distributed to other tissues and organs through the portal
system. OTA binds to serum proteins (albumin) in the blood stream; 99.8% of OTA
found is albumin bound [Pfohl-Leszkowicz and Manderville, 2007]. The dianionic
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form of OTA is bound to human serum albumin and does not readily pass through
membranes [Pfohl-Leszkowicz and Manderville, 2007]. Various CYP450 enzymes or
peroxidase can remove the chlorine ion from OTA and transform it into OTB or
aryl radicals, phenoxyl, and benzoquinone intermediate that can then go on to form
DNA adducts [Kőszegi and Poór, 2016]. Organs that have been found to accumulate
OTA include kidneys, liver, skeletal muscle, fat tissue, brain, and testes [Kőszegi and
Poór, 2016]. An in vivo study conducted by Hallén et al., 1998 was able to show
placental and lactational transfer of OTA in rats [Hallén et al., 1998]. OTA and
metabolites can be eliminated via renal excretion route, however, glomerular filtra-
tion is limited due to the high binding affinity of OTA to plasma proteins, which
increases its ionization and decreases its lipid solubility [Ringot et al., 2006]. Instead,
carrier-mediated transport across tubular membranes by transporter proteins (i.e.
organic anion transporters OAT) eliminate OTA into urine [Pfohl-Leszkowicz and
Manderville, 2007]. However, OATs have a duel nature, in which they mediate the
efflux of OTA as well as its reabsorption [Anzai et al., 2010, Pfohl-Leszkowicz and
Manderville, 2007]. The reabsorption of the secreted OTA occurs in the nephron
segments (proximal tubules, distal tubules, and collecting ducts) by similar organic
anion transport systems. The constant reabsorption leads to accumulation of OTA
in renal tissue and may be an integral aspect to the nephrotoxicity of OTA [Anzai
et al., 2010,Pfohl-Leszkowicz and Manderville, 2007]. OTA and its metabolite OTα
can be eliminated in feces through biliary excretion. However, after the conjugated
OTA compounds are secreted in the intestines they can be hydrolyzed by microflora,
which allows the released OTA to participate in the enterohepatic circulation [An-
zai et al., 2010,Ringot et al., 2006,Pfohl-Leszkowicz and Manderville, 2007]. Breast
milk (pH 6.5) is more acidic than plasma, therefore xenobiotics can diffuse into the
mammary glands. Many in vivo studies have described the lactational transfer of
OTA in breast milk in animals and humans [Hallén et al., 1998, Kőszegi and Poór,
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2016]. A study by Skaug et al., 2001 found a correlation between dietary intake of
OTA and its contamination in human breast milk [Skaug et al., 2001].
OTA has been shown to be genotoxic, cytotoxic, carcinogenic, nephrotoxic (kid-
ney is a major target organ), immunotoxic, neurotoxic, embryotoxic, and teratogenic
in animal models and human cell lines [Patil et al., 2006,Ringot et al., 2006,Pfohl-
Leszkowicz and Manderville, 2007, Kőszegi and Poór, 2016]. Ochratoxin a is clas-
sified as a group 2B carcinogen, showing that it is a possible human carcinogen
based on several animal carcinogenicity studies in mice and poultry [Ostry et al.,
2017]. OTA has both non-genotoxic mode of action and a direct genotoxic mode
of action [Kőszegi and Poór, 2016, Wen et al., 2016]. OTA can i) inhibit protein
synthesis, ii) disrupt phenylalanine metabolism leading to reduction in gluconeoge-
nesis, iii) induce cell apoptosis, iv) produce reactive oxygen species (ROS) causing
lipid peroxidation and cell membrane damage, v) interrupt hormonal calcium sig-
naling and homeostasis, vi) cause DNA damage [Benesic et al., 2000, Stoev et al.,
2001, Wen et al., 2016]. Since the 1970s, OTA has been regarded as causative fac-
tor in porcine nephropathy in Denmark, and since then has also been associated
with human diseases from epidemiological studies like Balkan Endemic Nephropa-
thy (BEN) and Chronic Interstitial Nephropathy (CIN) and urinary tract tumors
(UTT) in Tunisia [Petkova-Bocharova et al., 1988, Stoev et al., 2001, Kőszegi and
Poór, 2016,Ringot et al., 2006].
3.1.2 FB1
Absorption of fumonisins are relatively low, and in most species the bioavailability
is less than 6% [Klarić et al., 2013,Voss et al., 2007]. Because of its low absorption
rate, it has been suggested that enterohepatic cycling contributes to its intesti-
nal absorption as well as incorporation into mixed micelles from cholesterol or bile
salts [Grenier and Applegate, 2013]. Fumonisins are distributed throughout vari-
ous tissues, however, they have species-specific target organs such as the brain in
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horses or the lungs in pigs [Voss et al., 2007]. Information on biotransformation of
fumonisns is relatively limited. However, Spotti et al., 2000 found that FB1 was
able to alter CYP450 with in vivo and in vitro studies by inhibiting ceramide syn-
thase [Spotti et al., 2000]. In addition to the distribution of the toxin, elevated levels
of Sa and So can be found throughout the body [Voss et al., 2007, Voss and Riley,
2013]. It also interferes with lipid metabolism and lipid-dependent signaling path-
ways [Voss and Riley, 2013]. FB1 can be partially or fully hydrolyzed (losing one or
both tricarballylic acid side chains) in the gut by microflora [Voss et al., 2007].
The IARC classifies FB1 as a group 2B carcinogen [IARC, 1993]. FB1 has a
non-genotoxic mode of action via sphingolipid metabolism disruption, DNA could
be damaged when lipid metabolism is disrupted from the inhibition of ceramide
synthase. Additionally, FB1 can induce global DNA hypomethylation which can
affect the balance of DNA methylates/demethylases, and potentially cause genome
instability and tumorigenesis [Wen et al., 2016].
Well known animal diseases attributed to FBI exposure are porcine pulmonary
edema (PPE), and equine leukoencephalomalacia (ELEM) [Smith et al., 2002,Gumprecht
et al., 1998]. In humans, fumonisin exposure is associated with nueral tube de-
fects (NTDs) seen in Mexico-Texas, esophageal cancer in China, and decreased
growth [CAST, 2003,Voss et al., 2007,Liew and Mohd-Redzwan, 2018].
3.1.3 ZEA
ZEA is readily absorbed after oral administration in the intestines. Several in vivo
studies have been conducted on animal models to investigate ZEA absorption [Zine-
dine et al., 2007, Metzler et al., 2010, Fleck et al., 2016]. In rats, Ramos et al.,
1996 used an in situ technique to find that ZEA was absorbed in the intestines
by passive diffusion [Ramos et al., 1996]. Using cultured Caco-2 cells, Press & Di
Grandi 2008, found that the permeability coefficient of ZEA and α-ZAL correlated
with human absorption in vivo and are consistent with intestinal absorption of ZEA
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and α-ZAL [Press and Di Grandi, 2008]. ZEA is distributed in different tissues
(kidney, liver, adipose) and estrogen target tissues (uterus, testes and ovarian fol-
licles) [Zinedine et al., 2007, Metzler et al., 2010]. The placenta has various CYP
enzymes, reductases, and transferases and their expression and level is dependent on
the stage of placental development [Pasanen, 1999, Partanen et al., 2009]. Placen-
tal transfer of ZEA and a-ZAL has been shown in rats and rabbits [Bernhoft et al.,
2001,Lange et al., 2002]. Two well supported biotransformation pathways have been
suggested by Olsen et al for ZEA in animals: i) enzymatic reduction via hydroxyla-
tion by hydroxysteroid dehydrogenase (HSDs) to α-ZOL and β-ZOL (Phase I), and
ii) is a uridine diphosphate-glucuronosyltransferase (UGT) dependent conjugation
of ZEA reduced with glucuronic acid (Phase II) [Olsen et al., 1981, Metzler et al.,
2010]. Other animal studies have also suggested reduction of the keto group by hy-
droxysteroid dehydrogenases (HSD) to α-/β-ZAL, cytochrome P450-catalyzed hy-
droxylation on aromatic and aliphatic positions, and Phase II conjugation to sulfates
by sulfotransferases (SULT) [Metzler et al., 2010]. Pfieffer et al., 2009 used rat and
human hepatic microsomes to show that two of the major oxidative metabolites are
the highly unstable catechols 13-hydroxy-ZEA and 15-hydroxy-ZEA hydroxylation
of ZEA [Pfeiffer et al., 2009]. These catechol metabolites occur through aromatic
hydroxylation and can be substrates for catechol-O-methyl transferase.
Note that it is important to consider the animal used in the study because there
is some discussion and evidence showing different hepatic biotransformation of ZEA
in different species [Malekinejad et al., 2006]. For example, pigs predominantly
convert ZEA to α-ZOL while β- ZOL is the dominant hepatic metabolite in rumi-
nants [Malekinejad et al., 2006, Zinedine et al., 2007]. Recently an in vivo study
conducted by Fleck et al., 2017 used 2 month old female pigs as a sensitive model
system for oral and intravenous dosing to further understand ZEA metabolism and
competitive pathways [Fleck et al., 2016]. Their findings supported previous litera-
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ture that Phase II conjugation and keto-reduction to α- and β-ZOL were the primary
reactions observed. However, they found no LC/MS/MS evidence to support CYP-
mediated hydroxylation reactions of aromatic to form catechols and methylcatechols
after catechol-O-methytransferase- mediated methylation [Pfeiffer et al., 2009,Fleck
et al., 2016]. The ZEA glucuronide is excreted from the bile and then re-absorbed
and metabolized again by intestinal mucosal cells leading to distribution in the
liver. Urinary excretion occurs in conjugated and unconjugated forms and reductive
metabolites. In humans, excretion via urine has been found to account for approxi-
mately 10% of the administered dose, with glucuronides of ZEA and α-ZOL as the
main metabolites and minor amounts of β-ZOL [Metzler et al., 2010,Zinedine et al.,
2007]. There is lactational transfer of ZEA in milk, however, it has a low trans-
mission rate [Metzler et al., 2010]. ZEA and its metabolites competitively binds to
estrogen receptors, is genotoxic, and may cause reproductive issues in a variety of
animals [Metzler et al., 2010,Zheng et al., 2018]. In vitro studies with different cell
lines (i.e. MCF-7, HEK293) have shown that the estrogen mimicking effects of ZEA
at low doses stimulates cell proliferation and anti-apoptic effects (carcinogenesis)
while high doses of ZEA result in cell death from oxidative stress, DNA damage,
mitochondrial damage, cell cycle arrest and apoptosis [Yu et al., 2005,Zheng et al.,
2018].
3.1.4 DON
Bioavailability of DON has high variability amongst species due in part to the chem-
ical and physical parameters of the GI tract; intestinal absorption and metabolism
of ingested xenobiotics (DON) is heavily dependent on the ability of these bacteria
to metabolize them [Maresca, 2013]. In ruminants (7%) DON is the least bioavail-
able, followed by chicken (20%) and rats (25%) and pigs (55-80%) [Goyarts and
Dänicke, 2006, Grenier and Applegate, 2013, Bernhoft et al., 2017]. Mono gastric
organisms have high bacterial content in the colon while polygastric animals (ru-
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minants) have high bacterial content before and after the small intestines, this will
determine where along the GI tract the mycotoxin will be metabolized, absorbed, or
excreted [Maresca, 2013]. There have not been any reports on Phase I metabolism
reactions involving DON, however, microflora have been shown to transform DON
into de-epoxy DON (DOM-1) in the digestive tract [Maresca, 2013, Cirlini et al.,
2014]. Various Phase II reactions have been shown with species specific site modi-
fications [Goyarts and Dänicke, 2006]. Several toxicokinetic studies of radio-labeled
DON in animals has shown tissue distribution was shown in all organs including the
brain, reproductive organs, and fat tissue [Sobrova et al., 2010,Amuzie and Pestka,
2009b, Tola et al., 2015]. A more polar compound (like D3G) is less absorbed in
the small intestines compared to parent [Maresca, 2013,Cirlini et al., 2014]. DON is
able to pass through biological barriers and can affect cellular function and viabil-
ity [Maresca, 2013]. The IARC classifies DON as a group 3 compound, meaning that
its carcinogenic information in animals and humans is limited or inadequate [Sobrova
et al., 2010]. Acute doses at low levels have been shown to cause nausea, diarrhea,
and emesis while prolonged chronic exposure decreases weight gain, causes anorexia,
decreases nutritional absorption, and increases immune dysfunction [Amuzie and
Pestka, 2009b].
3.2 Endocrine Disrupting Chemicals & Effects on Endocrine/Neuroendocrine
Systems
The endocrine system is an intricate network of glands that secrete various hor-
mones and is controlled by the hypothalamus which is the base of operations for
the neuroendocrine system by sending out neurotransmitters and by receiving tar-
get hormone feed-back information. Together, these neuroendocrine and endocrine
pathways are responsible for orchestrating necessary life processes for the body such
as the regulation of growth, metabolism, and reproductive function. There is a
broad range of mechanisms for EDCs such as nuclear hormone receptor binding
52
to stimulate/antagonize, interference with enzymes involved in steroid biosynthe-
sis, hormone degradation/elimination, and confound communication/signaling sys-
tems [Diamanti-Kandarakis et al., 2009, Gore, 2010]. Continued research has dis-
covered more interactions for EDCs involving non-nuclear steroid hormone recep-
tors and orphan receptors [Diamanti-Kandarakis et al., 2009]. This interconnected
system relies on properly functioning components and clear communication, so im-
balance in the level of hormones or disruption in this system to result in disease (i.e.
diabetes, obesity), adverse reproductive affects, altered behavior, and disruption of
homeostasis could also inhibit appropriate response to environmental stimuli [Gore,
2010].
Humans and animals can be exposed to EDCs though different routes - con-
sumption, inhalation, indirect exposure via contaminated tissue and excretions, and
through contaminated water [Diamanti-Kandarakis et al., 2009]. There are several
factors that must be considered in order to understand both the chemical and the
effect on the biological system. A review article by Diamanti-Kadarakis et al., 2009
lists a few of these critical factors that must be considered when understanding the
nature and effect of EDCs: “i) age : there are different effects and consequences of
exposure to a developing fetus or infant to that of matured adult, ii) sex : EDCs
may have sexually dimorphic effects on the organisms reproductive system, iii) la-
tency form exposure : there may be lag time between exposure and appearance
of the disease/disorder, iv) mixture : individuals/populations are exposed to many
compounds which may have synergistic or additive effects on each other, v) nontra-
ditional dose-response dynamics: any level of exposure to EDCs can cause endocrine
or reproductive abnormalities and may exert non-traditional dose-response curves
(inverted U or U-shaped curves) , vi) transgenerational, epigenetic effects: effects
might be transmitted by DNA methylation or histone acetylation which could mod-
ify factors regulating gene expression” [Diamanti-Kandarakis et al., 2009].
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3.3 Gut Health, Liver Metabolism, and Inflammatory Processes
In many ways, the intestinal epithelium is the first target for mycotoxins and the
first selective barrier against them [Grenier and Applegate, 2013, Liew and Mohd-
Redzwan, 2018]. A healthy gut in animals and humans helps to determine the
overall health of the host. There are many things that can be affected in the GI
tract (the largest endocrine organ in the body) which cause overwhelming impacts
for the rest of the body: such as alterations in enzyme activity, nutrient uptake,
digestive microflora interaction, epithelial barrier integrity, mucosal immunity and
more [Suzuki, 2013]. The transcellular pathway (transporters or channels on ba-
solateral or apical membrane absorb and transport nutrients, amino acid, peptide,
minerals, and vitamins) and the paracellular pathway (movement through intracel-
lular space between cells) help create selective permeability [Suzuki, 2013]. The
mucosal barrier acts as a selective barrier because it can regulate the paracellular
permeability through its tight junction protein structures (i.e. claudins (CLDN),
occludins (OCLN), cadherins, junction adhesion molecules (JAM), etc.) [Suzuki,
2013]. When the barrier function of the intestine is impaired this can mean in-
creased permeability or translocation of dietary antigens, bacterial pathogens, or
other harmful compounds (mycotoxins) which can then go on to over-activate the
immune system or other cellular damage [Akbari et al., 2017, Suzuki, 2013]. This
also means decreased nutrient absorption, which in the case of damage is in high
demand [Grenier and Applegate, 2013].
It has been reported that approximately 70% of immune defenses are located
within the GIT [Grenier and Applegate, 2013]. Intestinal epithelial cells and mucus
themselves are apart of the guts innate immune system. An immune response can
be induced by immunocomponent cells that are located on gut associated lymphoid
tissues (GALT) such as Peyers patch and, mesenteric lymph nodes [Grenier and Ap-
plegate, 2013]. Throughout the intestinal lymphoid tissue, dendritic cells (DCs) act
54
as a link between the innate and adaptive immune system by receiving, processing,
and distributing antigens to T-cells. The two effector sites, the epithelial layer and
the lamina propria (LP) have a range of different immune cells. Those within the
LP are macrophages, plasma cells, memory B-/T-cells, mast cells, cytotoxin natural
killer (NK) cells, and innate lymphoid cells [Grenier and Applegate, 2013,Maresca,
2013]. The innate lymphoid cells and other immune cells can produce cytokines
which are small peptide proteins that act as signals for cellular communication thus
stimulating the proliferation of antigen specific effector cells and regulating both
local and systemic inflammatory pathways [Grenier and Applegate, 2013, Maresca,
2013]. In low doses, mycotoxins can stimulate immune response and induce CYP en-
zymes, while higher doses suppress immune system and the increased accumulation
of toxins can lead to increased oxidative stress [Wen et al., 2016].
Experiments that show adverse effects on gut health can be seen with intesti-
nal barrier breakdown through: i) decrease in transepithelial electrical resistance
Figure 3.1: Normal vs. impaired barrier function (adapted and modified from [Gre-
nier and Applegate, 2013,Akbari et al., 2017]).
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(TEER) values, ii) increase in paracellular transport of a chosen compound/bacteria
(i.e. dextran, antibiotics), and iii) modulation of the expression of TJ proteins [Ak-
bari et al., 2017, Gao et al., 2017]. A decrease in TEER could be caused by an
alteration in paracellular permeability or from differences in transcellular ion flux
with alterations in plasma membrane channels and pumps [Akbari et al., 2017]. To
further confirm the permeability tagged paracellular markers can be used [Akbari
et al., 2017]. Alterations in expression and morphology of TJ proteins could be from
the disruption of protein synthesis, oxidative stress, and the activation of MAPK
pathways [Grenier and Applegate, 2013]. Additionally, studies have shown that co-
contamination of mycotoxins will have greater impairment on barrier integrity [Gao
et al., 2017,Bracarense et al., 2012].
Maresca et al., 2001 showed that Caco-2 (human epithelial colorectal adenocar-
cinoma) cells and HT-29-D4 (human adenocarcinoma) cells exposed to OTA had
disrupted barrier function with decreased TEER values [Maresca et al., 2001]. A
subsequent study with Caco-2 cells exposed to OTA up to 100 M had decreased
TEER value along with increased permeability of the paracellular markers horse
radish peroxidase (HRP 44kDa) and 4 kDa fluorescein isothiocyanate compound
dextran (FITC-dextran), and increased translocation of Escherichia coli at concen-
trations beginning at 1 M [Maresca et al., 2008]. Marin et al., 2015 exposed IPEC-1
cells to ZEA and α-/β-ZOL for 10 days at 25-50 M; the parent compound ZEA
has no effect on TEER values, however, α-/β-ZOL did induce decreases in TEER
values [Marin et al., 2015]. Additionally, an in vivo study Liu et al., 2014 gave rats
0.3-146 mg ZEA /kg bw for 7 days and found it decreased the transcription levels
of CLDN4 and OCLN transcription proteins [Liu et al., 2014]. Goossens et al.,
2012 showed the T-2 decreased TEER values and increases permeability to doxycy-
cline [Goossens et al., 2012]. Broiler chickens exposed to AFB1 (1.5 mg/kg bw) for 20
days showed increased transcription levels of CLDN1 and CLDN2 and increased in
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plasma lactulose and rhamnose ratio with growth inhibitory effects on proliferating
cells by altering the intestinal barrier and selected transport functions [Chen et al.,
2016]. Loiseau et al., 2007 exposed IPEC-1 cells to 50-200 M of FB1 which resulted
in decreased TEER values and increased permeability to FB1 [Loiseau et al., 2007].
Additionally, FB1 (0.5 mg/kg bw) given to piglets for 7 days significantly increased
the translocation of Escherichia coli [Oswald et al., 2003]. Most food/feed are con-
taminated by more than one mycotoxin as well as the presence of masked mycotoxin,
therefore, it is especially important to understand the combined effects of mycotox-
ins together [Grenier and Applegate, 2013, Pinton et al., 2012]. The effect of DON
on the intestinal barrier has been shown in IPEC-J2 (porcine jejunal enterocytes)
by Vandenbroucke et al., 2011 to increase translocation of pathogenic Salmonella ty-
phimurium [Vandenbroucke et al., 2011]. Pinton et al., 2012 showed that 15ADON
had greater toxicity than DON and 3ADON; all were able to decrease TEER values,
increase permeability, and decrease protein expression of CLDN3 and CLDN4 [Pin-
ton et al., 2012]. Bracarense et al., 2012 showed that exposure of 5 week old piglets
to both DON + FB1 had various interactions (synergistic/additive/antagonistic)
depending on the test parameter but in general significantly induces morphological
and histological changes that suggested FB1 in the presence of DON could absorbed
more through intestinal barrier disruption [Bracarense et al., 2012]. Gao et al.,
2017 showed that both AFM1 and OTA alone and combined can effect intestinal
epithelial cells, however, when combined they have and additive/synergistic affect
on barrier function [Gao et al., 2017].
Some mycotoxins can disrupt nutrient absorption directly, or indirectly. Stevens
& Tang 1997 treated Caco-2 cells with FB1 which showed inhibited receptor-mediated
uptake of folate by 50% [Stevens and Tang, 1997]. Other mycotoxins (i.e. DON and
T-2) have been shown to interfere with glucose absorption by suppressing the ex-
pression of important transport proteins like the sodium glucose transport protein
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1 (SGLT) and glucose transporter 2 (GLUT2) [Maresca et al., 2002,Maresca, 2013].
Also, morphological alterations to micro villi as well as decreased mucosal produc-
tion can also interrupt nutrient absorption and cause inflammatory effects [Grenier
and Applegate, 2013].
The liver plays an important role in metabolism (i.e. lipid, cholesterol, amino
acid), nutrient and glycogen storage, and biotransformation/detoxification and re-
moval of toxins, production of various proteins (i.e. albumin, clotting factor, trans-
port, antimicrobial, lipoproteins), and immunologic response activity. Approxi-
mately 80% of hepatic blood supply comes from the portal vein after it picks up
various dietary antigens, molecules from gut microflora, mycotoxins, cellular signal-
ing molecules etc. The liver undergoes constant and highly regulated inflammation
and resolution: i) hepatocytes detect cytokines from the blood stream and initiate
Table 3.4: Mycotoxin effects on intestinal barrier functions.
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systemic response, ii) recruitment and production of more immune cells/cytokines
(i.e. IL-6) occurs within the liver and leads to tissue fibrosis, iii) protection mech-
anism in place to reduce liver cell sensitivity and save undamaged cell tissue, iv)
liver cell regeneration is activated by macrophage production of pro-resolution me-
diators [Robinson et al., 2016, Ramachandran and Iredale, 2012]. However, if liver
homeostasis is dysregulated, chronic inflammation and fibrosis without regenera-
tion could occur and lead to liver damage, chronic infections, autoimmunity, and
metabolic disorders [Robinson et al., 2016,Kensler et al., 2010]. Aflatoxin has been
shown to cause lipid accumulation in liver cells (steatosis) of animals because of its
effects on liver enzyme activity and genes related to lipid metabolism and when in
conjunction with Hepatitis B virus X antigen (HBx) and other dietary risk factors
(i.e. high fat/cholesterol/alcohol) can lead to hepatocellular carcinoma [Groopman
et al., 1985,CAST, 2003,Lu et al., 2013].
Growth hormone (GH) is a peptide hormone involved in growth promotion, cell
division, and regeneration. It is released by the anterior pituitary somatotroph cells.
Insulin like growth factors (IGF1) gets its name by its similarity with insulin. It
is secreted in response to GH binding to the surface of liver cells, IGF1 then acts
on growth plates at the end of long bones to promote growth. In addition to bone
growth. IGF1 also stimulates differentiation and proliferation of myoblasts for mus-
cle growth as well as stimulating amino acid uptake and protein synthesis in several
tissues. The production of IGF1 occurs in the liver primarily, however, periph-
eral tissues (bone and cartilage) may also be synthesizers. Linear growth (height)
in immature organisms is the main action of GH via IGF1, therefore a deficiency
somewhere along the system could result in shorter stature or growth issues. Fol-
lowing subchronic and chronic DON exposure studies, it had been thought that feed
refusal and thereby decreased food consumption was the cause for reduced weight
gain [Prelusky, 1993, Akbari et al., 2017, Grenier and Applegate, 2013]. Prelusky,
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1993 proposed that DONs accumulation in the brain and interactions with serotonin
resulted in a behavioral modification through appetite control pathways [Prelusky,
1993]. However, DON also induces pro-inflammatory cytokines from multiple loca-
tions, and subsequent expression of suppressors of cytokine signaling (SOCS) which
have the potential to interrupt GH signaling [Amuzie and Pestka, 2009b, Grenier
and Applegate, 2013,Grenier and Applegate, 2013]. Amuzie & Pestka 2009 reported
that 4-week old mice fed DON (20 ppm) for 2-8 weeks showed decreased weight gain,
steady-state DON plasma concentrations, down regulated hepatic mRNA expression
of insulin-like growth factor acid labile subunit (IGFALS), and decreased circulating
IGF1 and IGFALS levels [Amuzie and Pestka, 2009b].
Calcium signaling is vital in immune cells (T lymphocytes) and tumor cells are
regulated by continuous Ca2+ ion flux for survival, activation and proliferation.
Disruption of calcium signaling can result in over activation of immune system,
nephrotoxicity, and neurodegenerative diseases [Grenier and Applegate, 2013]. Im-
mortalized human kidney epithelial cells (IHKE-1) treated with OTA resulted in
disrupted Ca2+ hormonal signaling and altered cell proliferation effects [Benesic
et al., 2000,Ringot et al., 2006].
3.4 Reproductive Toxicity
Phytoestrogens (estrogens produced from plants) and mycoestrogens (estrogens pro-
duced from fungi) are some examples of naturally occurring EDCs that can be reg-
ularly found in animal feed and human food [Patisaul and Jefferson, 2010]. The
mycotoxins ZEA and its derivatives (α-ZAL, β-ZAL, α-ZOL, β-ZOL, and zear-
alanone/ZAN) are resorcyclic acid lactones and fall under the category of mycoe-
strogens [Tatay et al., 2017, Bräse et al., 2013]. They are structurally analogous
to estrogen and have shown estrogenic activity in vitro and in vivo [Tatay et al.,
2017]. A review by Kowalska et al., 2016 discussed several ways that ZEA exhibits
disrupting effects on the endocrine system in animals and humans [Kowalska et al.,
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2016]. The ability of ZEA to competitively bind with estrogen receptors can lead to
hyperestrogenism, and these abnormally elevated levels of estrogenic activity in the
body can result in infertility issues such as the inhibition of oocyte maturation and
the disruption of cortical granule free domains (CGFD) which could prohibit fertil-
ization ability [Minervini and DellAquila, 2008, Demaegdt et al., 2016, Hou et al.,
2015].
Several studies have found that placental tissue disturbed by AFB1 results in
hormonal imbalance through the inhibition of estrogen synthesis or an increased
expression of corticotropin-releasing hormone (CRH) [Wang et al., 2016,Zhu et al.,
2016,Storvik et al., 2011]. In vivo studies with pregnant mice exposed to AFB1 late
in gestation have shown earlier delivery times, and placental tissue with elevated
levels of crh mRNA expression [Wang et al., 2016].
Storvik et al., 2011 treated JEG-3 cells with (0.3 - 1.0 M) AFB1 and found that
it induced expression of CYP19A1, metabolized AFB1 to AFL (aflatoxicol), and
also interrupted the expression of aromatase (enzyme needed for estrogen synthesis)
[Storvik et al., 2011]. This could be one potential endocrine disrupting effect of
AFB1 [Storvik et al., 2011]. Another study conducted by Zhu et al., 2016 looked
at the effect of AFB1 in human placental JEG-3 cells also [Zhu et al., 2016]. They
found that AFB1 treated JEG-3 cells showed a dose-dependent increase of COX-
2 expression, with significant increases at 0.1 nM AFB1. The initial increase in
intracellular calcium could then activate the PKC-ERK signaling pathway. It has
been observed that COX-2 is necessary for reproductive functions, and that defective
or absent cox-2 genes could cause infertility. Other AFB1 effects have been shown
to cause fetal growth retardation, increased fetus malformations/birth defects, and
toxin accumulation in eggs from laying hens and AFM1 accumulation in milk for
dairy cows [Roll et al., 1990,Jia et al., 2016,CAST, 2003].
In steroidogenesis, cholesterol is converted to testosterone by a cascade of en-
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zymes. Luteinizing hormone (LH) is secreted by the pituitary gland under go-
nadotropin releasing hormone (GnRH) stimulus and the transcription of genes in-
volved in testosterone biosynthesis in the (interstitial) leydig cells is induced. Steroido-
genic acute regulatory protein (StAR) is a rate limiting protein that transports
cytosol to the mitochondria. In the mitochondria cholesterol is converted to pre-
nenolon and the transported to the smooth ER for remaining steps. Sertoli cells form
the blood testis barrier (BTB) form around germ cells. If a toxin impairs/inhibits
any of the steps in the biosynthesis processes involved in steroidogenesis, barrier
cells involved, spermatogenesis could be disrupted resulting in adverse effects on
reproductive capacity [Liu et al., 2014,Zheng et al., 2018]. Supriya et al., 2014, con-
Table 3.5: Toxicity of AFB1 and DON.
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Table 3.6: Toxicity of various mycotoxins.
ducted a study using male Wistar rats to determine the effect through a complete
spermatogenic cycle [Supriya et al., 2014]. They found that AFB1 competitively
binds to StAR proteins, and interrupts cholesterol transport into mitochondria and
decreases the biosynthesis of testosterone which is required for spermatogenesis, and
low levels affect quality of sperm. Alternatively, ZEA decreased TM4 mouse sertoli
cell viability with increased doses [Zheng et al., 2018]. The authors found that,
ZEA was able to cause cytoskeletal structural damage and possibly disrupt sper-
matogenesis [Zheng et al., 2018]. Yang et al., 2015 showed that T-2 was able to
decrease testosterone production by inhibiting the expression and activity of key
steroidogenic enzymes [Yang et al., 2015]. Sprando et al., 2005 gave male rates
0.5-5.0 mg DON/kg bw for 28 days, they showed that groups dosed with 2.5 and
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5.0 mg/kg had characteristic male reproductive toxicity endpoints and sperm tail
abnormalities (5.0 mg/kg bw) [Sprando et al., 2005]. There were dose-related de-
creases in spermatid number, increases in serum FSH and LH, and decreases in
serum testosterone [Sprando et al., 2005].
3.5 Summary
The extent to which a mycotoxin effects an individual depends greatly on the species,
sensitivity, age, gender, nutritional status, and any predisposed genetic condition or
viral infection (i.e. HBV). Gut health is important to overall health of the organism’s
system it relies on structural barrier integrity, and immune responses (innate and
adaptive). Interruption to barrier integrity with subsequent activation of inflamma-
tory responses can lead to systematic inflammation. Furthermore, mycotoxins can
interfere with critical metabolic processes and can alter nutrient absorption. Addi-






Despite the seemingly endless variety of food items available to us on a daily ba-
sis in developed countries there are really just a few staple crops that make up
the human diet, regardless of the socio-economic standing of the country. Cereals,
such as rice, wheat, maize, sorghum, and millet are estimated to make up 50 to
54% of calories consumed by humans alone in developed and developing countries
respectively [Kearney, 2010]. Food and feed can be directly contaminated by the
presences of mycotoxins in plant materials or products and can be indirectly con-
taminated through carry-over of the mycotoxin or metabolite into animal tissues,
milk, and eggs from bioaccumulation [Yang et al., 2014,CAST, 2003,Escrivá et al.,
2017].
Dietary intake studies can help identify health hazards and gives scientists, re-
searchers, and policy makers a birds eye view of food consumption patterns and
potential toxins. In order to characterize the mycotoxin associated risks to indi-
viduals or populations, a thorough exposure assessment must be performed eval-
uating food intake and mycotoxin induced health effect along with any available
dose-response relationship (hazard characterization) information [Codex Alimenta-
rius Commission, 2003, World Health Organization, 2009]. These studies can also
help to identify populations at risk of mycotoxin exposure by collecting information
on the kind of foods they are eating and in what quantities. Identifying people at
risk to mycotoxin exposure is important for all populations, especially in areas where
the diet consists of a single crop, the conditions are favorable for fungal growth and
mycotoxin production, and very limited knowledge, regulation, or technology for
proper handling procedures [CAST, 2003].
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4.1.1 Food Consumption Patterns, Mycotoxin Contamination, and Exposure As-
sessments
The basis of an exposure assessment is to evaluate the probable ingestion of a con-
taminant with either qualitative or quantitative methods [World Health Organiza-
tion, 2009]. For humans or animals, researchers combine food consumption data
with available information on the occurrence of the contaminant in question from
tested samples [De Nijs et al., 2016]. Data will need to include in depth information
about the food product, the food chain, the microbiological hazard, and the con-
sumer. Information on food products would include geographical location of origin,
seasonal variety, storage time, and processing if any. Food chain information should
include descriptions from every step of the production process as it pertains to pro-
duction practices, hygiene practices, and environmental conditions [World Health
Organization, 2009,CAST, 2003]. Prevalence and level of contamination for hazard
data should also reflect relevant factors for onset, growth, survival, distribution, and
any decontamination measure. Consumption data can be characterized by social,
economic, geographic, gender, or age related factors as well as the frequency or
handling practices of products [World Health Organization, 2009].
There are many challenges associated with data from consumption surveys, par-
ticularly when predicting patterns for whole populations without considering vari-
ations among groups of people who adhere to different diets due to age, disease,
cultural or religious customs. Although it is often difficult to obtain, data can be
found from a variety of methods and sources. Data can be collected from question-
naires in epidemiological surveys such as case-control and cohort studies, however,
they are limited by their costliness, small sample group, and are not readily accessi-
ble by the public due to the inability of the studies to disclose personal information
on subject. When data is limited or contains extreme gaps, modeling techniques can




There are a number of national and international surveillance systems in place for
general food consumption as well as toxin contamination. Many agencies help sup-
port surveillance programs and have different duties.
The USDA partners with other agencies such as the National Center for Health
Statistics (NCHS), Centers for Disease Control and Prevention (CDC), Department
of Health and Humans Services (DHHS), Agricultural Research Services (ARS), and
the Food and Drug Administration (FDA) to run the surveillance program What
we eat in America (WWEIA) and the National Health and Nutrition Examination
Survey (NHANES), which collect and quantify dietary data on nutrient composi-
tion and food consumption [Ahuja et al., 2012]. See figure 4.1 for food consumption
for total population. The databases associated with these are National Nutrient
Database for Standard Reference (SR) and the Food and Nutrient Database for
Dietary Studies (FNDDS) [Ahuja et al., 2012]. From WWEIA and NHANES, to-
tal diet market basket studies can be conducted that evaluate many contaminants
and nutrient intake [Ahuja et al., 2012]. It should be mentioned that the USDAs
TDS surveillance focuses mainly on toxic elements, pesticide residues, and radio
nucleotides, not mycotoxins; however, the data can be used in conjunction with
information from other regulatory bodies that do monitor mycotoxins.
For European countries, the European Food Safety Authority (EFSA) set up
a data collection and analysis system on the food supply chain in EU member
states [Szűcs et al., 2013]. To obtain more accurate and reliable exposure assess-
ment information, they developed the Comprehensive European Food Consumption
Database and a hierarchical food classification system (FoodEx) [Szűcs et al., 2013].
The FoodEx 2 is even more advanced and allows for food classification and de-
scription at a global level and could act as a common language for all databases.
Continuing their theme for a more harmonized approach, the EFSA launched the EU
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Table 4.1: Surveillance Systems for Food Consumption and Contamination (ab-
breviations National Health and Nutrition Examination Survey (NHANES), What
we eat in America (WWEIA), National Nutrient Database for Standard Reference
(SR), Food and Nutrient Database for Dietary Studies (FNDDS), Joint Expert
Committee of Food Additives (JECFA), Global Environmental Monitoring Sys-
tem (GEMS/Food), Chronic Individual Food Consumption Database and Summary
Statistics (CIFOCOss), Global Individual Food Consumption Data Tool (GIFT).
[Ahuja et al., 2012,Ahuja et al., 2017,EFSA, 2015a,EFSA, 2013,EFSA, 2014,EFSA,
2015b,FAO, 2018].
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Menu project (Whats on the menu in Europe?), this EU wide survey is proclaimed
as more age appropriate and covers all four seasons throughout the 2012-2017 col-
lection period [Szűcs et al., 2013].
In 1976, Global Environmental Monitoring System - Food Contamination and
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Figure 4.1: Total foods consumed in g/day for total U.S. population. For Child
consumption vs Adult consumption see figure A.11 Source: 2007-10 National Health
and Nutrition Examination Survey
Monitoring (GEMS/Food) was established to help provide information and trends to
governing bodies about food consumption and contamination. They collect data for
hazard occurrence, food composition, and food consumption for sharing information
on international risk [World Health Organization, 2009]. As part of a collaboration
with the WHO working group, and 30 more collaborative agencies and center. Us-
ing data from food balance sheets, WHO and GEMS/Food created 5 regional diet
patters (Middle Eastern, Far Eastern, African, Latin American, and European),
this was later transformed in 1997 into 13 cluster diets for 183 countries [World
Health Organization, 2009, Szűcs et al., 2013, World Health Organization, 2014, Sy
et al., 2013]. In 2012, GEMS/Food introduced 4 additional clusters (17 cluster diets
total) [Szűcs et al., 2013,World Health Organization, 2014,World Health Organiza-
tion, 2012,Sy et al., 2013]. In this cluster method, the US falls into G10 along with
Belarus, Bulgaria, Canada, Croatia, Cyprus, Estonia, Italy, Japan, Latvia, Malta,
New Zealand, Republic of Korea, and Russia [World Health Organization, 2012,Sy
et al., 2013,World Health Organization, 2014]. See figure 4.2for products consumed
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Figure 4.2: Products consumed in g/day data from Group 10. To see complete
breakdown of food items see appendix. Data from [World Health Organization,
2012].
in grams per day for GEMS/Food 2012 Cluster Diet G10.
Chronic Individual Food Consumption Database and Summary Statistics (CIFO-
COss) is a newly developed database by WHO and FAO that aims to harmonize
data and make it publicly accessible [De Nijs et al., 2016, FAO/WHO, 2017]. The
criteria for its data are food consumption surveys that have a duration of 2 or more
days, thus representing a more chronic range of consumption. Currently, they have
the summary statistics from 37 surveys of 26 countries (17 within the EU). The dis-
semination platform meant to make data accessible is the Global Individual Food
Consumption Data Tool (GIFT) [FAO, 2018].
The Joint FAO/WHO Expert Committee of Food Additives (JECFA) is re-
sponsible for evaluating food additives as well as naturally occurring contaminants
and veterinary drug residues. They develop and assess principles for quantifying
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risk, analytical methods, and guidance values of exposure for reliable and harmo-
nized information [FAO/WHO, 2017]. Through toxicological evaluations, they es-
tablish acceptable daily intakes (ADI) or tolerable intakes for acute and chronic
exposure [FAO/WHO, 2017]. Still there are many more food consumption surveys
conducted by national bodies that are not listed here. The main goal of these
international organizations is to develop a harmonized approach that allows for
comparisons and easy access for scientific evaluations and risk assessment decisions.
4.1.3 Food Monitoring Surveys, Total Diet Studies, and Duplicate Diet Studies
Several different types of data collection strategies can be used for assessing food
consumption and exposure to mycotoxins. A review article by de Nijs et al., 2016
concisely describes established exposure assessment strategies using various data
collection methods that can make up food consumption surveys (FCSs). These
strategies include the use of food monitoring studies, total diet studies, and dupli-
cate diet studies along with developing methods in human biomonitoring. Many
FCSc are based on questionnaires or surveys that try to estimate the amount and
the frequency of foods consumed that are suspected of being contaminated by my-
cotoxins [De Nijs et al., 2016]. These are compiled into databases by national and
international organizations for further assessment.
Mycotoxin occurrence data can be collected using food monitoring studies, total
diet studies, and duplicate diet studies. All of which can be used for chronic and
Table 4.2: Range of mycotoxin concentration levels that may occur in nature (ng/g)
(adapted from [Grenier and Applegate, 2013]).
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Table 4.3: Contamination levels of mycotoxins in assorted food and feed products
from North America only.
acute exposure assessment with strategies such as point estimates, observed indi-
vidual mean, or a probabilistic approach [De Nijs et al., 2016]. In food monitoring
studies (FMS), random samples from any point along the food supply chain can
be collected/tested to assure compliance within regulatory and legal limits [De Nijs
et al., 2016]. Table 4.2 shows a range of mycotoxin concentration level that can be
found in nature, these ranges come from studies from multiple countries and help
illustrate what may usually occur vs. the worst case scenario from bad weather
conditions or something enhancing fungal ability to produce mycotoxins [Grenier
and Applegate, 2013].
Mycotoxin occurrence data can also be found via food recall databases, such
as the Rapid Alert System for Food and Feed (RASFF) or WHOs Global Environ-
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Table 4.4: Contamination levels in border detection of US products. There are
several hundred more examples, these are just show the kinds of mycotoxins are
common occurrences/ issues [RASFF, 2018].
Product Contaminant Conc. Classification Notifying Country M-D-Y
spaghetti OTA: 7.2 mg/kg border rejection Finland 12-18-12
pistachios OTA: 32 µg/kg alert Netherlands 8-9-16
pistachios OTA: 44 µg/kg (AFB1: 18; AF Tot: 20 µg/kg) border rejection Netherlands 1-18-17
pistachios OTA: 94 µg/kg border rejection Netherlands 2-24-17
soft wheat DON: 1676.6 µg/kg border rejection Italy 7-1-16
common wheat DON: 3.138 mg/kg border rejection Italy 7-7-16
maize DON: 2688 µg/kg information Ireland 8-28-17
soya hulls (feed) ZEA: 0.76 mg/kg alert U.K. 8-27-07
dog food AFB1: 22 µg/kg info Finland 2-22-06
peanut butter AFB1/AFTot: 3.7/4.4 µg/kg border rejection Cyprus 4-7-17
groundnuts for birdfeed AFB1: 220 µg/kg border rejection Netherlands 11-16-17
unshelled pistachios AFB1/AFTot: 270/290 µg/kg alert Netherlands 1-12-18
groundnuts AFB1/AFTot: 4.7/14.92 µg/kg border rejection Netherlands 1-17-18
unshelled pistachios AFB1/AFTot: 8/10 µg/kg border rejection Italy 1-18-18
pistachios in shells AFB1/AFTot: 45.3/51.3 µg/kg border rejection Lithuania 1-19-18
pistachios in shells AFB1/AFTot: 16/17 µg/kg border rejection U.K. 1-31-18
ment Monitoring System/Food Contamination Monitoring and Assessment Program
(GEMS/food) [World Health Organization, 2009,De Nijs et al., 2016]. Food moni-
toring studies are helpful in providing point estimates with an overall exposure esti-
mated for entire geographic regions, which are help initial risk identification [De Nijs
et al., 2016].
Total diet studies (TDS) sample food from diets that are prepared as they would
be consumed [Tanase et al., 2011]. The market basket approach can parallel the
dietary habits of a given population [Raad et al., 2014,Tanase et al., 2011]. Processed
and cooked food items are analyzed, not just single food items. Mitchell et al., 2017
conducted a risk assessment for dietary OTA in the USA [Mitchell et al., 2017].
They compiled occurrence data from previous studies that collected food and drinks
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from grocery stores throughout the US during 2012 and 2013. In total, 2296 food
susceptible to OTA contamination were randomly selected at different times and
from 9 different locations (IL, CA, TX, PA, ND, ID, MN, MI, NE); these samples
were then analyzed to determine contamination values. Consumption information
by age group (<12 mo, >12 mo-5yrs, >5yrs-18yrs, and >18yrs) from What we eat in
America was used to determine dietary exposure for each commodity by multiplying
daily consumption (ng/kg bw) with the related median OTA contamination levels
from the samples for an observed individual mean. In Fig. 4.5 the tolerable daily
intake (TDI) or the provisional maximum tolerable daily intake (PMTDI) which
is set by JECFA and based on the most sensitive no-observable-adverse-effect-level
(NOAEL) studies is shown for several mycotoxins, except for CIT which only has
a level of no concern. The estimated dietary intake (EDI) (see equation 4.1) of
different mycotoxins for average U.S. adult were compiled from different studies
with U.S. data (AFB1, OTA, ZEA) or from JECFA global averages. There is no
EDI average for CIT so one was calculated using both GEMS/Food Cluster Diet
(283.8 g/day) and USDA/NHANES (183 g/day) food consumption data estimates
with the lowest CIT occurrence level of 19 µg/kg in cereal grains [World Health
Organization, 2012, World Health Organization, 2014, EFSA, 2012]. Both EDIs for
CIT were calculated to show the difference in exposure estimates given the difference
in consumption data. The percentage of the TDI/PMTDI consumed with the EDI
is given for each mycotoxin; the average EDI for AFB1 in the average American
adult is almost double the TDI and DON is 100% of health based guidance value.
Another TDS was conducted by Sirot et al., 2013 in France using food data from
the second national individual dietary consumption survey (INCA2) that occurred
from 2006-2007, and required a 7-day food diary and questionnaire [Sirot et al.,
2013]. From the survey, 212 core foods were selected based on their consumption
popularity and possible contributions to exposure. All samples were prepared as
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Table 4.5: Estimated dietary intake of mycotoxin by U.S. adult and the percentage
of the PMTDI/TDI that they comprise or exceed. The EDIs were collected from
different studies involving U.S. population data or calculated [Mitchell et al., 2017,
Zinedine et al., 2007,EFSA, 2012,CAST, 2003](Wogan et al., 1974, Kuiper-Goodman
et al., 2010, EFSA 2011, Cressey 2014)
would be cooked described in the INAC2 survey and then subjected to analysis for
25 mycotoxins; levels were determined with lower bound (LB) and upper bound
(UB) approach. From this data, they found that adults and children exceeded
the guidance values for DON (1000 ng/kg bw/d) and for T-2 and HT-2 (60 ng/kg
bw/d) [Sirot et al., 2013].
Alternatively, a duplicate diet study (DDS) will sample duplicates of the same
foods that are consumed by an individual over a 24 hour period by an individual in
the study [De Nijs et al., 2016]. Sizoo & Van Egmond 2005 analyzed a 24 hour DDS
for AFB1, AFM1, and OTA in 123 participants from s small Dutch village [Sizoo and
van Egmond, 2005]. To represent seasonal fluctuations, dietary collection periods
were separated and obtained in March and then in September of 1994. The authors
stated that the results of their DDS were comparable to those of another study
determined via probabilistic exposure assessment that used food consumption data
and mycotoxin concentration from individual food product [Sizoo and van Egmond,
2005].
From 2012 to 2016, Frances ANSES led a 4 year collaborative research project
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with 26 partners from 19 different countries called the TDS-Expsoure project which
focused on many food contaminants and mycotoxins [ANSES, 2018a]. The project
was funded by the EU, the projects objectives were to “i) identify how TDSs could
benefit exposure information, ii) develop TDSs throughout Europe by use of small
scale studies, iii) harmonize the TDS method and use a Quality Management System,
iv) create a database that is available for further assessment and management”
[ANSES, 2018b]. Through collaboration and evaluation, countries that have high
levels of mycotoxin contamination could establish TDSs that focus on whichever
mycotoxin is most prevalent. The outcome of this project is slowly trickling into
scientific reports and will hopefully expand the available information on mycotoxin
contamination to different populations and can increase the available data about
mycotoxin contamination.
4.1.4 Equations and Calculations
In order to calculate the exposure estimates, both occurrence data and consumption
data is combined. The different approaches that can be used are either probabilistic
or deterministic methods. The general equation for assessing the dietary exposure
is given by:
Dietary Exposure =
Σ conc. of mycotoxins in food x food consumption
Body Weight
, (4.1)
where the dietary exposure is defined as the concentration of mycotoxin in the food
multiplied by how much food is consumed divided by the weight of the individual
[World Health Organization, 2009,De Nijs et al., 2016].
A deterministic approach uses known/available data measured from the food
product as well as the data gathered from food consumption studies [World Health
Organization, 2009]. A point estimate would be a value from one mycotoxin and
one input of consumption [De Nijs et al., 2016]. The observed individual mean
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would use the mean mycotoxin concentration per food product multiplied by the
food consumed per day per consumer that has been averaged over the amount of
days shown in the survey [De Nijs et al., 2016, Boon et al., 2015]. For both of
these deterministic methods, either means, minimum/maximums, of 95th percentile
values can be used [World Health Organization, 2009, Assunção et al., 2016]. Al-
ternatively, the probabilistic method, can utilize mathematical models to determine
the probability of an exposure estimate [World Health Organization, 2009, De Nijs
et al., 2016, Assunção et al., 2016]. In place of having any one value input, these
models use distribution functions. The most used model for this approach is Monte
Carlo simulations [CAST, 2003, World Health Organization, 2009, De Nijs et al.,
2016]. There are relative uncertainties with each method.
4.1.5 The downside of memory-based assessment methods
Alternatively, nutrient and food consumption intake methods based on memory-
based dietary assessment methods (M-BM) could lead to misrepresented inferences
based on flawed data. These M-BMs such as FFQs or 24 hour recalls which are taken
in the form of interviews and surveys are open to error and flawed in their designs.
A review by Archer et al., 20125 suggests that M-BM data does not realistically
represent the actual energy and nutrient consumption of the individuals studied
[Archer et al., 2015]. Their reasoning for the inadmissibility of this nutritional
epidemiological research data is rooted in the flaws of the collection methods used
due to the inaccuracy of human memory, adherence to protocols that illicit false
recalls, and the subjective nature of the data in general. Some of the evidence they
give in support of their theory, is the disparity between NHANES M-BM data and
USDA Food Availability economic data, where trends in one have been historically
opposite of the trends in the other [Crane et al., 1992,Archer et al., 2015].
Considering this, it would stand to reason that mycotoxin exposure estimates
based off of M-BMs may be widely inaccurate. These inaccuracies may be further
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compounded by the questionable reliability and difficulties in sampling procedures
and analytical methods used to obtain occurrence data [Miraglia et al., 1996]. This
could potentially lead to both drastic over and underestimations. Biomonitoring
of mycotoxins in tissues and fluids of animals and humans offers an appealing and
more accurate approach to exposure and risk assessments.
4.2 Biomarkers and biomonitoring
Biomarkers offer a more accurate measure of individual level exposure that can relate
to the internal dose [Routledge and Gong, 2011]. They can help uncover various
aspects of its metabolism as well as determine the mechanism of action; excreted
mycotoxins and their metabolites, interaction products, or DNA adducts can be
important biological markers of exposure [Routledge and Gong, 2011].
Biomarkers can be divided into three groups: exposure, effect, and susceptibility.
Exposure biomarkers help to determine the presence of toxins and their metabolites
as well as the severity of recent or prior exposure [Miraglia et al., 1996]. These
can be used in health risk assessments, occupational safety, and epidemiological
studies which can help guide and influence public health regulations [Kensler et al.,
2010, Groopman et al., 2005]. Examples of biomarkers of exposure are conjugated
or unconjugated mycotoxins found in plasma and tissue or excreted in urine, feces,
milk [De Nijs et al., 2016]. The presence of a mycotoxin in a biological sample
matrix is not necessarily indicative a certain risk. Therefore, biomarkers of effect
maybe more useful when conducting risk assessments. Biomarkers of effect show the
occurrence and severity of any biological response from the toxin exposure and can
be applied to hazard identification [Kensler et al., 2010]. Examples of biomarkers of
effect are DNA mutations, DNA adducts, altered mRNA expression, or interrupted
metabolic pathways.
Aflatoxin biomarkers of effect can offer insight into exposure and the passage of
time; AFB1N7-Guanine is used for recent exposure studies and detection of AFB1-
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albumin or AFB1-lysine can be used for longer exposure studies (few months) due
to the longer half life of albumin [Scholl and Groopman, 2008]. Fumonisins inhibit
ceramide synthase and disrupts the sphingolipid metabolism which then leads to
build up of sphinganine-1-phosphate (Sa1P) and sphingosine-1-phosphate (So1P)
levels, therefore, Sa:So rations may be useful in evaluating the effect but also contend
with a great degree of variation [Voss and Riley, 2013,Riley et al., 2015].
The final biomarker category is that of susceptibility, which aims to provide
information about inter-individual sensitivity, this can be an inherent or acquired
trait that can initiate associations between environmental toxins and the onset of
a clinical diseases [Groopman, 2017, Kensler et al., 2010]. Basically, the ability
of an organism to respond based on differences in different genotype/phenotype,
environmental exposure, and modified diet. Examples of susceptibility biomarkers
can be a genetic polymorphism or altered metabolic enzymes [Kensler et al., 2010].
4.2.1 Current biomarker/biomonitoring
Absorption, distribution, metabolism/biotransformation, and excretion of the my-
cotoxin are part of the foundation for developing a specific biomarker [Routledge
and Gong, 2011]. Different matrices such as blood, urine, milk, or tissue samples will
have different biomarkers. Various fluid, tissue, and organ samples of animals can
be analyzed to determine adverse effect, bioaccumulation and subsequent potential
for contamination up the food chain. Many methods and studies are developed and
validates on animal species such as pigs and lab rats before being used in human
studies. Additional factors that need to be considered are ”i) sample collection
method, ii) sample extraction and preparation, iii) sensitivity of assays, iv) cost,
and v) reliability,” [Routledge and Gong, 2011,Turner et al., 2015]. Sometimes the
methods that work for in vitro or in vivo studies may not be applicable to human
population studies, because of either detection sensitivity or species differences in
metabolism [Escrivá et al., 2017]. Noninvasive fluid or tissue collection methods
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may be preferred for human studies because invasive collection methods might limit
a sample pool and increase costs. Methods that minimize analyte losses during ex-
traction and cleanup and from matrix effect, have increased sensitivity, and that
conserve time are the most effective methodologies. Validation criteria biomonitor-
ing methods are defined by the EU commission regulations.
Parameters of quantification and detection are very important to method vali-
dation and can greatly impact the accuracy of risk assessments [World Health Or-
ganization, 2009]. The Limit of Detection (LOD) is the lowest concentration of
the analyte that can be detected without quantification under the stated experi-
mental conditions [FAO/WHO, 2017]. The Limit of Quantification (LOQ) is the
lowest concentration of an analyte determined with acceptable levels of compounds
in sample matrix [World Health Organization, 2009]. These (LOQs) should be as
low as possible and much lower than any regulatory limit. Contaminants, especially
mycotoxins, are present in foods at very low levels which can be easily missed if
the detection techniques are not sensitive enough and data without a quantification
(censored data) may then become a source of misrepresentation for exposure calcu-
lation [World Health Organization, 2009,FAO/WHO, 2017]. The resulting risk can
then become either an underestimation or an overestimation [FAO/WHO, 2017].
Sample extraction and clean up and analytical detection methods used for human
biomonitoring are similar to those used for detection in other food matrices, and will
only be briefly discussed discussed here. Previous analytical methods used to detect
mycotoxins in human biological samples were liquid chromatography coupled to
a fluorescence detector (LCFD) or enzyme-linked immunosorbent assays (ELISA),
however, these were not without their issues. Extensive sample preparation for
LC-FD and the potential for target compounds to cross react with metabolites or
matrix components in ELISA methods make them less optimal when compared to
more recent analytical methods using LC systems coupled with mass spectrometers
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(LC-MS) [Capriotti et al., 2015,Turner et al., 2015].
In the late 1980s Fenn et al., 1989 developed electrospray ionization (ESI) that
ionizes intact (no fragmentation) chemical species through multiple charging and
helped pave the way for proteomics [Fenn et al., 1989, Banerjee and Mazumdar,
2012]. This analytical process has greatly enhanced the ability of LC-MS methods
to further elucidate information and understanding about the structure of mycotox-
ins and their interactions [Banerjee and Mazumdar, 2012]. Additionally, the recently
developed ultra high performance liquid chromatography (UHPLC) has the advan-
tage of smaller incorporation of tandem quadruple mass spectrometers (MS/MS) or
high resolution mass spectrometry (HRMS) there is enhanced specificity, reliability,
and sensitivity and therefore become more common in research [Gumustas et al.,
2013,Turner et al., 2015]. That being said, LC/ESI-MS/MS system are vulnerable
to sensitivity and selectivity issues from matrix effect, which is the differential re-
sponse of an analyte in a standard solution compared with the same analyte in a
biological matrix [Kebarle and Tang, 1993]. A recent article by Shaw et al., 2014
describes how these effects interrupt chromatographic behavior and ionization and
possible ways to overcome these issues (i.e. use of a internal standard) [Shaw et al.,
2014].
One of most important ways to not only prevent interfering matrix compounds
but to also increase sensitivity and reproducibility of the analysis is through careful
sample preparation and extraction methods [Shaw et al., 2014]. When combined
with LC-MS, either a direct or indirect approach can be taken. A direct approach
called dilute and shoot (DaS) does not require enzymatic hydrolysis of the sample
but instead relies on commercial reference standards for a specific mycotoxin and
major urinary metabolites and other synthesized standards for glucuronide conju-
gates [Huybrechts et al., 2015]. It can forgo the added costs of sample cleanup and
the risk of losing biomarkers in those processes, however, this can be problematic
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due in part to the limited amount of available commercial reference standards and
the costly and time consuming requirements for a lab to make their own [Huybrechts
et al., 2015]. For example, Warth et al., 2011 developed a direct method for DON
exposure using DON and an in house synthesized DON-3-O-glucuronide (D3GlcA)
because there were no commercially available standards for conjugated mycotoxins
like DON-GlcA [Warth et al., 2016].
An indirect approach will determine total mycotoxins once the sample has been
subject to enzymatic deconjugation and sample clean-up. This can be done through
a variety of methods such as immunoaffinity clean up (IAC), solid-phase extraction
(SPE), liquid-liquid extraction (LLE) [Mally et al., 2016]. The effectiveness of the
methods for clean-up and detection depend on the nature of the target mycotoxin
and the matrix. For example, Blaszkewicz et al., 2013 developed a sensitive method
for analyzing CIT in human plasma and urine [Blaszkewicz et al., 2013]. The authors
compared the sensitivity of two analytical methods, HPLC-FD and LC-MS/MS.
Results indicated that LC-MS/MS was more sensitive and could detect the lowest
amounts of CIT and was therefore considered the better method. They used protein
precipitation to clean up plasma before analysis with LC-MS/MS. Only CIT was
measured in the plasma matrix, with an LOD of 0.07 ng/mL and an LOQ of 0.15
ng/mL. Two clean-up methods of sample prep were tested on urine, SPE with a C18
cartridge and IAC. Due to the matrix effect, detection using SPE was difficult and
therefore IAC was more suitable for extraction of CIT and HO-CIT in urine samples.
CIT had a LOD and LOQ in urine of 0.02 ng/mL and 0.05 ng/mL respectively. The
LOD and LOQ for HO-CIT in urine was determined to be 0.05 ng/mL and 0.10
ng/mL respectively.
In addition to the technological advancements of liquid chromatography tools,
trends in sample preparation and extraction methods have evolved to combat ear-
lier disadvantages with traditional methods such as LLE and SPE which are more
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time consuming and require large volumes of solvent and sample [Huybrechts et al.,
2015, Escrivá et al., 2017, Cigić and Prosen, 2009]. These trends generally looked
toward greater efficiency of technique and time which could arise from method
simplification and conservative volumes of solvent and samples [Cigić and Prosen,
2009, Escrivá et al., 2017]. Escrivá et al., 2017, used urine to help develop a sen-
sitive and fast analytical method for 11 mycotoxins (AFB1, AFB2, AFG1, AFG2,
OTA, ZEA, BEA, EN A, EN B, EN A1 and EN B1). They compared three different
extraction methods: salting-out liquid-liquid extraction (SALLE), miniQuEChERS
(quick, easy, cheap, effective, rugged, and safe), and dispersive liquid-liquid microex-
tractoin (DLLME) to determine the most efficient one based on LODs and LOQs
and validation results from recovery, reproducibility, and repeatability. The sample
size In regards to their findings, DLLME was the most appropriate and had to low-
est LODs/LOQs of the three (0.005-2/0.5-4 µg/L) [Escrivá et al., 2017]. In a study
conducted by Andrade et al., 2013, breast milk was simultaneously analyzed for
AF(B1, B2, G1, G2, M1) and OTA with HPLC-FD. They optimized and validated
a this methods using LLE followed by low temperature purification for clean up and
separation (LLE-LTP), which was found to require less time and cost and better
recoveries when compared with the use of an SPE column [Andrade et al., 2013].
4.3 Matrices
4.3.1 Blood
According to WHO, blood is the most common matrix used for human biomonitoring
studies, primarily because blood has continuous contact with mycotoxins throughout
the whole organism and is in equilibrium with tissue and organs [WHO, 2015].
Overarching disadvantages to the use of blood is that it is invasive, requires specially
trained individuals, and needs special transport/storage. When using blood, there
are well established protocol for matrix preparation and either plasma or serum can
be used. A study conducted by Yu et al., 2011 investigated the differences between
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metabolite profiles in plasma and serum, they concluded that both matrices showed
similar results, however, higher metabolic concentrations found in serum make it
a better option for more sensitive results with biomarkers [Yu et al., 2011]. Jager
et al., 2016 conducted a pilot study from June 2011 to March 2012 in São Paulo,
Brazil that analyzed the biomarkers in serum and urine for AFB1 and AFM1. They
tested for serum AFB1-Lysine adducts and urinary AFB1-N7-Guanine adducts but
no urine sample was positive [Jager et al., 2016]. However, 74 out of the 113 (65%)
urine samples had detectable amounts of AFM1 which had a positive correlation
with to the PDI they determined from food questionnaires and AFB1 and AFM1
detection levels in foods they tested [Jager et al., 2016]. This just further shows
that biomarkers are matrix specific also.
4.3.2 Urine
Urine is useful for multiple mycotoxin biomarker analysis and is readily available. It
is non-invasive and can be collected easily and in large amounts. Animal and human
urine can help with the accuracy of exposure assessment at both individual levels
as well as establish population reference ranges to help identify vulnerable groups
[WHO, 2015]. It can be used for rapidly metabolized and excreted mycotoxins,
however, some issues or challenges can that arise with urine are the low analyte
concentration [Escrivá et al., 2017]. Biomarkers that are excreted in urine can
be the parent compound, conjugated/metabolized compounds, or DNA adducts.
For example most ingested DON is eliminated in the urine, therefore biomarkers
used for detection are DON or its glucuronidated form DON-GlcA [Warth et al.,
2011,Ali et al., 2015]. Egner et al., 2006 validated a method using isotope dilution
mass spectrometry for detecting a major aflatoxin DNA adduct, AFB1-N7-Guanine
that is excreted in urine. They used and internal standard, triple-quadruple mass
spectrometry, SPE, and IAC to improve the accuracy, sensitivity, and specificity of
the method to detect the biomarker, and was validated for a range of 0.8-25 pg/
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20 mL urine. Twenty samples were collected from an AF contaminated region to
asses the method, and 80% of the samples were positive at concentrations above the
LOQ [Egner et al., 2006].
4.3.3 Breast milk
Breast milk is a complex matrix that can be used to monitor the presence of envi-
ronmental pollutants and exposure to lactating mother and infant child [Capriotti
et al., 2015, Mally et al., 2016]. Biomonitoring of breast milk can help to ascer-
tain the risks of consumption and exposure to contaminated food products as well
as helping determine the efficiency of intervention programs [Routledge and Gong,
2011, Fenton et al., 2005]. It is especially important to monitor for biomarkers of
exposure in breast milk because it is a primary food source for infants and therefore
represents their primary source of exposure to a contaminant; infants exclusively
breastfeed for up to 6 months. Substitution of human breast milk with infant for-
mula produced from cow milk or soy protein may also pose a risk depending on the
level of contaminants that may persist through those processing methods which will
be discussed further below.
There are many methods for determining mycotoxin concentration levels in milk
and other dairy products such as cheese, yogurts, etc. and are similar to those used
for biomonitoring [Capriotti et al., 2015,Turner et al., 2015]. Though, transfer rates
and data is limited, mycotoxins that are excreted in breast milk with considerable
(enough to cause alarm in highly contaminated diets) carry-over concerns are afla-
toxins, ochratoxins, zearalenone, and fumonisins [Capriotti et al., 2015,Warth et al.,
2016, Escrivá et al., 2017, Mally et al., 2016]. Composition of milk changes at dif-
ferent stages of breastfeeding so timing of sample collection will influence the level
of contamination present in the sample matrix [Fenton et al., 2005]. To understand
the full scope of exposure and effect it is helpful to collect more than one matrix and
decipher a relationship. Although some relationships between breast milk and other
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biological matrices (plasma, urine) have been observed more are necessary [Capriotti
et al., 2015].
Like urine, breast milk offers a promising potential for multi-analyte detection.
Rubert et al., 2014 modified a QuEChERS-UHPLC-HRMS to unambiguously iden-
tify target mycotoxins and screen for non-target mycotoxin compounds. Detection
of the parent compounds and their metabolized products (DON, 3-ADON, NIV,
FUSX, NEO, DAS, HT-2, T-2, ZEA, α-/β-ZOL, FB1, FB2, FB3, EN (A, B, A1,
B1), BEA, AF(B1, B2, G1, G2, M1), STE, OTA, OTα) were effectively quantified
with LOQs ranging from 1-50 µg/L [Rubert et al., 2014].
4.3.4 Alternative Matrices
Alternative matrices besides urine, serum, and breast milk may offer additional op-
portunities to look at long term effect [Mupunga et al., 2017]. Hair, nails, teeth,
and saliva each represent their own advantages and disadvantages for use with ap-
propriate biomarkers. Sewram et al., 2003 used human hair to show the possibility
of long term accumulation assessment for FB1, FB2, and FB3. They collected hair
samples from 5 population clusters in South Africa exposed to contaminated maize
then used methanol extraction and strong anion exchange (SAX) cleanup followed
by detection with HPLC-ESI-MS. Using hair is noninvasive and offers a long term
window for chronic exposure assessment [Sewram et al., 2003,Mupunga et al., 2017].
4.4 Summary
In this section, different types of diet studies (food monitoring surveys, total diet
studies, duplicate diet studies) and how they can be used to help characterize risks
associated with mycotoxin exposure at the individual and population level was dis-
cussed. Food consumption patterns combined with contamination and occurrence
data help determine populations at risk. In the absence of data, modeling methods
can be used. Most food consumption data is obtained by memory based methods
and can give unreliable estimates that are over or under the actual values, however,
86
when combined with biomonitoring, approaches the estimates can be more accu-
rate. Several agencies such as WHO, FAO, USDA, EFSA, etc. run international
and national surveillance and biomonitoring programs that monitor food consump-
tion and mycotoxin/ chemical intake, however, the US program does not monitor
for mycotoxin intake. More biomonitoring programs using different biomarkers: i)
exposure (presence of toxin or metabolite), ii) effect (occurence and severity of bi-
ological response), and iii) susceptibility (predisposition and onset of disease) can
help and should be considered for areas of concern within the US. Of the programs
that are in place, they lack standardization and comparability, therefore, group ef-
forts like ANSES can help achieve a more coherent regulation. When analyzing
samples, LOD and LOQ need to be as low as possible, because mycotoxins can be
present in matrix samples in very low levels and can have an effect on the outcome
of the study estimated exposure. Analytic methods and the sample preparation
methods bedpan on the target mycotoxin and the matrix that it is in. Biomarkers
can be matrix specific also. Moving forward, the incorporation and use of -omics
technology into exposure-response health risk assessments has the potential to un-
veil new biomarkers [WHO, 2015]. The abbreviation of -omics incorporates many
fields of study including genomics, metabolomics, lipidomics, trascriptomics, and
proteomics. With -omics tools, researchers can simultaneously screen vast amounts
of targets and alterations from a particular environmental influence at different levels
of cellular organization [Kyrtopoulos, 2013]. These global profiling techniques can
further help elucidate the exposome which is defined as “the measure of all exposures
of an individual in a lifetime and how those exposures relate to health,” [Dellafiora
and DallAsta, 2017].
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Figure 4.3: a) Molecular perspective of OMIC technology b) The exposome as it
pertains to mycotoxin contamination (adapted from [Dellafiora and DallAsta, 2017]
(Arbona et al.,2013)
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Table 4.6: A variety of validated or potential biomarkers for use in human and
animal biomonitoring and the analytical methods used to detect them.
Matrix Biomarker Prep. Method LOD LOQ Reference
URINE AFB1-N7-Gua IAC, SPE: C18 HPLC-ESI-MS/
MS
0.02 pg/mg 0.07 pg/mg (Egner et al.2006)
SERUM AFB1-N7-Gua SPE UPLC-ESI-MS/
MS
3 pg/mL 10 pg/mL (Jager et al.2016)
URINE UAFM1 IAC UHPLC-ESI-MS/
MS
0.075 pg/mL 0.25 pg/mL
SERUM AFB1-lys SPE C18 HPLC-FD 10 pg/mL - (Johnson et al.2010)
URINE UAFM1 IAC HPLC-FD 0.5 pg/mL -
MILK AFM1 - ELISA 0.92 ng/L 2.79 ng/L (Cantú-Cornelio et al.
2016)
URINE DON, DOM-1 IAC LC-MS/MS 0.16, 0.10 ng/mL - (Ali et al. 2015)




OTA LLE HPLC-FD 30, 70, 10 ng/L 50, 100, 30 ng/L (Muñoz et al. 2014)
URINE OTA , OTα IAC HPLC-FD 0.05 µg/L 0.1 µg/L (Ali et al. 2017)
SERUM OTA IAC, SPE: C18 HPLC-FD - 0.1 µg/L (Malir et al. 2013)
PLASMA CIT - HPLC-MS/MS 0.07 ng/mL 0.15 ng/mL (Blaszkewicz et al. 2013)
URINE CIT, HO-CIT SPE vs IAC HPLC-MS/MS 0.02-0.05 ng/mL 0.05 - 0.1 ng/mL
URINE ZEA, α-/β-ZAL,
α-/β-ZOL, ZAN





0.004-0.1 ng/mL 0.01 - 0.2 ng/mL (Capriotti et al. 2015)
URINE FB1, FB2, FB3,
HFB1
SPE LC-MS 0.04 - 0.18 ng/mL - (Riley et al. 2012)
MILK FB1 LLE, SAX HPLC-FD 5500 ng/L 19500 ng/L (Magoha et al. 2014)




EN (A, A1, B,
B1), BEA
SPE: GCB LC-ESI-MS/MS 0.01 - 0.04, 0.02 µg/L
0.0025 - 0.02, 0.005 µg/L
0.02 - 0.04, 0.04 µg/L
0.005 - 0.02, 0.01 µg/L
(Serrano et al. 2015)
MILK AF(B1, B2, G1,
G2, M1), OTA
LLE-LTP HPLC-FD - 0.005 - 0.03 ng/mL (Andrade et al. 2013)
SKIN EN(A,A1, B, B1,
D, E, C/F) , BEA
- UHPLC-MS/MS 10 - 17 pg/mL - (Taevernier et al. 2014)
URINE AF(B1, B2, G1,
G2) OTA, ZEA,





HPLC-MS/MS 0.1 - 10; 0.1 - 2; 0.05 - 2
µg/L
0.5 - 40; 0.5 - 6; 0.5 -
4 µg/L






EN (A, B, A1,
B1), BEA, AF(B1,
B2, G1, G2, M1),
STE, OTA, OTα
QuEChERS UHPLC-HRMS - 1 - 50 µg/L (Rubert et al. 2014)
89
Chapter 5
Epidemiological Studies with Dietary Perspective:
Exposure Groups
There are many populations which require special consideration, in part due to
their specialized diets along with other genetic or physical conditions. As previously
discussed, diet plays a large role in how humans are exposed to mycotoxins. This
particular section will focus on how populations with diets different than the average
individual for some biologically or personally related reason can be a cause of concern
for chronic exposure and adverse health effects. Some of the populations that will
be discussed here are pregnant women, infants/young children, vegetarians/vegans,
and immune compromised individuals.
5.1 Pregnant Populations
Pregnant populations in particular are important high risk associated group to ob-
serve for chronic exposure. During pregnancy, the human body undergoes chem-
ical, physiological, and behavioral changes at different stages [Groopman et al.,
2014, Klaassen et al., 1996]. Aside from the obvious physiological changes of an-
other life growing inside the human body, there are minor and major changes that
affect the cardiovascular, respiratory, gastrointestinal, immune, endocrine systems,
and more [Groopman et al., 2014]. These changes can result in alteration of toxicoke-
netics of xenobiotics in the maternal system, particularly mycotoxins. An example
of theses changes, such as the increase of blood volume leading to a decrease in
plasma protein concentration levels, could mean more unbound mycotoxins. An-
other example is the rising levels of progesterone reducing intestinal mobility, which
then delay gastric emptying and prolongs the toxicants retention time in upper gas-
trointestinal tract [Klaassen et al., 1996, Groopman et al., 2014]. Additionally, the
slight immune suppression and modulation of the mothers system which occurs to
allow for the fetus to develop, can further increase adverse risk. Finally, internal
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and environmental factors influence gut microbiota which might alter bacterias role
metabolizing mycotoxins [Nuriel-Ohayon et al., 2016].
Behavioral changes in regards to diet and health during pregnancy could stem
from conscious behavior, as well as internal cues from the body [Nuriel-Ohayon et al.,
2016]. Pregnant women have increased needs for energy and nutrients and therefore
consume a greater amount of food. They may also have a behavioral incentive to
follow a healthier diet during their pregnancy for the best outcome of their progeny.
A study conducted by Verbeke and Bourdeaudhuij 2007, investigated the dietary
behavior of pregnant women versus women that were not. Primarily their findings
inferred that pregnant women are more conscious about their diet and their food
choices are strongly motivated by food safety concerns. According to the data,
many pregnant women have a higher fruit, beef, dairy, and fat intake. However,
contrary to initial assumptions, very few women from the study observed health
and safety guidelines like avoiding alcohol, tobacco, and raw foods [Verbeke and
De Bourdeaudhuij, 2007]. A majority of pregnant women do not follow prescribed
health and food safety guidelines. The reasons that prevent them from doing so
could depend on the food availability or a variety of socio-economic factors (i.e.
lack of access to health care, education).
Current research also highlights the importance of diet and the effects of epi-
genetic controls for future generations [Hernandez-Vargas et al., 2015, Han et al.,
2016]. It is not just what a mother eats or is exposed to before or during pregnancy,
but also the pregnancy diet itself that may effect the reproductive outcome, as well
as progeny fitness. These epigenetic changes from environmental stresses and expo-
sures may lead to, predispose, or contribute to the development of immunological
and chronic diseases of the offspring later in life [Hernandez-Vargas et al., 2015].
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Table 5.1: Mycotoxins ability to affect reproductive health [CAST, 2003, Collins
et al., 2006,Piekkola et al., 2012,Capriotti et al., 2015,Wang et al., 2013,Han et al.,
2016,Yu et al., 2017]
5.1.1 Mycotoxin Exposure and Risk to Maternal-Fetal Unit
Over the last two decades several biomonitoring studies (cohort, case control, cross-
sectional studies) have been carried out on pregnant women all over the world.
The goal has been to help determine potential risk from mycotoxin exposure to
both the mother and the fetus. Pregnant women are mainly exposed to mycotoxins
through contaminated food, however, some may have been exposed through the use
of medical treatments originating from a specific mycotoxin (i.e. ergotamine for
headaches) [Hughes and Goldstein, 1988, Acs et al., 2006]. Mycotoxins have been
linked to or associated with Neural Tube Defects (NTDs), growth stunting, immune
system impairment, late term abortions, and congenital abnormalities [Kristensen
et al., 2000, Marasas et al., 2004, Missmer et al., 2006, Acs et al., 2006, Hernandez-
Vargas et al., 2015,Gupta et al., 2017]. There is still a great uncertainty regarding
the impact of mycotoxins on birth outcomes and defects in humans.Biomonitoring
studies and use of laboratory animal studies could help to fill these gaps. These
biomonitoring studies use a combination of food frequency questionaries (FFQs) and
biological samples (serum, urine, cord blood, milk, placenta ) collected at different




Reproductive and developmental toxic effects of OTA have been observed in research
and farm animals. Not only can OTA pass through the placental barrier, it is also
transferred via lactation [Gupta et al., 2017]. Studies indicate OTA exposure in
pregnant research animals results in birth defects of the central nervous system
(Neural Tube Defects) [Gupta et al., 2017].
OTA has a high binding affinity for protein albumin, since 99.8% of OTA in the
human circulatory system is bound to plasma proteins (albumin) with a very small
amount available in its freely unbound state [Kőszegi and Poór, 2016]. Evidence sug-
gests that during pregnancy there is a decrease in serum albumin concentration and
chemical-binding protein, resulting in reduced protein binding availability [Groop-
man et al., 2014, Zimmerli and Dick, 1995]. This could mean that drugs and other
Figure 5.1: Reproductive stages of development and sensitivity to teratogens
with Carnagie stage comparison for human, rat, mouse, and pig. Adapted from
[O’Rahilly, 1979,Witschi, 1962,Pérez-Cano et al., 2012].
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Table 5.2: Reproductive biomonitoring studies. (NTD = Neural Tube Defect Cases,
Cont. = Control, CB = Cord Blood, NSA = Non South Asian, SA = South Asian,
Sub = Suburban, alb = albumin, cr = creatinine).
natural chemicals such as OTA, which usually have higher concentrations of OTA-
plasma bound proteins molecules, might exhibit different concentration profiles in
pregnant women. The concentration of plasma protein bound OTA may decrease
and unbound, free OTA molecules may increase during pregnancy [Groopman et al.,
2014,Zimmerli and Dick, 1995]. As a free molecule, OTA can pass through the pla-
cental barrier, a greater portion may impact the embryo. The detection of higher
amounts of OTA in human fetal serum and cord blood confirms in utero expo-
sure [Woo et al., 2012,Zimmerli and Dick, 1995].
As term approaches, the placenta thins and may become more susceptible to
environmental toxins, which may suggest that OTA exposure is greater in late in
pregnancy [Zimmerli and Dick, 1995, Woo and El-Nezami, 2016]. However, results
from human placental perfusion study by Woo et al., 2012, suggests that is not the
case and OTA can reach the fetus just as well [Woo et al., 2012]. Because of this,
94
exposure to OTA during early gestation may have an increased teratogenic potential
and developmental effects (see Fig. 5.1).
A study conducted by Malir et al., 2013 used blood samples from 100 pregnant
Czech women in the first trimester of pregnancy, that were obtained and evaluated
using HPLC-FD to determine OTA serum level [Malir et al., 2013]. Of the 100
samples, 96% tested positive for OTA ( contamination > 0.1 µg/L). A dietary
exposure estimate for pregnant women was estimated based on food consumption
data from a national food survey and food samples were analyzed with validated
ultra-trace HPLC. For pregnant Czech women (age 19-40), the average daily intake
from a combination of all cereals and cereal products, baked goods, spices, coffee,
pork meat, juices, and chocolates was 0.58 ng/kg bw. The intake assessment based
on OTA level in blood serum, which had a mean of 0.15 µg/L (range of 0.10 - 0.35
µg/L) was calculated to be between 0.2 - 0.5 ng/kg bw/day [Malir et al., 2013]. For
this study, the estimated intake was significantly less than the TDI for OTA, which
is 17.1 ng/kg bw/day, however, the potential toxicity to the fetus may be higher
considering its lack of development (metabolism, immune) and small size [Malir
et al., 2013]. Monitoring OTA intake through diet adjustments during the first
trimester, when the fetus is most sensitive to teratogens could be an important
consideration for researchers and pregnant women.
Woo & El-Nezami 2016, conducted a study to assess the maternal-fetal cancer
risk of OTA in Egyptian women during their third trimester of pregnancy [Woo and
El-Nezami, 2016]. A total of 98 serum samples and FFQs were obtained, OTA was
detected in 80 urine samples. The mean and range for serum OTA concentrations
was 0.33 ng/mL and 0.20 - 1.53 ng/mL respectively. Using the Klaassen equation,
the derived maternal estimated dietary intake was in the range of 0.43 - 3.26 ng/kg
bw/day, however, the authors suggest that the in utero exposure to the fetus was
twice that of the maternal exposure (0.86 - 6.52 ng/kg bw/day). The estimates
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from this study show that the mothers intake of OTA was less than the TDI (17
ng/kg bw/day). However, based on a tumorgenic study in the kidneys of male
rats, a negligible cancer risk intake (NCRI) was calculated to be 3.38 ng OTA/kg
bw/day [National Toxicology Program, 1989,Woo and El-Nezami, 2016]. Thus, the
fetus exposure was greater than the pregnant Egyptian women, but less than the
TDI and NCRI, except for the high exposure group (6.52 ng/kg bw/day) which
exceeded the NCRI [Woo and El-Nezami, 2016]. It is important to mention that,
although all of these estimates are highly uncertain, they can help identify potential
hazards.
FB1
As mentioned before, disease outbreaks among animals can be an indicator for
contamination in food. Equine leukoencephalomalacia (ELEM) is an indicator for
fumonisin contamination and was linked to several clusters of nueral tube defects
(NTDs) amongst hispanic population in border regions of Texas/Mexico [Gelineau-
van Waes et al., 2005, Gelineau-van Waes et al., 2009, Voss et al., 2017, Voss et al.,
2005, Missmer et al., 2006]. The incidence rate for NTDs went from 15/10,000 live
births to 27/10,000 live births [Marasas et al., 2004,Voss et al., 2005,Missmer et al.,
2006]. The incidence rate for NTDs on average are 10/10,000 live births globally,
however, areas of the world that rely on maize as a primary staple have rates 6
- 11 times higher (i.e. China, Guatemala, Mexico, South Africa ranging between
35 -106/10,000) [Bolger et al., 2001,Marasas et al., 2004,Gelineau-van Waes et al.,
2005,Gelineau-van Waes et al., 2009,Voss et al., 2005].
Initially, several in vivo studies suggested that fumonisins could not cross the
placental barrier and were not teratogenic in animals that were not sensitive to FB1.
However, a model using LM/Bc mice (folate and GM1-responsive animal model for
FB1-induced NTDs), injected with FB1 on gestation days 7.5 and 8.5 with doses
from 5 -20 mg/kg bw, demonstrated dose dependent increases of affected litters and
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exencephaly [Gelineau-van Waes et al., 2005, Voss et al., 2005]. Maternal livers,
placentas, and embryos showed increased concentrations in sphinganine (sa) and
sphinganine to sphingosine (sa:so) ratios with increasing FB1 treatments [Gelineau-
van Waes et al., 2005]. In mice treated with FB1 at doses of 20 mg/kg bw, 80% of
the fetuses in those litters were NTD positive [Voss et al., 2005]. To further assess
the biodistribution potential,14C−FB1 was administered on gestation day 10.5 and
confirmed that FB1 does cross the placenta in this sensitive strain of mice [Gelineau-
van Waes et al., 2005, Voss et al., 2005]. Supplementation with folate and GM1
(deficiency for beta-galactosidase) in the FB1-treated mice helped to reduce the
amount of NTD positive fetuses in the litters [Gelineau-van Waes et al., 2005,Voss
et al., 2005].
To address strain susceptibility FB1-treated CD1 mice and LM/Bc mice were
compared. The mice were given FB1 contaminated feed with doses of 50 or 150
mg/kg five weeks prior to mating and throughout the study and the corresponding
EDI to these amounts were 25 (LM/Bc) and 38 (CD1) mg/kg bw/day [Voss et al.,
2005]. Authors observed that fetotoxicity and NTDs can develop at maternally
toxic doses and that there are strain/species dependent differences in sensitivity
(CD1 are less sensitive and have a stronger placental barrier) [Voss et al., 2005].
A preliminary dietary NOAEL for FB1-induced NTDs is < 50 µg/kg [Voss et al.,
2005,Gelineau-van Waes et al., 2005].
A case-control study conducted along the Mexico-Texas border by Missmer et
al., 2006, looked into fumonisin exposure from periconceptional (time before and
during early pregnancy) intake of maize tortillas. As a biomarker for fumonisin
exposure, sphinganine:sphingosine (sa:so) ratio in serum from the first trimester
and from postpartum serum were analyzed and compared. The results from the
data have inverted U-shape responses.Women with a daily exposure to FB1 of 0.15
- 0.65 µg/kg bw have more NTD cases [Missmer et al., 2006, Voss et al., 2005].
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This suggests that the risk for NTD increases with increased exposure to fumonisins
during the first trimester, especially in weeks 3 and 4 of gestation, which is suspected
to occur in diets with high consumption of maize tortillas [Missmer et al., 2006,Riley
et al., 2015,Voss et al., 2017].
There is speculation on the validity of using sphinganine concentrations and sa:so
ratios in epidemiological studies and there are suggestions that studies should con-
sider the metabolized sphengoid base-1 phosphate compounds, which are bioactive
and play an important role in signaling pathways [Voss et al., 2005]. Sphinganine
(sa) is phosphorylated by sphingosine kinases (SphK1 and SphK2) into the active
sphingaonine-1-phosphate (Sa1P) [Voss et al., 2005]. Two important effects are that
Sa1P binds and saturates cell surface G protein coupled receptors (interferes with
signaling pathways, especially ones in neural tube closure) and elevated Sa1P inter-
feres with actions of histone deacytlases (HDACs) that affect epigenetic regulation
of gene expression [Gelineau-van Waes et al., 2012].
Gelineau-van Waes et al., 2012 treated pregnant SWV dams and inbred LM/Bc
mice-strains with injections of FB1 at 20 mg/kg/day on embryonic days (ED) 7.5
and 8.5 or orally gavaged with FTY720, a S1P receptor agonist, at 10 mg/kg/day on
ED 6.5 to 8.5 [Gelineau-van Waes et al., 2012]. Blood spots and embryonic tissues
from each group were collected on various days from ED 9.0 - 12.5. Mouse embryonic
fibroblasts (MEFs) and serum free mouse embryo (SFME) neural progenitor cells
were treated with 40 µM of FB1 for 24 hours. All samples were analyzed with
LC-ESI-MS/ MS for sphengoid bases, sphengoid base-1-phosphates, FTY720, and
FTY720-1-phosphate. The rationale was that prolonged exposure to elevated levels
of sphenoid base-1-phosphates following FB1 or FTY720 treatment would activate
S1P receptor signaling pathway and result in failed neural tube closures [Gelineau-
van Waes et al., 2012]. Their findings confirmed early studies, suggesting differential
susceptibility to FB1-NTDs between LM/Bc and SWV, and the potential use of
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Sa1P as a biomarker of effect for FB1-NTDs research. Additional studies with
FB1 treated LM/Bc MEFs conducted by Garnder et al., 2016 suggests that the
FB1-induced disruption of sphingolipid metabolism leads to Sa1P accumulation,
HDAC inhibition, and histone hyperacetylation is the potential mechanism for FB1-
NTDs [Gardner et al., 2016].
Guatemala has an NTD incidence rate of up to 106/10,000 live births in cer-
tain areas [Voss et al., 2005, Bolger et al., 2001]. Riley et al., 2015 (Guatemala
study) conducted a series of studies that looked at consumption of tortillas and
NTDs [Riley et al., 2015]. After developing a urinary exposure biomarker and blood
spot mechanism-based biomarker method, they then conducted a year long study
to determine potential correlations [Riley et al., 2012, Torres et al., 2014]. Every 3
months (during 2011-2012), samples of maize from community resources and bio-
logical samples of urine and blood spots from 1240 women in 3 areas in Guatemala
(Chimaltenango, Escuintla, and Jutiapa) with varying degrees of fumonisin exposure
were collected [Riley et al., 2015]. A biomarker validation response study was also
performed, in which sampling sites across Guatemala were chosen in order to repli-
cate the results of the 2011-2012 biomarker study. From February to March 2013,
samples of maize, urine, and blood (female participants n=299) were collected from
Sacatepquez, Santa Rosa, and Chiquimula [Riley et al., 2015]. Important informa-
tion for consideration from theses studies are: UFB1 levels of Guatemalan women
with 0.5 ng/mL corresponds to intake of 1.67 µg/kg bw/day, which is less than the
PMTDI. However, women with UFB1 > 0.5 ng/mL will exceed the PMTDI (2.0
µg/kg bw/day) and increased ratios of Sa:So or Sa1P:So1P (by fumonisin inhibition
of ceramide biosynthesis) positively correlates with fumonisin intake based on levels
of UFB1 [Riley et al., 2012,Riley et al., 2015].
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AFB1
It has been suggested that in utero exposure to AFB1 early in life can negatively
impact immune health and growth and increase the chance of developing diseases
later in life [Turner et al., 2007,Piekkola et al., 2012,Hernandez-Vargas et al., 2015].
The ability of AFB1 to cross the placental barrier has been shown in many animal
studies, as well as in the detection of AF-alb adducts in human cord blood [Turner
et al., 2007,Partanen et al., 2009]. Further evidence of this transfer has been shown
with human placental perfusion models. Partanen et al., 2009 used 8 human pla-
centas in a placental perfusion model to demonstrate both the transfer and the
biotransformation of AFB1 into aflatoxicol (AFL). The adverse effects of exposure
are dependent on the timing. Essentially, exposure at different time points dur-
ing gestation my have different effects. Both AFB1 and DON transfer through the
placenta at a faster rate than OTA [Nielsen et al., 2011,Woo et al., 2012].
Given that the placenta itself acts as an endocrine gland during pregnancy, the
disrupting effects of AFB1, such as altering gene expression can result in various
developmental and birth outcomes [Mesiano and Jaffe, 1997, Wang et al., 2016].
Wang et al., 2016 studied the effect of AFB1 exposure in late gestation on ICR
pregnant mice. Different groups were treated with 0, 0.05, 0.5, and 5 mg/kg/d.
Compared to the control group, dams given doses of 0.05 mg/kg and above gave
birth sooner, and dams given the highest dose of 5 mg/kg/d had pups with lower
birth weight. Higher doses of AFB1 were also found to have increased placental
cox-2 (cyclooxygenase-2) and crh (corticotropin) mRNA expression and decreased
15-hgpd (15-hydroxyprostoglandin dehydrogenase) mRNA expression. The higher
dosage of AFB1 given late in gestation caused an increase of CRH and estrogen
in the plasma that may have lead to the onset or premature delivery [Wang et al.,
2016].
Roll et al., 1990 investigated the reproductive and teratogenic effects of AFB1
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using pregnant Chinese hamsters [Roll et al., 1990]. On days 12 and 13 of gestation,
AFB1 doses of 15, 45, and 90 mg/kg were injected intraperitoneally while another
group received 45 mg/kg orally. The AFB1 injected hamsters demonstrated reduced
fetal development and dose-related increases of teratogenic effects (cleft palates,
wavy ribs, and diaphragm changes). The orally dosed hamsters resulted in pups
with lower fetal weights, diaphragm changes, and kidney malformations [Roll et al.,
1990].
A cohort study of 115 pregnant women in Gambia conducted by Hernandez-
Vargas et al., 2015 investigated the effects of AF exposure during the embryonic
development stage and epigenetic changes that occur as a result [Hernandez-Vargas
et al., 2015]. The plasma samples were collected from these women between 1-
16 weeks and analyzed for aflatoxin albumin (AF-alb) adducts as a biomarker for
exposure. The range of AF-alb adducts found in the women was between 3.9-4 58.4
pg/mg albumin. White blood cell samples from their infants were then collected
between 2-8 months of age for genome-wide DNA methylation as an epigenetic
marker. One analysis used the AF-alb data as a continuous variable to determine
the association of methylation patterns between a single locus and regional DNA,
resulting in the identification of 71 aflatoxin-associated methylation sites (AfMSs),
CpG sites that correlate with AF-alb, and a 1.7% alteration in methylation. A large
portion of these CpG sites have been previously annotated and involved in genes with
important immune and growth functions [Hernandez-Vargas et al., 2015]. Though
more studies are needed, these results suggest that differential DNA methylation
patterns resulting from aflatoxin exposure may affect growth and immune response
[Hernandez-Vargas et al., 2015].
This information also further supports an earlier study in Gambia conducted by
Turner et al., 2007 that investigated a connection between exposure to low levels
of AFB1 in utero and growth faltering of those infants during their first year of
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life [Turner et al., 2007]. The study collected blood samples from 119 women at two
collection times (4.5 and 1 months prior to birth), 99 cord blood samples, and 118
blood samples from the corresponding infant at 16 weeks. Analysis of the samples
by ELISA methods found that mothers, cord blood, and infants had AF-alb levels of
40.4 (4.8-260.8), 10.1 (5-89.6), and 8.7 (5-30.2) pg/mg respectively. Measurements
of height and weight from 138 infants (born to women in the study) were taken
monthly. The authors found that levels of AF-alb in maternal samples acted as a
predictor for both the height and the weight of the infants [Turner et al., 2007]. Thus
an inverse relationship was detected where infants born to mothers with higher levels
of AF-alb adducts showed reduced height and weight gains. They also suggested
that by reducing maternal AF-alb from 110 pg/mg to 10 pg/mg there could be
a corresponding increase of 0.8 kg in weigh and 2 cm increase in height during
the first year, [Turner et al., 2007]. Biomonitoring studies that look at the effects
of aflatoxins in Africa often deal with consumption of corn and groundnuts which
are critical dietary staples and are often contaminated with aflatoxins. Therefore
the results of theses studies should stimulate further research by looking at other
geographical areas (even in developed countries) that also produce and consume
large portions of groundnuts like China and the United States (especially in major
peanut producing states like GA, TX, AL, FL, etc.) [CAST, 2003, USDA-NASS,
2010].
ZEA
From the onset of pregnancy, estrogen plays many roles, from regulating embryo-
genesis, cell proliferation and differentiation, organogenesis, to parturition (birth)
[Kaludjerovic and Ward, 2012]. As mentioned in earlier sections, mycoestrogens
can have numerous endocrine disrupting effects on the reproductive systems of ex-
posed male and female organisms. Several in vivo studies have demonstrated that
ZEA can cross the placental barrier of animals (rats, rabbits, and pigs) and indicate
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its potential in doing so in the human placenta [Bernhoft et al., 2001, Lange et al.,
2002,Goyarts et al., 2007,Gao et al., 2017]. In pigs, placental transfer of ZEA results
in teratogenic effects that manifest as various abnormalities of the genitals [Min-
ervini and DellAquila, 2008, Dmello et al., 1999]. An in vitro study using both
JEG-3 cells and human placental sub-cellular organelles showed the that the human
placental enzymes metabolize ZEA and ZAN into primary OH-metabolites (espe-
cially α-ZAL) which have even greater binding affinity for estrogen receptors than
the parent compound [Huuskonen et al., 2015]. This metabolic proclivity toward
α-ZAL may increase the risk of disruption to placental estrogen signaling, which
becomes the primary source of estrogen during the 8th week of pregnancy [Mesiano
and Jaffe, 1997,Kaludjerovic and Ward, 2012,Huuskonen et al., 2015]. The fetus is
developing its own endocrine system prior to and during this time period, and could
be interrupted by hormonal imbalance [Kaludjerovic and Ward, 2012]. Also, it has
been hypothesized that exposure to estrogenic compounds in the perinatal phase
(weeks leading up to birth) could result in altered epigenetic gene regulation, result-
ing in postponed effects (positive or negative) or even trans-generational inheritance
or toxicity [Kaludjerovic and Ward, 2012, Gao et al., 2017]. This suggests it might
be perfectly acceptable to blame your mother for everything thats wrong with you.
Therefore, mycoestrogens in pregnant women could induce long-term programming
effects on developing fetus as well as modulate adrenal gland growth and develop-
ment through DNA methylation [Kaludjerovic and Ward, 2012]. It is important to
mention that these mycoestrogens do not directly donate/accept a methyl group,
but may open a region for methylation by promoting histone acetylation from its
interaction with estrogen receptors [Kaludjerovic and Ward, 2012].
To ascertain this risk, Fleck et al., 2016 used a cohort of 30 pregnant women
from the metropolitan area of Salt Lake City, Utah to estimate the internal exposure
to dietary estrogens (including ZEA and its metabolites) during a period of fetal
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development (15-35 weeks) that is uniquely sensitive to estrogen [Fleck et al., 2016].
Urine was collected over a 6 hour field exposure and a 24 hour clinical period,
during which subjects ingested food items that consisted of corn. The urinary
elimination of ZEA is approximately 10-20% of the administered dose and can be
used to ascertain the estimated daily intake [Šarkanj et al., 2013]. Though, no
consistent dietary source of ZEA was determined for the subject cohorts, both ZEA
and α-ZOL were detected in urine samples with an average of 0.10 µg/L (range of
LOD - 0.31 µg/L) and 0.11 µg/L (range of LOD - 0.25 µg/L), respectively [Fleck
et al., 2016]. In comparison to a study with ZEA consumption at 83% of the TDI
(0.25 µg/kg bw/day) and corresponding urinary concentrations of 0.3-0.6 µg/L, it
can be concluded that the lower urinary concentrations from the Fleck et al., 2016
were significantly lower than the TDI [Šarkanj et al., 2013,Fleck et al., 2016].
Trichothecenes
Trichothecene such as DON, T-2, and their metabolites have been shown to gen-
erate negative or toxic effects on maternal and fetal systems. When cold and wet
climate conditions promote the growth of Fusarium graminearum and the produc-
tion of DON, its effects can be seen in the reactions and effects in animals. In 1981,
midwestern states around Illinois were subject to such conditions, which resulted in
animal feed with DON concentrations ranging from 0.1 to 41.6 ppm [Cote et al.,
1985]. Of the swine fed with this contaminated feed, Côté et al., 1985 observed
that half of all veterinary clinical complaints made about the pigs were reproductive
related problems [Cote et al., 1985].
Ndossi et al., 2012 investigated the endocrine disrupting effects of DON, T-2,
and HT-2 in vitro with H295R cell model subjected to various assays [Ndossi et al.,
2012]. Specifically, this cell model was used to show alteration of gene expression
in steroidogenesis process and the reporter gene assay (RGA) to detect any steroid
hormone (androgen, estrogen, and glucocorticoid) agonist or antagonistic behavior
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on behalf of trichothecene exposure [Ndossi et al., 2012]. Unlike the estrogenic ac-
tivity shown with ZEA, trichothecene endocrine disrupting potential does not occur
through direct interaction with steroid hormone receptors [Doi et al., 2008, Ndossi
et al., 2012, Yu et al., 2017]. Instead, the endocrine disrupting nature of these tri-
chothecenes relies on processes that reduce cell viability, inhibit DNA synthesis and
interrupt steroidogenesis by altering gene expression or hormone synthesis [Ndossi
et al., 2012,Yu et al., 2017].
Collins et al., 2006 studied the developmental effects of DON in utero in female
rats (Sprague-Dawley) [Collins et al., 2006]. During gestational days 6-19 pregnant
females were gavaged with doses of DON between 0 - 5 mg/kg bw. Maternal toxicity
was established at 1, 2.5, and 5 mg/kg bw where dose-related increases in maternal
liver weight correlated with cytoplasmic alteration of hepatocytes. Fetal size was
reduced significantly at 2.5 mg/kg bw, while doses of 5 mg/kg bw were teratogenic
with many skeletal malformations [Collins et al., 2006]. Other issues related to
high doses were increased deaths per litter and number of runts in litter [Collins
et al., 2006]. Studies using female pigs have shown placental transfer and effects
of DON on maternal and fetal toxicity [Diaz-Llano and Smith, 2006,Goyarts et al.,
2007, Yu et al., 2017]. Diaz-Llano & Smith 2006, demonstrated the effects of DON
with pregnant sows that were fed naturally contaminated feed with 5.5 mg/kg bw
in the last 3 weeks of gestation, which resulted in maternal weight loss and stillborn
piglets. A review article by Doi et al., 2008 discusses the maternal and fetal toxicity
in pregnant mice and rats due to T-2 and HT-2 toxins. Many of the toxic effects
reported in this article are a result of apoptosis in maternal, placental, and fetal
tissues, induced by oxidative stress from alterations in genes being expressed for
specific metabolic pathways (i.e. lipid) [Doi et al., 2008].
In addition to crossing the placental barrier in animals, DON and T-2 have
the potential to transfer through human placentas as shown by in vitro modeling
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methods [Collins et al., 2006, Diaz-Llano and Smith, 2006, Nielsen et al., 2011, Doi
et al., 2008, Wang et al., 2013]. Nielsen et al., 2011 used both an in vitro study
with BeWo b30 Transport Assay and an ex vivo dual placenta perfusion model with
5 term placentas to demonstrate the ability of DON to transfer across the human
placenta. Data results from the placental perfusion model demonstrated that after
4 hours of incubation 21% of the initial DON concentration was transported to the
fetal reservoir [Nielsen et al., 2011]. Wang et al., 2014 used BeWo cells to study
the transport kinetics of T-2 and HT-2 toxins across the placental barrier. They
hypothesized that the uptake of T-2 and HT-2 toxins into fetal circulation was by
transporter proteins (i.e. multi-drug resistance-associated protein, MRP; organic
anion transporter, OAT; organic anion-transporting polypeptide B, OATPB; organic
cation transporter, OCT) and passive diffusion respectively, while the efflux of the
toxins back into the maternal circulation was through simple diffusion [Wang et al.,
2013]. This study also suggests that T-2 and HT-2 induced toxicity are associated
with increased cellular accumulation of the toxins and membrane transport could
be the first fundamental stage in embryotoxicity and teratogenicity, [Wang et al.,
2013]. All together, these studies indicate that maternal dietary exposure to DON
and T-2 toxin can result in fetal exposure and detrimental effects from either indirect
or direct interaction of the toxins with important systems. Therefore, implementing
programs for biomonitoring trichothecenes for pregnant women who reside in areas
that have history of toxicosis may be beneficial for evaluating the public health of
that area and to determine the need of interventions.
A cohort study in Bradford, UK conducted by Hepworth et al., 2012 analyzed
the urine of 85 pregnant women in their last trimester along with a FFQ that
characterized the traditional British diet as well as a British-Asian diet [Hepworth
et al., 2012]. Based on the FQQ food groups of cereals, breads, pastas, baked goods,
and snacks, the authors suggest that the greatest exposure of DON is through white
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bread. A urinary creatinine analysis was utilized to detect both free DON and DON-
glucuronide (fd-DG). Urinary DON levels were found in all 85 samples and had a
mean of 10.3 ng/mg creatinine and ranged between 0.5 - 116.7 ng/mg creatinine.
The overall and combined estimated daily intake based on the FFQ for the pregnant
UK women was 10.1 µg/kg bw, however when categorized via ethnicity, it was found
that intake of DON at 8.4 µg/kg bw for non South Asian women was significantly
less than the 13.7 µg/kg bw seen in South Asian women. The dietary intake of
DON by South Asian women was supported by the higher amount of UDON (15.2
ng/mg creatinine) found in urine [Hepworth et al., 2012]. These findings highlight
the importance of understanding different dietary habits and their association with
mycotoxin exposure based on a region as well as different ethnicity within that
region.
Other important comparisons that can help understand diet and exposure are
the difference between people living in rural vs suburban areas. In a cohort study
of pregnant women in Bangladesh, India, conducted by Ali et al., 2015, 32 urine
samples from a rural setting and 22 urine samples from a suburban setting were
collected during their third trimester [Ali et al., 2015]. Food consumption data
was acquired through a FQQ. The mean level of UDON ranged from 0.86±1.57
ng/mL creatinine, with a significant difference between the mean urinary level of the
suburban (1.44±2.20 ng/mL) and rural (0.47±0.73 ng/mL). The provisional daily
intake calculated based on UDON concentrations had a total mean of 52.5±94.4
ng/kg bw, a rural mean of 26.8±39.0 ng/kg bw, and suburban mean of 89.9±133.2
ng/kg bw. All of these findings are still less than the TDI, however the data do not
fit the trend of having higher mycotoxin exposure in more rural and lower income
areas.
In comparison, Ŝarkanj et al., 2013 conducted a pilot study on 40 pregnant
women in Croatia to determine exposure. The women were sub-categorized based
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on location and then education level; urban (n=20), rural (n=20), university (n=18),
high school (n=22). Urine was collected during the third trimester and analyzed
for multiple mycotoxins including two glucoronidated forms of DON (DON-15-GlcA
and DON-3-GlcA). Positive samples for DON (31/40), DON-15-GlcA (39/40), and
DON-3-GlcA (33/40) had a average concentration of 18.3, 120.4, and 28.8 µg/L
respectively. Estimated equivalents of DON intake was calculated for the total,
urban, rural, university, and high school groups to be 2.5, 1.8, 3.1, 1.8, 3.0 µg/kg
bw/ day and the averages ranged between 176 - 775% of TDI [Šarkanj et al., 2013].
Though these are only a few examples DON biomonitoring, a majority of them
are conducted later on in the pregnancy during the third trimester. This may
indicate concern for growth and fetal development issues or adverse birth outcomes
(preterm birth, low birth weight, late term abortions, etc). For example, Kristensen
et al., 2000, found a correlation between the increased ratio of late term abortions
among grain farmers in Norway during seasonal warnings for blight [Kristensen
et al., 2000]. It should also be noted that during seasonal climate periods favorable
to fungal growth, pregnant woman may be exposed to both increased pesticides,
especially fungicides as well as mycotoxins [Kristensen et al., 2000].This may lead
to increased adverse reproductive outcomes. Up to the time of birth as well as
after, neural, endocrine, immune, and gastrointestinal micro flora systems continue
to develop and can be negatively affected by DON or T-2 (more information section
5.2).
5.1.3 Additional Exposure Through Medication
Historically, ergot had been used to help speed up pregnancy but soon shifted to
primarily help control bleeding during miscarriages and postpartum hemorrhag-
ing [Bove, 1970, Raymond, 1995, CAST, 2003]. Recent use of its purified form,
ergotamine is widely accepted to treat migraine headaches but may have adverse
health effects in utero [CAST, 2003,Acs et al., 2006]. Ergotamine has the ability to
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cross the placental barrier and has a variety of effects on the vascular system and will
increase uterine motor activity [Rall and Schleifer, 1985,Raymond, 1995]. Pregnant
rats were used in an animal study by Sch/”o et al., 1975 to determine the effect
of ergotamine. Between days 4 and 19 of gestation, 10 mg/kg bw ergotamine tar-
trate was orally administered; resulting effects between day 11 to 14 (max) showed
increased prenatal mortality, while days 13 to 16 presented with cleft palate and
limb defects. The deformities are suggested to be characteristically similar to the
anomalies that occur as a result of uterine vessel clamping [Schon et al., 1975].
A case study/clinical report by Hughes & Goldstein 1988 hypothesized that birth
defects may result from vascular occlusion due to ergotamine therapy during preg-
nancy. The subject of their study was an infant born at term with microcephaly
and underdeveloped, contracted lower limbs to a mother who was treated for mi-
graine headaches with a concoction of ergotamine and caffeine during the first 14
weeks along with propranolol during and up to 20 weeks. This case study was small
and based on a combination of toxins, however, it provides some insight into the
contraindication for using ergotamine itself or with other drugs due to potential
synergistic activity during pregnancy [Hughes and Goldstein, 1988].
There have also been studies that look at ergotamine exposure from an epi-
demiological view. Bánhidy et al., 2007 used data from Hungarian Case-Control
Surveillance of Congenital Abnormalities (HCCSCA) from 1980 to 1996 to evalu-
ate the potential associations between ergotamine treatment during pregnancy and
the incidence of low birth weight and preterm births [Acs et al., 2006]. The study
found a significant decrease in gestation time and birth weight and an increase in
frequency of low birth weight newborns and preterm births of those treated with er-
gotamine compared to controls. Additionally, researchers found the greatest of these
instances to occur with ergotamine treatment in the third trimester and with male
fetuses. They suggest low birth weight and preterm birth as a result of ergotamines
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dose-dependent effect on the placenta [Acs et al., 2006].
Live stock and other animals may still be exposed to ergot alkaloids through
contaminated feed and tall fescue grasses and as such can experience neurological
effects and abortions [Klotz, 2015]. Fortunately, there is very little chance for ergot
exposure through human diet today, however, its daily use in the form ergotamine
as medicine poses its own risks. Based on circumstantial evidence from animal
studies and available clinical/case studies, it has been suggested that ergotamine
has teratogenic potential and, therefore, should be avoided throughout the duration
of pregnancy, if possible, in order to avoid birth defects [Rall and Schleifer, 1985,
Raymond, 1995,Schon et al., 1975,Acs et al., 2006].
5.2 Infants and Children
Mycotoxin exposure in infants and young children is different than that of adults.
They are in an important phase of life for growth and development and, as such,
could be more at risk to certain mycotoxins than adults due to many physiological
differences. Infants and children are still developing critical pathways for metabolism
and their higher food consumption to body weight ratio may increase their exposure
and risk to negative health outcomes [CAST, 2003,Klaassen et al., 1996,Cappozzo
et al., 2017]. The diet of infants and young children revolve heavily around milk
which can be potentially contaminated with several mycotoxins, especially AFM1.
Most experiments with young animals have shown higher sensitivity to mycotoxins
[Smith et al., 2012]. Several studies suggests that aflatoxins and trichothecenes can
affect growth and immune function [Smith et al., 2012].
5.2.1 Infants, Break Milk, and Infant Formulas
It is strongly recommended that infants should consume breast milk exclusively for
the first 6 months. Breastfeeding should then continue for up to a year or more
with the addition of complementary foods [Rossen et al., 2016]. Evidence for this
advisory has been supported by many studies that compare health outcomes of
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infants who were breastfed exclusively and those that were never breastfed or had
supplemental formulas and food too early [Rossen et al., 2016]. Breastfed infants
are associated with lower risk of developing atopy, GI disorders (inflammatory bowel
disease and celiac), obesity, allergies and diabetes mellitus. Prior to the 19th century,
the alternative to breast milk for infants was animal milk, however, technological
advancements in food preservation lead to the development of evaporated milk in
the mid to late 1800s [Stevens et al., 2009]. Soy infant formula was later developed
and produced in the 1920s as an alternative for infants that exhibited allergies
towards lactose [Fomon, 2001, Stevens et al., 2009]. Over the past several decades,
globalization, industrialization, unregulated marketing, and government control of
food (i.e. the Special Supplemental Nutrition Program for Women, Infants, and
Children ’WIC’), helped artificial infant formula rise in opposition to breastfeeding
[Kent, 2015,Stevens et al., 2009].
There are different kinds of artificial infant formulas commercially available which
are milk (cow, goat) based or soy based and come in liquid (ready to use) or pow-
dered form. The processing of milk products through pasteurization, concentration,
or spray drying for infant formulas has conflicting results on its effect on the con-
centration of AFM1, and those showing alteration to concentration levels have been
reported to be insignificant [Fink-Gremmels, 2008]. According to the CDC Breast-
feeding report card, the percentage of breast fed infants in the U.S. has increased by
almost 20% over the past two decades, as breastfeeding rates at 60% in 1994 have
risen to 81.1% in 2013 [U.S.EPA, 2011, Li et al., 2002, CDC and National Immu-
nization Survey, 2016]. It is important to mention that these estimates can obscure
socio-demographic and cultural differences and represent the percentage of women
that have partially breastfed and not necessarily those sticking to the strict 6 month
exclusion period [Rossen et al., 2016]. For milk, the carry-over of mycotoxins from
feed to milk is the percentage of the recoverable toxic compound that has been
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excreted in the milk. Reviews by Fink-Gremmels 2008 and Becker-Algeri et al.,
2016 reported the feed to milk carry-over percentages in cows for DON (0.0001 -
0.0002%), T-2 (0.05 - 2.0%), FB1 (0.05%) ZEA (0.06 - 0.08%), OTA (0.03%), and
AFM1 (2.0 - 6.2%). Aside from AFM1, the carryover is generally considered to be
very low, and therefore not regulated in milk products, however, AFM1 is regulated
by the FDA (0.5 µg/kg) and the EU (0.025 µg/kg for infant formula and 0.05 µg/kg
other) in milk products sold [Fink-Gremmels, 2008,Becker-Algeri et al., 2016].
This carry-over occurs through lactational transfer where lipophilic chemicals can
penetrate membrane barriers and concentrate in milk fat globules [EFSA Scientific
Committee et al., 2017]. Fat content is a major determinant of mycotoxin level in
milk, so the concentration of mycotoxins can vary at different periods of lactation in
addition to other factors like diet, season, and volume production [Fink-Gremmels,
2008,Warth et al., 2016].
The milk to plasma ratio (M/P) for human or cow is the concentration of the
mycotoxin in milk divided by the concentration of mycotoxin in maternal plasma.
This ratio can help find the concentration of mycotoxin in milk and can be used
to estimate the infants mycotoxin dose excreted from their mother [Warth et al.,
2016]. It is important to consider the difference between ruminants and humans for
milk carryover in respect to metabolism and milk processes. However, given that
information on food to milk mycotoxin carryover in humans is more limited, the
percentages for cow milk can provide a guiding estimate on what to expect [Warth
et al., 2016]. Mycotoxins that have a longer half-life, less protein binding, lower
molecular weight, high bioavailability, greater tissue distribution, and an overall
higher M/P ratio are more likely to have greater transfer into milk [Fink-Gremmels,
2008,Degen et al., 2017].
Degen et al., 2017 recently assessed how maternal intake of mycotoxins at TDI
relates to a nursing infants exposure [Degen et al., 2017]. This is important to
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understand because while the TDI may be acceptable for the mother, it may not
be for infants who are consuming excessive quantities of milk as their only form
of nutrition. Through a series of calculations they determined the concentrations
of mycotoxins AFB1, CIT, DON, FB1, OTA, PAT, T-2/HT-2, and ZEA in breast
milk at TDI for single-dose and AFB1, CIT, OTA, and ZEA for a continuous daily
intake dose. The concentrations in breast milk were then multiplied by the average
amount of milk (0.185 L) consumed per kg of body weight for the given age range to
give infant daily dose (IDD) values for a mothers single dose and continuous daily
dose [Degen et al., 2017]. Given the relatively undeveloped excretory function of an
infant (up to 16 weeks of age), the IDD was then divided by a factor of 3 to adjust
for age [Degen et al., 2017]. The IDD/corrected TDI (ratio) values for the single
maternal dose and of AFB1, CIT, DON, FB1, OTA, PAT, T-2/HT-2, and ZEA
are 0.01/0.228 (0.04), 0.1/66.6 (0.002), 651/333 (1.96), 0.23/666 (0.0003), 1.33/5.8
(0.23), 296/133 (2.2), 2.55/33 (0.08), and 1.2/83 (0.02) ng/kg bw/day respectively.
The IDD/infant corrected TDI (ratio) for the continuous daily maternal doses of
AFB1, CIT, OTA, and ZEA were 0.04/0.228 (0.17), 0.09/66.6 (0.001), 314.2/5.8
(54.2), and 0.08/83 (0.001) ng/kg bw/day. From their data, the authors indicate
that the IDD for DON and PAT exceed the acceptable TDI for single doses, while
continuous maternal intake of OTA means an IDD that greatly exceeds the corrected
infant TDI [Degen et al., 2017]. It is therefore suggested that the TDI for OTA
Figure 5.2: Lactational transfer (adapted from [Warth et al., 2016])
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should be re-evaluated for nursing mothers [Malir et al., 2013,Degen et al., 2017].
Not unlike the idea of wet nurses from previous centuries, human milk banks
have been increasing over the past decades, with 27 in North America and several
hundred internationally (locations can be found and explored [HMBANA, 2016]).
First donors are thoroughly tested and screened for a variety of physical health fac-
tors and then the milk is also regularly tested and processed for bacterial pathogens.
However, there is very little information at all on whether or not they test for my-
cotoxins in donated breast milk [for Clinical Practice at NICE (UK et al., 2010].
Donor milk is generally received by preterm infants and neonates (less than 4 weeks),
who may be at an increased risk of exposure to mycotoxins. Therefore, it would
be beneficial to incorporate biomonitoring and detection methods for mycotoxins
into the donated milk screening process (and of the donors, as well), particularly in
areas that are known to have higher incidences of exposure. A study by Navas et
al., 2005 used HPLC-FD to detect and quantify AFM1 and OTA in samples of milk
from the Human Milk Bank of the Southern Regional Hospital, So Paulo, Brazil.
Of the 20 samples they analyzed, only 1 had detectable levels of AFM1 (20 ng/L)
and 2 for OTA (10 and 20 ng/L). They suggested that other Human Milk Banks
throughout Brazil should also be tested [Navas et al., 2005]. A follow up to this
study was conducted by Iha et al., 2014 with 100 samples from a Human Milk Bank
of the Hospital das Clnicas - USP, in Ribeiro Preto City during June 2011 to Aug
2012. This is predominantly agricultural region of So Paulo, Brazil [Iha et al., 2014].
For this study they used LC-FD and the LOD and LOQ for both mycotoxins was
0.3 ng/L and 0.8 ng/L respectively. The analysis showed 66 out of 100 samples had
OTA ranging from 1 - 21 ng/L with an average of 4 ng/L. Only 2 out of 100 samples
had AFM1 at 0.3 and 0.8 ng/L with one of them also containing OTA at 1.1 ng/L.
These concentrations were within legal limits.
As mentioned previously, formula cow milk and soy milk are alternatives. It has
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been reported that 25% of U.S. new borns consume soy infant formula, which may
pose chronic health issues due to a combination of phytoestrogens, mycoestrogens
(ZEA) and estrogenic isoflavins [Patisaul and Jefferson, 2010]. There are very few
reports or information on occurrence or detection of ZEA in soy based infant formula,
however, the EU guidance level for ZEA contamination in infant formula/food should
not exceed 20 ng/mL [Warth et al., 2016,EFSA CONTAM Panel et al., 2017].
Cappozzo et al., 2017 and Mitchell et al., 2017 conducted a two year survey
that investigated the occurrence of OTA in infant cereal and formula in the US
market. They collected both conventional and organic forms of milk, soy based
formula, and cereals (barley, rice, oat, wheat, and mixed grain) to be analyzed.
Based on LC-MS/MS, the LOD and LOQ for infant formula was 0.1 ng/g and 0.25
ng/g while infant cereals was 0.1 ng/g and 0.5 ng/g. Over the two year period,
there was no OTA detected in US infant formulas. However, OTA was detected
in 30% (first year) and 31% (second year) of infant cereals at levels above the
European Unions established limit (0.5 ng/g) for this food type. Similarly, oat and
rice based breakfast cereals were found to exceed the EU limit for cereal products not
intended for infant. There was no significant difference between the contamination
levels in organic versus conventional foods. Oat based infant cereals and oat based
breakfast cereals were found to have the highest occurrence of OTA (30/51 and
142/203) [Cappozzo et al., 2017,Mitchell et al., 2017]. In Brazil, AFM1 was detected
in 43.8% of the infant formula powder samples 0.024 ± 0.01 (n.d. - 0.046) ng/g which
just barely falls below the EU limit (0.025 ng/g) [Ishikawa et al., 2016]. This study
also showed that there was a lower occurrence of AFM1 in breast milk at much
smaller concentrations 0.018 ± 0.005 (n.d.- 0.025) ng/g. Areas of West Africa and
the Middle East had relatively high levels of AFM1 in most of their samples tested at
levels that exceeded the EU and US (0.5 ng/g) regulations [Ware et al., 2017,Raad
et al., 2014]. In Serbia, Torović et al., 2018 tested samples of juices and purées
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intended for infants and children for PAT. 44% of the juice samples and 16% of the
purée samples were contaminated with 8.3 and 7.7 ng/g respectively and falls just
below the EU regulation of 10ng/g for PAT in any product intended for infants and
children, while 43% of the juice samples for children had around 30.2 ng/g which
exceeds 10 ng/g [Torović et al., 2018]. The PMTDI for PAT is 0.4 µg/kg bw/day,
however, WHO/JECFA estimates that the daily intake for children is 0.2 µg/kg
bw/day which is 50% of what is deemed tolerable More examples are shown in the
table 5.3; and two studies show the occurrence of multiple mycotoxins in formula
and cereal which is a cause for more concern due to possible synergistic activity of
mycotoxins [Ware et al., 2017,Assunção et al., 2016].
Table 5.3: Mycotoxins in food meant for infants and young children. Occurrence and
concentration of mycotoxins in food products meant for infants and young children.
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5.2.2 Growth and Development in Children
Growth and development in children is dependent on several interrelated factors
such as nutrition, hormones (i.e. GH, insulin), environment, exposure to toxins and
medications, and recurrent or chronic illness [Smith et al., 2012]. Thus the patho-
genesis of growth stunting in children has been tied to environmental enteropathy
which may be caused by intestinal disruption from chronic exposure to AFB1, DON,
and FB1 amongst other things [Smith et al., 2012]. Several studies have shown that
AFB1, DON, and FB1 alone and together are able to decrease TEER (transep-
ithelial electrical resistance) values, transcription and expression levels of TJ (tight
junction) proteins and increase permeability, translocation as well as up-regulate
immune cell and cytokine expression [Bracarense et al., 2012,Gao et al., 2017,Chen
et al., 2016, Vandenbroucke et al., 2011]. Stunting can be associated with chronic
malnutrition while the occurrence of being underweight can indicate acute malnu-
trition [Gong et al., 2002]. Enteropathy in young children has been associated with
chronic immune stimulation and is inversely correlated with growth [Smith et al.,
2012,Turner et al., 2007].
A study conducted by Gong et al., 2002 studied 480 children (9 months to 5
yrs) from 16 villages in West Africa. They detected AF-albumin adducts in 475
samples that had a GM of 32.8 pg/mg. From ages 1-3 they found a steady increase
in AF-alb concentration, and that children who were weaned had almost 2.5 times
the concentration of those who were still being breastfed. Underweight children
with stunting displayed 30-40% greater AF-alb concentration as well. The authors
suggest that the weaning process and transition to solid foods in AFB1 prevalent area
and co-exposure with other infectious issues may result in growth faltering [Gong
et al., 2002]. Castelino et al., 2015 conducted a study using samples from 199
schoolchildren in Kenya that were analyzed for AF-alb, IGF1, and IGF-binding
protein-3 (IGFBP3) with ELISA. They found that levels of AF-alb were inverse
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to IGF1 and IGFBP3, IGF1 and IGFBP3 was associated with height and weight,
and those with highest AF-alb levels (>198.5 pg/mg) were shorter than children
with the lowest level of exposure (<74.5 pg/mg). They then conducted an in vitro
test using HHL-16 (human hepatocyte cell line) treated with 0.5-20 µg/mL for 24-
48 hours and measured the IGF1 and IGFBP3 gene expression by qPCR, which
revealed that AFB1 down-regulated the genes and protein levels of IGF [Castelino
et al., 2015]. A study conducted by Kimanya et al., 2010 revealed that children
with FB1 intake that exceeded the PMTDI had reduced height and weight than
those who had consumed less FB1 [Kimanya et al., 2010]. Several studies have
shown that DON can decrease growth and down regulate IGF1 and IGFALS (insulin
like growth factor binding protein acid labile subunit) [Amuzie and Pestka, 2009a].
Studies have also shown that DON decreases glucose absorption by inhibiting the
specific transport proteins as well as reducing the uptake and transfer of vitamin
B12 in different animal models [Hunder et al., 1991,Maresca et al., 2002,Amuzie and
Pestka, 2009a]. No studies have been conducted that correlate child stunting with
DON, however, in Belgium, the UK, and China children exposure to DON ranges
from 33-69.7% [Heyndrickx et al., 2015,Papageorgiou et al., 2018,Deng et al., 2018]
Some of the major effects of ZEA in children target the reproductive systems
and interrupt organ structure and function. In the late 70s and early 80s there were
increased epidemics of central precocious puberty and premature thelarche (onset
of breast development) in Northern Italy and Puerto Rico that was attributed to
the consumption of meat tissue and dairy that was contaminated with anabolic es-
Table 5.4: Urinary DON biomarker analysis for children and adolescents.
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trogens such as zeranol (α-zearalanol) that is used to increase the growth rate in
animals [Fara et al., 1979, de Rodriguez et al., 1985, Massart et al., 2008]. Ban-
dera et al., 2011 conducted a cross-sectional analysis of 163 healthy girls from 9
to 10 years of age that were participating in a Jersey Girl Study [Bandera et al.,
2011]. They used data from questionnaires, anthropometric measurements, puberty
staging, dietary intake and assessments to find a relationship with the presence of
ZEA mycoestrogens in urine. A subset (n=58) of girls had dietary recalls the day
before their urine was collected. Interestingly, they found that when urinary levels
were compared to food consumption on the previous day, beef and popcorn were
the only food products that were related to urinary ZEA and total mycoestrogens.
The GM of total mycoestrogens was 7.11 ng/mL for those who consumed beef and
popcorn before urine collection and was 0.07 ng/mL for those who did not con-
sume those products. When they evaluated anthropometric characteristics with
urinary mycoestrogen, they found that mycoestrogen-negative girls were taller, had
adiposity (more fat), and had reached the onset of breast development compared
to mycoestrogen-positive girls who were found to be shorter and less likely to have
reached the onset of breast development. These findings suggest that ZEA may
have an anti-estrogenic effect [Bandera et al., 2011]. The authors reviewed the im-
portance of this study due to evidence suggesting that the peri-pubertal period is
a critical window for the susceptibility and exposure to endocrine disrupting agents
at this time may lead to breast cancer [Bandera et al., 2011].
5.3 Obesity, Diabetes, and other Immunocompromised Individuals
On the opposite side of the spectrum from reduced weight, being overweight and
obese are risk factors for diabetes (Type 2 Diabetes Mellitus), cardiovascular dis-
ease, chronic kidney disease (CKD), cancer, and non-alcoholic fatty liver disease
(NAFLD). In the US, Louisiana, Arkansas, Mississippi, Alabama, and W. Virginia
have some of the highest rates of obesity [CDC, 2016a].
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The average American diet (aka Western Diet) is high in fat, alcohol, meat,
cholesterol and carbohydrates [Martins, 2015, Chen et al., 2016]. Glucose is taken
up through cells via facilitated diffusion with glucose transporters that is stimulated
by insulin binding to membrane receptors. Insulin resistance is an inability to re-
spond to insulin which means that glucose cannot be taken into the cell or that
there is excess blood glucose because hepatic glucose output cannot be turned off.
Insulin resistance is a common occurrence for obese and diabetic individuals [Kahn
and Flier, 2000]. As mentioned earlier, trichothecenes (DON and T-2) have been
shown to affect the expression for glucose transport proteins which could be an-
other mechanism in insulin resistance [Maresca et al., 2002, Amuzie and Pestka,
2009a]. Additionally, diets that are high in cholesterol or foods high in bacterial
LPS (lipopolysaccharides are components of the outer membrane in gram-negative
bacteria) and mycotoxins may promote increased absorption of mycotoxins and LPS,
which can then lead to or influence hypercholesterolemia (which negatively influence
cholesterol synthesis and liver cholesterol metabolism), dyslipidemia (elevated lev-
els of plasma cholesterol that can lead to atherosclerosis), and NAFLD [Martins,
2015, Anyanwu et al., 2006]. Cholesterol is a necessary membrane component that
is important to hepatocytes and neurons for proper function, as well as maintaining
Figure 5.3: A look at obesity in the US. Percent of Obese Adults having a body
mass index (BMI) greater than 30 [Trust for America’s Health et al., 2017, CDC,
2016a].
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synaptic connections. Therefore disruption of cholesterol homeostasis can result in
blood brain barrier issues or increase neurotoxicity in the form of neurodegeneration
and possible Alzheimers Disease (which is also referred to as Type 3 Diabetes) [Mar-
tins, 2015, Mittal et al., 2016]. Exposure to certain xenobiotics such as pesticides
could have additive or synergistic effects that might interfere with hepatic elimi-
nation of mycotoxins, therefor preventative measures in encouraging diets that are
healthy and that optimize lower absorption of LPS and mycotoxins into may help
reduce neurotoxic effects [Martins, 2015].
In order to assess the effect of DON exposure in obese humans, Kobayashi-
Hattori et al., 2011 used high fat diet-induced obese mice to characterize DONs
impact on body weight and composition. Two subsets of high fat (HF) diets (45%
and 60% kcal) were fed to female B6C3f1 mice for 94 days, then each group was
divided with one half given 10 mg/kg DON added to their HF diet for 54 more days.
A control group had a low fat diet (10% kcal) for 148 days. Their results showed
that within 11 days of the addition of DON to the HF diets, the treated mice had
decreased body weight and fat mass to a level comparable to control group, along
with decreased food consumption. Using ELISA and RT-PCR they found that DON
reduced plasma insulin, leptin, IGF1, IGFALS, and increase hypothalamic mRNA
levels of orexigenic peptide agouti-related protein (AgRP) [Kobayashi-Hattori et al.,
2011].
Individuals with inflammatory diseases such as Celiac disease (CD), irritable
bowel syndrome, and gluten sensitivity (GS) have been linked with impaired intesti-
nal barrier from decreased amounts of tight junction proteins or misconfiguration of
their proper distribution [Akbari et al., 2017]. Gluten is a protein found in varieties
of wheat, barley, and rye. For CD, the ace in glutens tool box is the immunogenic
peptide gliadin, because of its resistance to pancreatic and enzymatic digestion [Proi-
etti et al., 2013, Hausch et al., 2002]. Under healthy conditions, gliadin is unable
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to pass into the lamina propria, however when tight junction proteins are modified
they can pass through. When this happens, enterocytes will secrete immune cells
signals and thus a cascade of of events ensues resulting in the secretion of cytokines
and chemokines and the recruitment of more immune cells which go on to attack
the enterocyte cells resulting in an inflammatory reaction [Vanga and Kelly, 2014].
It has been reported that if left undiagnosed or untreated, CD could precipitate
more autoimmune diseases, diabetes, osteoporosis, reproductive issues, neurological
issues, and possibly cancer [Rubio-Tapia et al., 2012]. In the U.S., it is estimated
that 3 million (1%) have CD [Rubio-Tapia et al., 2012]. Thus, it is important to
understand what mycotoxins individuals who follow gluten free diets are exposed
to. DallAsta et al., 2012 conducted a study to determine the fumonisins exposure
risk in a gluten-free diet followed by adult celiac patients as opposed to non-celiac
patients [Dall’Asta et al., 2012]. They collected data on dietary habits and analyzed
the fumonisin level in the most frequently consumed corn-based products. Their
findings indicated a higher intake of fumonisins daily for celiac patients (0.395 ±
0.049 µg/kg bw) than non-celiac patients (0.029 ± 0.006 µg/kg bw). The take away
points from this study was the increased potential of exposure risk to gluten-free
diets may consume greater amounts of maize-based products could potentially put
individuals with celiacs disease (or individuals who follow gluten-free diets for other
health reasons) at risk. However, a case-study based in Italy conducted by Cirlini
et al., 2016 collected urine samples and 7 day dietary dairies from 55 celiac patients
and 50 non-celiac individuals. The urine was analyzed for DON, ZEA, and FB1
with ZEA being the most detected in both subject groups. No significant difference
was found between celiac and non-celiac groups for mycotoxin exposure and both
were below the TDI values for each of the detected mycotoxins. However, there are
differences in diet and mycotoxin levels depending on geographical location, so the
results for Italy may not represent other regions [Cirlini et al., 2016]. There is a
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need for more data on nutritional intake for celiac and gluten-free sub-populations.
As mentioned previously, Hepatitis B virus (HBV) is a co-etiological agent with
AFB1 for the development of hepatocellular carcinoma (HCC) [Groopman et al.,
1985, CAST, 2003, Liu and Wu, 2010]. For every ng AF/kg bw/day for individuals
without HBV the incidence rate is 0.01 cases of HCC per year per 100,000 people,
however, there is a 2900% increase for individuals with HBV to 0.3 cases of HCC
per year per 100,000 people [Groopman et al., 2005, Liu and Wu, 2010]. For the
United States, the average rate of HBV per 100,000 people is just at 1.0 (s.d. 0.08),
however, some states like West Virginia, Kentucky, and Tennessee had rates of 9.8,
4.0, 3.3 respectively [CDC, 2016b]. For more information on HBV rate see figure
5.4. This could mean that individuals within theses states are at an even higher risk
for HCC from AFB1 and HBV exposure.
Figure 5.4: Average rate (green) and standard deviation (blue) of HBV per
100,000 people over 7 year period (2010-2016) in AL=Alabama, AR=Arkansas,
DE=Delaware, FL=Florida, GA=Georgia, IN=Indiana, KY=Kentucky,
LA=Louisiana, MS=Mississippi, NV=Nevada, NC=North Carolina, OH=Ohio,
OK=Oklahoma, SC=South Carolina, TN=Tennessee, VA=Virginia, WV=West
Virginia, and US=United States. Data from [CDC, 2016b].
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5.3.1 Altered diet - Vegetarians
There are many environmental benefits associated with a vegetarian diet as it is
environmentally sustainable and conscious efforts to reduce certain meat consump-
tion (demitarian) could also improve individuals health. The production behind a
vegetarian diet demands less phosphorous and nitrogen. It has been suggested that
changing from the average western diet to a vegetarian diet may reduce phosphorous
consumption by 20-25% [Cordell et al., 2009]. However, it would be beneficial to
know the degree to which vegetarian individuals are exposed to mycotoxins and if
it is within guidance values.
There are several kinds of vegetarian diets, which are devoid of flesh products but
may or may not contain egg or dairy products. Lacto-ovo-vegetarian eat both egg
and dairy products while lacto-vegetarians eat dairy but no eggs and ovo-vegetarians
eat eggs but no dairy. Vegans on the other hand do not eat eggs or dairy products and
raw vegans consume between 75-100% of uncooked vegetables, fruits, nuts/seeds,
legumes and sprouted grains [Melina et al., 2016].
In the United Kingdom, a recent cohort study was conducted by Wells et al.,
2017, which compared urinary DON levels and food consumption data of vegetar-
ians and non-vegetarians over the course of two days. Specifications for vegetari-
ans to be used in this study required that the subjects had followed this dietary
pattern for more than 12 months and that they were lacto-ovo-vegetarian. Lacto-
ovo-vegetarian do not eat meat or fish but do consume grains, nuts, seeds, fruits,
vegetables, dairy products, and eggs. In the study, DON tested positive in 100%
of non-vegetarian adults while only 77.8-90.5% for vegetarians, which the authors
suggested was counter intuitive being that vegetarians are considered to be a high
risk group. Additionally, they reported that female vegetarians tested positive for
urinary DON more often than males. On day 1 and 2 of the study, non-vegetarians
had mean levels of 3.05 ng DON/mg creatinine and 2.98 ng/mg respectively, with
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an estimated intake of 422 ng/kg bw/day and 537 ng/kg bw/day which was within
TDI levels. Vegetarians on the other hand, had 6.69 ng DON/mg creatinine fol-
lowed by 2.42 ng/mg, this meant that intake of DON was 855 ng/kg bw/day of
DON and 654 ng/kg bw/ day, suggesting that 32% of UK vegetarians exceed the
TDI for DON [Wells et al., 2017].
There are no biomonitoring studies that monitor mycotoxin exposure in America.
Based on data from the Continuing Survey of Food Intake by Individuals (CSFII) in
1994-1996 and 1998, around 13,341 participants aged 6 and older were asked if they
define themselves as vegetarians [Haddad and Tanzman, 2003]. Approximately 2.5%
of the respondents identified as vegetarians. According to 2016 online poll conducted
by the Vegetarian Resource Group approximately 3.3% of the American population
identifies as vegetarian (which also includes vegan) based on 2,015 responses from
adults over the age of 18 (for more details on this online poll, see [Vegetarian Re-
source Group, 2016]). Food consumption studies have shown that vegetarians may
consume more grains and nuts than non-vegetarians [Haddad and Tanzman, 2003].
Additionally, the increased consumption of soy based products could also increase
exposure to estrogenic chemicals like ZEA and isoflavones [Messina and Messina,
2010]. There is an ongoing dispute between the benefits of soy rich diet versus
chronic health risks from endocrine disrupters. However, there is not enough in-
formation and more research is required [Messina and Messina, 2010, Patisaul and
Jefferson, 2010]. More biomonitoring studies should be conducted on vegetarian
populations for DON, AFB1, FB1, OTA, and ZEA in order to determine if there
are significant exposure related differences that could lead to health problem and to
inform people of possible preventative measures that could alleviate them (chemo-
protection, additives, or binding agents).
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5.4 Summary
Several factors determine an individuals dietary habits such as age, geography, cul-
ture, socioeconomic standing, or disease. Diets in conjunction with various differ-
ences in physiological processes can show a myriad of issues from toxic exposures.
Multiple animal studies have shown that mycotoxins can be reproductively toxic
both prior to conception and during gestation. Epidemiological studies where preg-
nant women have been exposed to doses above TDI/PMTDI have been correlated
with adverse birth outcomes. Chronic low levels of exposure may result in epigenetic
modifications that could lead to defects and diseases latter in the life of the progeny
exposed to mycotoxins during gestation. The timing that a lactating woman is ex-
posed to mycotoxins may result in different concentrations of excreted metabolite in
milk depending on milk fat content, individual clearance rate, and prior exposures.
Regulations and MLs have been imposed by the FDA and EU to monitor AFM1
in dairy products that are sold on the market, however there is no such regula-
tion of AFM1 in breast milk from human milk banks. Adding mycotoxin testing
to breast milk donated to human milk banks could provide a platform in which
regional monitoring for an area could inform the population of regular mycotoxin
exposure in infants. There should also be more occurrence data and studies for soy
milk infant formula and the potential occurrence of mycoestrogens. In light of these
issues: i) more clearance and half-life data is necessary for better understanding and
estimation, ii) breast milk in milk banks should be regularly tested/monitored for
mycotoxins, iii) areas where foods and diets are uncharacteristically high in myco-
toxins should help educate breast feeding mothers so they can adjust their intake
or take precautionary measures. Young children also consume a great amount of
milk and milk alternatives so occurrence studies exposure assessments in relation
to other milk alternatives such as almond milk, rice milk, flax milk would also be
beneficial. In children and adults, mycotoxin induced alterations in metabolic en-
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ergy and nutrient uptake processes, GIT disruption, and endocrine disruption could
negatively affect growth, reproductive development and processes, chronic immun-
odeficient complications, neurodegenerative disorders, or cancer (breast/hepatic).
Public education and outreach regarding such contamination in foods is critical so
that the individual be informed enough on the topic help them plan their diet or
monitor their intake in such a way that prevents significant exposure that may lead




A significant chronic health risk exists due to multiple mycotoxin levels in the Ameri-
can diet. Human exposure to mycotoxins present in food poses a greater health risk
than presently acknowledged due to combinations of different mycotoxins, which
harbor potential synergistic adverse health impacts.
One of the goals of this document is to paint a solid picture of just how ubiquitous
mycotoxins are in our world and how constant they are in our diet. Humans and
animals are generally exposed to multiple mycotoxins in chronic low doses daily.
For the most part, it is assumed that a majority of mycotoxin exposures occurs
through dietary ingestion. According to a worldwide survey that looked at samples
from 72 countries, 71% were co-contaminated with more than one mycotoxin de-
tected [BIOMIN, 2018]. From the limited but increasing information available for
fungal genomics, it is understood that some genes involved in mycotoxin synthesis
are clustered together on chromosomes and are co-regulated under similar mecha-
nisms [Keller and Hohn, 1997,Keller et al., 2005,Woloshuk and Shim, 2012]. Thus,
multiple mycotoxins can actually be expressed under the same regulatory conditions
and factors [Keller et al., 2005]. Additionally, as food items continue along the food
or feed processing chain, they can find themselves infected by different fungal species
(i.e. Aspergillus spp. and Penicillium spp.) that can produce more and different
mycotoxins. Table 4.2 shows a range of mycotoxin concentration levels averaged
from multiple studies around the world with usual conditions and worst case sce-
nario conditions [Grenier and Applegate, 2013]. Table 4.3 and 4.4 show mycotoxin
levels detected in food/feed samples after some kind of processing or transportation.
The ability to detect mycotoxins depends on the sample preparation and detection
method used, due in part to the chemical properties of different mycotoxins and if
they are in conjugated form. Also the LOD matters a great deal because mycotox-
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ins can be present in very low levels which may elude detection. There have been
advances in recent years that allow multiple mycotoxin to be detected in a sample
(food matrix or biological matrix) at once (see Table 4.4), however techniques for
detection still need to be improved.
Diet studies and food monitoring surveys can help to understand food consump-
tion trends at an individual and national level, and when combined with mycotoxin
occurrence data can provide estimates of daily exposure intake. In Table 4.5, average
adults were evaluated based on whether they consumed more than the health based
guidance values. Most mycotoxins EDIs for the average American adult are below
acceptable limits, (except for AFB1 and DON), however, vulnerable groups such
as pregnant woman and children could be exposed to almost a double the average
adult intake (see Table 6.1).
Current diet and food monitoring studies are still very limited in their ability to
predict accurate estimates, and can be severely over or under estimated. Biomon-
itoring studies using mycotoxin biomarkers from human and animal samples can
further improve the mycotoxin exposure estimates and the potential effects on the
human body (see Table 5.2) with more evidence from the biological sample testing.
Acute high doses of mycotoxins that can lead to drastic mycotoxicosis diseases
or high mortality rates have been seen throughout the 20th and 21st centuries in
multiple countries for both animals and humans. Some of the reported outbreaks
and cases have occurred in countries such as Russia (Toxic Alimentary Aleukia),
Table 6.1: Comparison of Mycotoxin Exposure for Avg. Adult and Vulnerable
Groups (U.S. centered information or GEMS/Food cluster alternative G10 or world
wide estimates) [].
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Japan (Akakabi-byo), Denmark (porcine nephropathy), Africa (aflatoxicosis), India,
France, and the U.S. [CAST, 2003, Desjardins, 2003]. Acute high doses are rep-
resentative of unusually high concentrations of mycotoxin level in food due to an
assortment of factors that optimize mycotoxin(s) production. Different regions may
have higher prevalence of certain mycotoxins synthesized over the others depending
on climate, crop, or ecology, however, we live in such a globalized economy and we
often eat food from different regions and places. This means that its very hard to
assume that one country is only being exposed to certain contaminants. Further,
even if a country or region is not exposed to acute high doses, these compounds can
still be present in chronic low daily doses. It is important to realize that regardless
of where an individual lives, they are very likely getting chronic low daily doses of
multiple mycotoxins.
The mycotoxin itself can have different mechanisms of action such as inhibition of
protein, DNA, or RNA synthesis, or the inhibition of critical enzymes (i.e. ceramide
synthase) and these mechanisms generally all lead to adverse effects at the cellular
level (see Table 3.2). Further complicating matters are the interactions between co-
contaminating mycotoxins and other chemicals that an individual can be exposed
to on a daily basis (i.e. residual pesticides, pharmaceuticals, lead). Interacting ef-
fects can be described as additive (combined effect equal to sum of the individuals),
synergistic (combined effect greater than the individuals), and in some cases antag-
onistic (combined effect less than the individuals). Alarmingly, The most common
interactions between mycotoxins are additive and synergistic; figure 6.1 shows the
combined toxicity and interactive effects between several mycotoxins in different ex-
perimental systems for cytotoxic and genotoxic endpoints. It is important to point
out that major mycotoxins such as AFB1, OTA, FB1, and DON all have strong
synergistic interactions with each other.
The chronic exposure to small doses of synergistic mycotoxins in the American
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Figure 6.1: Combined toxicity and interactive effects of multiple mycotoxin studies
in different experimental systems (see appendix Table A.2 for references).
diet is very alarming. However, compared to other organizations, such as the Euro-
pean Commission of the EU, the FDAs regulatory agenda for mycotoxins is lacking.
Action levels are set limits that, if surpassed, the FDA will remove a product or
substance from the market. There are action levels set for aflatoxins (see Table 6.2)
and patulin (see Table 6.3). The EU, has much lower maximum limits for total afla-
toxins, AFB1, and especially AFM1 in milk and dairy products for both the general
public and an even lower dose for anything intended for infants and children. The
action levels for animal feed in the US range from 20-300 ppb, with 20 ppb for feed
intended for dairy cows and immature animals and 300 ppb for finishing feed. The
EU on the other hand sets the maximum AFB1 level in any feed at 20 ppb. Pat-
ulin has similar levels in both the FDA and the EU, however, the EU requires any
product designated for the consumption of small infants and children to be below
10 ppb.
The FDA currently has advisory levels for DON (see Table 6.4), which means that
should the contamination level exceed a certain limit, they can take action, however,
they also might not. This is not exactly reassuring. There are also guidance levels
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Table 6.2: Regulatory Levels for Aflatoxins by FDA and EU [Council of European
Union, 2006].
for combined FB1+FB2+FB3 (see Table 6.5), but theses guidance levels again have
no enforcement behind them. The FDA only considers 4 mycotoxins (and ergot)
to be of any importance, regulatory-wise. The EU, on the other hand, considers
10 different mycotoxins and are consistently updating their regulatory limits for
mycotoxins as more information emerges. Further, they follow a consistent pattern
of setting much lower limits for products destined for infants and children, as well
as immature, breeding, and dairy animals.
The reason for the difference in the EU and US approach to mycotoxin regulation
is how they consider the problem. The FDA is considering single mycotoxins by
themselves, whereas the EU may be considering the whole picture, which allows
for multiple exposures to multiple mycotoxins in chronic low doses every day. This
Table 6.3: Regulatory Levels for Patulin by FDA and EU [Council of European
Union, 2006].
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Table 6.4: Regulatory Levels for Deoxynivalenol by FDA and EU [Council of Euro-
pean Union, 2016].
difference in approach could explain why the EU has much lower limits on mycotoxin
exposure. Therefore, the FDA needs should update and reevaluate and consider
lowering mycotoxin regulatory limits as well as add regulations for more mycotoxins.
Research funding for human biomonitoring could further help understanding
the effects of life long exposure to chronic low doses of multiple mycotoxins and
Table 6.5: Regulatory Levels for Fumonisins by FDA and EU [Council of European
Union, 2010].
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may be especially beneficial to pin point areas, populations, or both that are at
higher risk from mycotoxin exposure. Southwest Texas along the Mexican border
is such an area in the United States that have a routinely high precedence for
mycotoxin occurrence and livestock disease from mycotoxin exposure. Populations
that have been discussed in this thesis that are more susceptible to chronic low
level mycotoxin co-exposure are infants, children, pregnant or lactating women, and
individuals with viral infections (i.e. HBV) or disease (i.e Celiac disease). Important
observational and biomonitoring areas should be states like West Virginia, Kentucky,
and Tennessee because they exceed the national average rate of HBV incidence (see
Figure 5.4). Obesity also enhances the deleterious effects of mycotoxin exposure, and
therefore areas that are known to have high BMIs (see Figure 5.3) could benefit from
mycotoxin biomonitoring. There are human milk banks all around the U.S. that take
in breast milk and screen the mothers and test the milk for various contaminants
already, therefore its seems prudent to add an additional mycotoxin test to the
screening process. This would be beneficial to monitor the level of mycotoxins the
neonates and preterm infant recipients of said breast milk and to use an already
existing system to provide critical information on human mycotoxin exposure in
two vulnerable populations. Research from human biomonitoring programs could
help inform and encourage policy makers to change regulatory limits as necessary
as well as educate the public so that they can make better consumer choices.
Efforts to educate the public about the chronic persistence of mycotoxins in daily
diet as well as make mycotoxin occurrence data information available for consumer
information would be beneficial. Simply stating that certain mycotoxins are present
in the product on the product label would be a step forward. Gluten for example is
on the product label and now the gluten free industry is projected to be worth over
7.5 billion USD world wide by 2020 [Masih, 2018]. In this way a combination of
regulatory and dietary guidelines might help influence consumer choice, which may
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help change our agricultural processes. Education gaps about mycotoxins among
the agricultural industry and public could be bridged so that people are more aware
of this chronic problem, and come up with helpful ways to mitigate mycotoxin
occurrence and exposure. This could hopefully encourage mycotoxin detection levels
to be made more public and updated for U.S. products.
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[Bräse et al., 2013] Bräse, S., Gläser, F., Kramer, C., Lindner, S., Linsenmeier,
A. M., Masters, K.-S., Meister, A. C., Ruff, B. M., and Zhong, S. (2013). The
chemistry of mycotoxins, volume 97. Springer Science & Business Media.
[Brown et al., 1999] Brown, R., Chen, Z.-Y., Cleveland, T., and Russin, J. (1999).
Advances in the development of host resistance in corn to aflatoxin contamination
by aspergillus flavus. Phytopathology, 89(2):113–117.
[Burn, 2000] Burn, D. (2000). Parkinson’s disease: treatment. Pharmaceutical Jour-
nal, 264:476–479.
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der, J., Barreg̊ard, L., Bignami, M., Brüschewiler, B., Ceccatelli, S., Cottrill, B.,
Dinovi, M., Edler, L., Grasl-Kraupp, B., Hogstrand, C., Hoogenboom, L., Nebbia,
C., Ptersen, A., Rose, M., Roudot, A., Schwedtle, T., Vleminckx, C., Vollmer, G.,
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[Klarić et al., 2013] Klarić, M. Š., Rašić, D., and Peraica, M. (2013). Deleterious
effects of mycotoxin combinations involving ochratoxin a. Toxins, 5(11):1965–
1987.
[Klotz, 2015] Klotz, J. L. (2015). Activities and effects of ergot alkaloids on livestock
physiology and production. Toxins, 7(8):2801–2821.
[Kobayashi-Hattori et al., 2011] Kobayashi-Hattori, K., Amuzie, C. J., Flannery,
B. M., and Pestka, J. J. (2011). Body composition and hormonal effects following
exposure to mycotoxin deoxynivalenol in the high-fat diet-induced obese mouse.
Molecular nutrition & food research, 55(7):1070–1078.
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A.1 Chapter 1 Supplementary Figures
Figure A.1: Fungal cell metabolism chart showing secondary metabolism pathways
and products (modified from [Nielsen and Nielsen, 2017]).
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A.1 Mycotoxin Structure & Characteristics




Figure A.3: Citrinin derivatives and molecular weight.
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Tricothecene
R1 R2 R3 R4 R5
MW
(g/mol)
A T-2 OH OAc OAc H OCOCH2
CH(CH3)2
466.527
HT-2 OH OH OAc H OCOCH2
CH(CH3)3
424.49
DAS OH OAc OAc H H 366.41
NEO OH OAc OAc H OH 382.16
B DON OH H OH OH O= 296.12
3-ADON OAc H OH OH O= 338.356
15-ADON OH H OAc OH O= 338.35
NIV OH OH OH OH O= 312.12
FUS-X OH OAc OH OH O= 354.13
Figure A.4: Trichothecene derivatives and molecular weight.
Patulin MW (g/mol)
PAT 154.12


































Figure A.8: Zearalenone derivatives and molecular weight.
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R1 R2 R3 MW(g/mol)
ENA sec-butyl sec-butyl sec-butyl 681.90
ENA1 isopropyl sec-butyl sec-butyl 667.87
ENB isopropyl isopropyl isopropyl 639.82
ENB1 isopropyl isopropyl sec-butyl 653.85
BEA benzyl benzyl benzyl 783.50
Figure A.9: Enniatins and beauvericin derivatives and molecular weight
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A.2 Chapter 3 Supplementary Material
Figure A.10: Bioactivation of AFB1 (modified from [Bbosa et al., 2013])
A.3 Chapter 4 Supplementary Material
Figure A.11: Total foods consumed in g/day by children and adults. For total pop-
ulation consumption see figure 4.1. Source: 2007-10 National Health and Nutrition
Examination Survey []
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Afganistan, Algeria, Azerbaijan, Iraq, Jordan, Libya, Mauritania, Mongolia, Morocco, Occupied
Palestinian Territory, Pakistan, Syrian Arab Republic, Tunisia, Turkmenistan, Uzbekistan, Yemen
G02
Albania, Bosnia & Herzegovina ,Georgia, Kazakhstan, Kyrgyzstan, Montenegro, Republic of
Moldova, Ukraine
G03
Angola, Benin, Burundi, Cameroon, Congo, Côte d’ivoire, Democratic Republic of the Congo,
Ghana, Guinea, Liberia, Madagascar, Mozambique, Paraguay, Togo, Zambia
G04
Antiga and Barbuda, Bahamas, Barbados, Brunel Darussiam, French Polynesia, Grenada, Israel,
Jamaica, Kuwait, Netherlands Antilles, Saint Kitts and Nevís, Saint Lucia, Saint Vincent and the
Grenadines, Saudi Arabia, United Arab Emirates
G05
Argentina, Boliva, Brazil, Cape Verde, Chile, Colombia, Costa Rica, Djibouti, Dominican Republic,
Ecuador, El Salvador, Guatemala, Guyana, Honduras, India, Malaysia, Maldives, Mauritius, Mexico,
New Caledonia, Nicaragua, Panama, Peru, Seychelles, South Africa, Suriname, Tajikistan, The
former Yugoslav Republic of Macedonia, Trinidad and Tobago, Bolivarian Republic of Venezuela
G06 Armenia, Cuba, Egypt, Greece, Islamic Republic of Iran, Lebanon, Turkey
G07
Australia, Bermuda, Finland, France, Iceland, Luxembourg, Norway, Switzerland, United Kingdom,
Uruguay
G08 Austria, Germany, Poland, Spain
G09
Bangladesh, Cambodia, China, Democratic People’s Republic of Korea, Guinea Bissau, Indonesia,
Lao People’s Democratic Republic, Myanmar, Nepal, Philippines, Sierra Leone, Thailand, Timor
Leste, Vietnam
G10
Belarus, Bulgaria, Canada, Croatia, Cyprus, Estonia, Italy, Japan, Latvia, Malta, New Zealand,




Botswana, Burkina Faso, Central African Republic, Chad, Ethiopia PDR, Gambia, Haiti, Kenya,
Malawi, Mali, Nambia, Niger, Nigeria, Senegal, Somalia, Sudan, Swaziland, United Republic of
Tanzania, Zimbabwe
G14 Comoros, Fiji Islands, Papua New Guinea, Solomon Islands, Sri Lanka, Vanuatu
G15
Czech Republic, Denmark, Hungary, Ireland, Lithuania, Portugal, Romania, Serbia and Montenegro,
Slovakia, Slovenia, Sweden
G16 Gabon, Rwanda, Uganda
G17 Samoa, Sao Tome and Principe
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A.4 Chapter 6 Supplementary Material
Table A.2: Table of Combined Mycotoxin Effects (see Figure 6.1).
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